File Name,Date of Petition,Identity of Submitting Entity,Source_Year
FDA-2000-P-0001-0002_Citizen_Petition_from_Pfizer__Inc_.pdf,"August 17,200",Pfizer  Inc,2000
FDA-2000-P-0060-0007_Citizen_Petition_from_Iceberg_Industries_Corporati.pdf,"September 
28,200",Iceberg Industries Corporati,2000
FDA-2000-P-0064-0002_Change_in_Classification_Petition_from_Biosite_Dia.pdf,"November 14, 2000",Biosite Dia,2000
FDA-2000-P-0097-0001_Frozen_Desserts__Petition_to_Revoke_Standards_for_.pdf,"November 30, 2021",Revoke Standards for,2000
FDA-2000-P-0097-0006_Citizen_Petition_from_Kraft_Foods__Inc_.pdf,"August 28,200",Kraft Foods  Inc,2000
FDA-2000-P-0097-0009_Citizen_Petition_from_Sartori_Foods_Corporation.pdf,"December 20,200",Sartori Foods Corporation,2000
FDA-2000-P-0097-0024_TMP_and_Petition_to_Amend_the_Standard_of_Identity.pdf,"November 30, 2021",Amend the Standard of Identity,2000
FDA-2000-P-0102-0018_Cargill_Inc___Covington___Burling____Petition_for_.pdf,"January 7, 2011",Cargill Inc   Covington   Burling,2000
FDA-2000-P-0126-0001_Milk___Cream_Products___Yogurt_Products__Petition_.pdf,"February 18, 2000",,2000
FDA-2000-P-0126-0006_Milk___Cream_Products___Yogurt_Products__Petition_.pdf,"February 18, 2000",,2000
FDA-2000-P-0126-0007_National_Yogurt_Association___Citizen_Petition.pdf,"September 21, 1982",National Yogurt Association,2000
FDA-2000-P-0126-0110_Milk_and_Cream__Petition_for_an_Administrative_Sta.pdf,"March 23, 2022",Milk and Cream,2000
FDA-2000-P-0133-0017_Covington___Burling__Cargill_Inc_____Petition_for_.pdf,"January 7, 2011",Covington   Burling  Cargill Inc,2000
FDA-2000-P-0212-0001_New_Jersey_General_Assembly___Citizen_Petition.pdf,"June 3,1993",New Jersey General Assembly,2000
FDA-2000-P-0244-0001_Citizen_Petition_from_American_College_of_OB_GYN__.pdf,"August 
23, 2000",American College of OB GYN,2000
FDA-2000-P-0252-0001_Citizen_Petition_from_Boston_Scientific_Corporatio.pdf,September 2000,Boston Scientific Corporatio,2000
FDA-2000-P-0409-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"June 22,200",Lachman Consultant Services,2000
FDA-2000-P-0412-0001_Citizen_Petition_from_Arnall__Golden___Gregory__LL.pdf,"May 16,2000",Arnall  Golden   Gregory  LL,2000
FDA-2000-P-0412-0014_Citizen_Petition_from_Consumer_Healthcare_Products.pdf,"September 8, 2000",Consumer Healthcare Products,2000
FDA-2000-P-0414-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"February 10, 2000",Lachman Consultant Services,2000
FDA-2000-P-0565-0001_Citizen_Petition_from_Pharmaceutical_Associates__I.pdf,"November 28,200",Pharmaceutical Associates  I,2000
FDA-2000-P-0756-0001_Citizen_Petition_from_Phoenix_Scientific__Inc_.pdf,"February 7, 2000",Phoenix Scientific  Inc,2000
FDA-2000-P-0916-0001_Citizens_Petition_from_The_Humane_Society_of_the_U.pdf,"March 10,200",The Humane Society of the U,2000
FDA-2000-P-0924-0003_Change_in_Classification_Petition_from_Cook_MED_In.pdf,August 282000,Cook MED In,2000
FDA-2000-P-1064-0001_Citizen_Petition_from_Mead_Johnson_Nutritionals.pdf,"January 24, 2000",Mead Johnson Nutritionals,2000
FDA-2000-P-1218-0001_Citizens_Petition_from_Public_Citizen_Health_Group.pdf,"March 7, 2000",Public Citizen Health Group,2000
FDA-2000-P-1219-0001_Citizen_Petition_from_GensiaSicor_Pharmaceuticals.pdf,"August 23, 2000",GensiaSicor Pharmaceuticals,2000
FDA-2000-P-1373-0002_Citizen_Petition_from_American_College_of_Obstetri.pdf,"August 
23, 2000",American College of Obstetri,2000
FDA-2000-P-1381-0001_Citizen_Petition_from_Yamanouchi_Pharma_Technologi.pdf,"June 19,200",Yamanouchi Pharma Technologi,2000
FDA-2000-P-1400-0001_Citizen_Petition_from_Genelabs_Technologies_Inc.pdf,"April 19, 2000",Genelabs Technologies Inc,2000
FDA-2000-P-1558-0001_Suitability_Citizen_Petition_from_GensiaSicor_Phar.pdf,"June 19, 2000",GensiaSicor Phar,2000
FDA-2000-P-1558-0004_Supplement_Letter_to_Suitability_Petition_from_Gen.pdf,"June 19, 2000",Gen,2000
FDA-2001-P-0030-0004_Duramed_Pharmaceuticals__Inc____Citizen_Petition.pdf,5/1/01,"Duramed Pharmaceuticals, Inc.",2001
FDA-2001-P-0054-0002_Citizen_Petition_from_Ferndale_Laboratories__Inc_.pdf,11/8/01,"Ferndale Laboratories, Inc.",2001
FDA-2001-P-0122-0002_Citizen_Petition_from_Ruth_Armstrong_Redacted.pdf,1/19/01,Ruth Armstrong,2001
FDA-2001-P-0154-0003_Citizen_Petition_from_ASTA_Medical__Inc_.pdf,7/26/01,"Asta Medical, Inc.",2001
FDA-2001-P-0238-0004_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,9/18/01,"Lachman Consultant Services, Inc.",2001
FDA-2001-P-0239-0001_Citizen_Petition_from_Krislov___Associates__LTD_.pdf,4/20/01,"Krislov & Associates, Ltd.",2001
FDA-2001-P-0241-0005_Citizen_Petition_from_Ferndale_Laboratories__Inc_.pdf,8/10/01,"Ferndale Labortories, Inc.",2001
FDA-2001-P-0283-0001_Citizen_Petition_from_Public_Citizen_Health_Resear.pdf,8/27/01,Public Citizen Health Research Group,2001
FDA-2001-P-0294-0001_Citizen_Petition_from_Public_Citizen_Health_Resear.pdf,"August 15, 2001",Public Citizen Health Resear,2001
FDA-2001-P-0321-0001_Citizen_Petition_from_Washington_Legal_Foundation.pdf,"April 
17, 
2001",Washington Legal Foundation,2001
FDA-2001-P-0412-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"February 
9,200",Lachman Consultant Services,2001
FDA-2001-P-0445-0001_Apotex_Corp____Citizen_Petition.pdf,"March 26,200",Apotex Corp,2001
FDA-2001-P-0483-0009_Petition_from_Center_for_Food_Safety___Transgenic_.pdf,"June 21,2004",Center for Food Safety   Transgenic,2001
FDA-2001-P-0521-0002_Citizen_Petition_from_Bennett__Turner___Coleman__L.pdf,"May 8,200",Bennett  Turner   Coleman  L,2001
FDA-2001-P-0563-0003_Boehringer_Ingelheim_Pharm_Inc___Petition_for_Stay.pdf,"October 10,200",Boehringer Ingelheim Pharm Inc,2001
FDA-2001-P-0565-0001_Citizen_Petition_from_Bioniche_Pharma__Canada__Ltd.pdf,"March 26,200",Bioniche Pharma  Canada  Ltd,2001
FDA-2001-P-0565-0006_Citizen_Petition_Supplement_from_Bioniche_Pharma__.pdf,"March 29, 2001",Bioniche Pharma,2001
FDA-2002-P-0001-0002_Citizen_Petition_from_CorePharma_LLC.pdf,11/5/02,"Corepharma, Llc",2002
FDA-2002-P-0002-0002_Petition_for_Stay_of_Action_from_Bayer_Corporation.pdf,8/5/02,Bayer Corporation,2002
FDA-2002-P-0007-0009_Citizens_Petition_from_The_Weinberg_Group_Inc_.pdf,"September 13,2002",The Weinberg Group Inc,2002
FDA-2002-P-0007-0011_Petition_for_Reconsideration_from_The_Weinberg_Gro.pdf,"June 1,2004",The Weinberg Gro,2002
FDA-2002-P-0041-0024_Petition_for_Health_Claims__Phosphatidylserine_and.pdf,4/19/02,,2002
FDA-2002-P-0046-0003_Citizen_Petition_from_Arla_Foods_Ingredients_amba_.pdf,1/9/02,"Arla Foods Ingredients Amba (Hyman, Phelps & Mcnamara, Pc)",2002
FDA-2003-P-0118-0003_Suitability_Petition_from_Vetoquinol_N__A__Inc_.pdf,"July 14, 2003",Vetoquinol N  A  Inc,2003
FDA-2003-P-0122-0004_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,10/1/03,"Lachman Consultant Services, Inc.",2003
FDA-2003-P-0127-0003_Citizen_Petition_from_The_Weinberg_Group__Inc_.pdf,6/27/03,"The Weinberg Group, Inc.",2003
FDA-2003-P-0174-0024_American_Lung_Association___Citizen_Petition.pdf,1/29/03,American Lung Association,2003
FDA-2004-P-0006-0005_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,7/2/04,Lachman Consultant Services Inc,2004
FDA-2004-P-0023-0002_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,9/13/04,"Lachman Consultant Services, Inc.",2004
FDA-2004-P-0036-0004_Citizen_Petition_from_The_Industry_Coalition.pdf,9/17/04,Industry Coalition,2004
FDA-2004-P-0086-0004_Citizen_Petition_from_Ben_Venue_Laboratories.pdf,11/18/04,Ben Venue Laboratories,2004
FDA-2004-P-0095-0003_Citizen_Petition_from_Coalition_To_Preserve_DSHEA.pdf,April 82004,Coalition To Preserve DSHEA,2004
FDA-2004-P-0099-0003_Citizen_Petition_from_The_Weinberg_Group_Inc.pdf,"March 23,2004",The Weinberg Group Inc,2004
FDA-2004-P-0115-0005_Citizen_Petition_from_Barbara_E__Kennedy_Neslusan_.pdf,2/25/04,Barbara E. Kennedy-Neslusan,2004
FDA-2004-P-0151-0009_McNeil_Pediatrics___Amendment_Petition.pdf,"March 19, 2004",Mcneil Consumer & Specialty Pharmaceuticals,2004
FDA-2004-P-0155-0004_Citizen_Petition_from_Cancer_Action_NY.pdf,12/30/03,Cancer Action Ny,2004
FDA-2004-P-0155-0007_Closure_of_Citizen_Petition_from_Donald_Hassig.pdf,1/24/24,Cancer Action Ny,2004
FDA-2004-P-0157-0003_Citizen_Petition_from_Robert_Cohen.pdf,2/6/04,Robert Cohen,2004
FDA-2004-P-0158-0003_Change_in_Classification_of_Petition_from_Roche_Di.pdf,12/5/03,Roche Diagnostics Corporation,2004
FDA-2004-P-0164-0009_Billy_G__Pierson___Citizen_Petition.pdf,10/13/03,Billy G. Pierson,2004
FDA-2004-P-0164-0013_Billy_G__Pierson___Petition_for_Stay.pdf,3/15/04,Billy G. Pierson,2004
FDA-2004-P-0164-0016_Bill_Pierson___Petition_for_Stay.pdf,5/10/04,Billy G. Pierson,2004
FDA-2004-P-0176-0005_Citizen_Petition_from_Arent_Fox_PLLC.pdf,12/14/04,Arent Fox Pllc,2004
FDA-2004-P-0176-0005_Citizen_Petition_from_Arent_Fox__P_L_L_C_.pdf,12/14/04,Arent Fox Pllc,2004
FDA-2004-P-0210-0006_Citizen_Petition_from_Center_for_Science_in_the_Pu.pdf,10/28/04,Center For Science In The Public Interest (Cspi),2004
FDA-2004-P-0210-0007_Citizen_Petition_Supplement_from_Center_for_Scienc.pdf,"October 28,2004",Center for Scienc,2004
FDA-2004-P-0215-0008_Hill_Dermaceuticals__Inc____Citizen_Petition.pdf,"April 14, 
2004",Hill Dermaceuticals  Inc,2004
FDA-2004-P-0274-0004_Alza_Corporation___Citizen_Petition.pdf,11/12/04,Alza Corporation,2004
FDA-2004-P-0278-0005_Citizen_Petition_from_Center_for_Science_in_the_Pu.pdf,7/22/04,Center For Science In The Public Interest (Cspi),2004
FDA-2004-P-0278-0006_Citizen_Petition_Supplement_from_Center_for_Scienc.pdf,"July 22, 2004",Center for Scienc,2004
FDA-2004-P-0279-0003_Citizen_Petition_from_the_Center_for_Science_in_th.pdf,5/18/04,The Center For Science In The Public Interest (Cspi),2004
FDA-2004-P-0290-0004_Citizen_Petition_from_Celltech_Americas__Inc_.pdf,5/6/04,"Celltech Americas, Inc.",2004
FDA-2004-P-0295-0003_Citizen_Petition_from_University_of_Medicine_and_D.pdf,3/3/04,University Of Medicine And Dentistry Of New Jersey-Robert Wood Johnson Medical School,2004
FDA-2004-P-0341-0001_Citizen_Petition_from_STD_Prevention_and_Control_S.pdf,"July 12, 2004",STD Prevention and Control S,2004
FDA-2004-P-0419-0004_Citizen_Petition_from_Nico_Worldwide__LLC.pdf,7/2/04,"Nico Worldwide, Llc",2004
FDA-2005-P-0003-0004_Sandoz_Inc____Citizen_Petition.pdf,11/1/05,Sandoz Inc.,2005
FDA-2005-P-0006-0003_Citizens_Petition_from_Warner_Chilcott_Inc.pdf,1/21/05,Warner Chilcott Inc.,2005
FDA-2005-P-0009-0004_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,4/7/05,"Lachman Consultant Services, Inc.",2005
FDA-2005-P-0056-0004_Citizens_Petition_from_David_S__Lowe.pdf,8/10/05,David S. Lowe,2005
FDA-2005-P-0056-0005_Supplement_re_Citizens_Petition_from_David_S__Lowe.pdf,"August
25,
2005",David S  Lowe,2005
FDA-2005-P-0059-0009_Citizen_Petition___American_College_of_Gastroenter.pdf,6/27/05,American College Of Gastroenterology,2005
FDA-2005-P-0068-0002_Citizen_Petition_from_Ben_Venue_Laboratories.pdf,1/4/05,Ben Venue Laboratories,2005
FDA-2005-P-0068-0005_Amendment__Citizen_Petition__from_Ben_Venue_Labora.pdf,9/2/05,Ben Venue Laboratories,2005
FDA-2005-P-0082-0004_Citizens_Petition_from_Sun_Pharmaceutical_Industri.pdf,"March 22,200",Sun Pharmaceutical Industri,2005
FDA-2005-P-0120-0004_Shire_Pharmaceuticals_Group_Citizen_Petition.pdf,10/17/05,Shire Pharmaceuticals Group,2005
FDA-2005-P-0126-0004_Citizen_Petition_from_David_J_Getoff___Redacted_.pdf,5/14/05,David J. Getoff,2005
FDA-2005-P-0130-0009_New_York_Medical_College__et_al___Citizen_Petition.pdf,2/15/05,"New York Medical College, Et Al",2005
FDA-2005-P-0134-0003_Citizens_Petition_from_Lachman_Consultant_Services.pdf,4/25/05,"Lachman Consultant Services, Inc.",2005
FDA-2005-P-0150-0004_Citizens_Petition_from_Teva_Pharmaceuticals_USA.pdf,2/18/05,Teva Pharmaceuticals Usa,2005
FDA-2005-P-0190-0005_Citizen_Petition_from_Sterne__Kessler__Goldstein__.pdf,10/5/05,"Sterne, Kessler, Goldstein & Fox, P.L.L.C.",2005
FDA-2005-P-0190-0006_Supplement_to_Citizen_Petition_from_Sterne__Kessle.pdf,"October 7,2005","Sterne, Kessler, Goldstein & Fox, P.L.L.C.",2005
FDA-2005-P-0191-0004_Citizen_Petition_from_Pine_Grove_Behavioral_Health.pdf,11/1/05,Pine Grove Behavioral Health & Addiction Services,2005
FDA-2005-P-0194-0004_Citizen_Petition_from_Warren_Rucker__redacted_.pdf,12/29/05,Warren Rucker,2005
FDA-2005-P-0196-0007_Salt_and_Sodium__Petition_to_Revise_the_Regulatory.pdf,"June 11, 2008",Revise the Regulatory,2005
FDA-2005-P-0196-0030_Citizen_Petition_from_Center_for_Science_in_the_Pu.pdf,11/8/05,Center For Science In The Public Interest (Cspi),2005
FDA-2005-P-0196-0036_Salt_and_Sodium__Petition_to_Revise_the_Regulatory.pdf,"October 23, 2007",Revise the Regulatory,2005
FDA-2005-P-0199-0003_Natural_Solutions_Foundation___Citizen_Petition.pdf,10/20/05,Natural Solutions Foundation,2005
FDA-2005-P-0221-0004_Citizens_Petition_from_UCSF_National_Center_of_Exc.pdf,3/15/05,Ucsf National Center Of Excellence In Women'S Health,2005
FDA-2005-P-0256-0003_Citizen_Petition_from_Public_Citizen.pdf,7/29/05,Public Citizen,2005
FDA-2005-P-0259-0005_Citizen_Petition_from_BioStratum__Inc_.pdf,1/22/09,"Biostratum, Inc.",2005
FDA-2005-P-0260-0003_Citizen_Petition_from_Ed_Groves__Sr___redacted_.pdf,1/18/05,"Ed Groves, Sr.",2005
FDA-2005-P-0266-0003_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,9/27/05,"Lachman Consultant Services, Inc.",2005
FDA-2005-P-0266-0004_Supplement_to_Citizen_Petition_from_Lachman_Consul.pdf,"August 24, 2006",Lachman Consul,2005
FDA-2005-P-0266-0005_Amendment_to_Citizen_Petition_from_Lachman_Consult.pdf,"June 28, 2006",Lachman Consult,2005
FDA-2006-P-0282-0001_Citizen_Petition_from_The_States_of_Kansas__Minnes.pdf,"August 3, 2006",The States of Kansas  Minnes,2006
FDA-2006-P-0284-0004_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,3/31/06,"Lachman Consultant Services, Inc.",2006
FDA-2006-P-0285-0003_Citizen_Petition_from_Olsson__Frank_and_Weeda__P_C.pdf,"February 9, 2006",Olsson  Frank and Weeda  P C,2006
FDA-2006-P-0325-0005_Citizen_Petition_from_Vaccine_For_All_LLC.pdf,12/28/06,Vaccine For All Llc,2006
FDA-2006-P-0327-0006_Beckloff_Associates___Citizen_Petition.pdf,9/28/06,Beckloff Associates,2006
FDA-2006-P-0329-0007_Mylan_Laboratories_Inc____Citizen_Petition.pdf,3/17/06,Mylan Laboratories Inc.,2006
FDA-2006-P-0332-0004_Citizen_Petition_from_Sparhawk_Laboratories__Inc.pdf,6/21/06,"Sparhawk Laboratories, Inc",2006
FDA-2007-P-0001-0004_Unimed_Pharmaceuticals__Inc____Citizen_Petition.pdf,9/27/07,"Unimed Pharmaceuticals, Inc.",2007
FDA-2007-P-0003-0004_Purdue_Pharma_L_P____Citizen_Petition.pdf,7/12/07,Purdue Pharma L.P.,2007
FDA-2007-P-0003-0007_Endo_Pharmaceuticals___Citizen_Petition_to_supplem.pdf,7/12/07,supplem,2007
FDA-2007-P-0004-0003_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,3/27/07,"Lachman Consultant Services, Inc.",2007
FDA-2007-P-0006-0002_Matrix_Laboratories__Inc____Citizen_Petition.pdf,10/22/07,"Matrix Laboratories, Inc.",2007
FDA-2007-P-0007-0006_Sara_Lee_Corporation___Citizen_Petition.pdf,04/13/2007,Sara Lee Corporation,2007
FDA-2007-P-0010-0002_Axcan_Scandipharm__Inc____Citizen_Petition.pdf,6/30/07,"Axcan Scandipharm, Inc.",2007
FDA-2007-P-0011-0004_Lachman_Consultant_Services_Inc_Citizen_Petition.pdf,1/16/07,"Lachman Consultant Services, Inc",2007
FDA-2007-P-0012-0004_Medicis___Citizen_Petition.pdf,4/20/07,Medicis,2007
FDA-2007-P-0013-0002_Fuerst__Humphrey__Ittleman__PL___Citizen_Petition.pdf,10/16/07,"Fuerst, Humphrey, Ittleman, Pl",2007
FDA-2007-P-0014-0003_Citizen_Petition_from_JR_Rapoza_Associates__Inc_.pdf,3/14/07,"Jr Rapoza Associates, Inc.",2007
FDA-2007-P-0015-0003_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,1/28/07,"Lachman Consultant Services, Inc.",2007
FDA-2007-P-0017-0002_Mutual_Pharmaceutical_Company___Citizen_Petition.pdf,7/27/07,Mutual Pharmaceutical Company,2007
FDA-2007-P-0050-0006_Supplement_to_Petition_from_Baltimore_City_Health_.pdf,"May 2, 2007",Baltimore City Health,2007
FDA-2007-P-0050-0023_Citizen_Petition_from_Baltimore_City_Health_Depart.pdf,3/1/07,Baltimore City Health Department Et Al,2007
FDA-2007-P-0052-0002_King_Pharmaceuticals__Inc___Citizen_Petition.pdf,10/30/07,"King Pharmaceuticals, Inc",2007
FDA-2007-P-0053-0003_Citizen_Petition_from_West_Ward_Pharmaceutical_Cor.pdf,2/19/07,West-Ward Pharmaceutical Corp.,2007
FDA-2007-P-0054-0003_Citizen_Petition_from_Zydus_Pharmaceuticals_USA__I.pdf,4/4/07,"Zydus Pharmaceuticals Usa, Inc.",2007
FDA-2007-P-0055-0004_Citizen_Petition_from_Pharmaceutical_Scientist_Inc.pdf,1/3/07,Pharmaceutical Scientist Inc.,2007
FDA-2007-P-0056-0004_Citizen_Petition_from_Greenberg_Traurig_LLP.pdf,3/12/07,Greenberg Traurig Llp,2007
FDA-2007-P-0058-0003_Citizen_Petition_from_Keller_And_Heckman_LLP.pdf,3/20/07,Keller And Heckman Llp,2007
FDA-2007-P-0059-0003_Citizen_Petition_from_Olsson__Frank_And_Weeda__P__.pdf,3/28/07,"Olsson, Frank And Weeda, P. C.",2007
FDA-2007-P-0062-0003_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,1/12/07,"Lachman Consultant Services, Inc.",2007
FDA-2007-P-0063-0003_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,1/31/07,"Lachman Consultant Services, Inc.",2007
FDA-2007-P-0064-0003_Emil_A__Tanghetti__M_D____Citizen_Petition.pdf,5/20/07,"Emil A. Tanghetti, M.D.",2007
FDA-2007-P-0065-0006_Citizen_Petition_from_Ropes___Gray_LLP__Ortho_McNe.pdf,3/30/07,"Ortho-Mcneil, Inc.",2007
FDA-2007-P-0065-0014_Petition_for_Stay_of_Action_from_Purdue_Pharma_LP_.pdf,"May 2, 2007",Purdue Pharma LP,2007
FDA-2007-P-0066-0002_W__L__Driscoll___Citizen_Petition.pdf,12/5/07,W. L. Driscoll,2007
FDA-2007-P-0107-0006_Citizen_Petition_from_Vaccine_for_All_LLC.pdf,1/4/07,Vaccine For All Llc,2007
FDA-2007-P-0108-0005_Citizen_Petition_from_University_of_Florida.pdf,2/6/07,University Of Florida,2007
FDA-2007-P-0109-0002_Mandatory_Alternatives_Petition_Coalition_Citizen_.pdf,11/20/07,Mandatory Alternatives Petition Coalition,2007
FDA-2007-P-0111-0003_Astellas_Pharma_US__Inc____Citizen_Petition.pdf,9/21/07,"Astellas Pharma Us, Inc.",2007
FDA-2007-P-0111-0013_FDA_to_Astellas_Pharma_US__Inc____Petition_and_Sup.pdf,"September 21,2007","Astellas Pharma Us, Inc.",2007
FDA-2007-P-0112-0002_Thunder_Bay_Seafood_Co___Inc____PASA_Petition_for_.pdf,9/19/07,"Thunder Bay Seafood Co., Inc.",2007
FDA-2007-P-0113-0002_Celgene_Corporation___Citizen_Petition.pdf,9/20/07,Celgene Corporation,2007
FDA-2007-P-0114-0003_Citizen_Petition_from_B__Braun_Medical__Inc_.pdf,3/25/07,"B. Braun Medical, Inc.",2007
FDA-2007-P-0114-0005_Amendment_to_Citizen_Petition_from_B__Braun_Medica.pdf,3/25/07,B  Braun Medica,2007
FDA-2007-P-0116-0003_Citizen_Petition_from_Dean_Andrew_Kantis.pdf,1/4/07,Dean Andrew Kantis,2007
FDA-2007-P-0116-0004_Citizen_Petition_from_Dean_Andrew_Kantis.pdf,"January 4, 2007",Dean Andrew Kantis,2007
FDA-2007-P-0118-0012_Thomas_J__Quinn___Citizen_Petition_1.pdf,8/26/07,"Dwight G. Castle. Rebecca Gilbert, James Whalen, Thomas J. Quinn, Michael E. Masterman, Jeffrey P. Frontier, John W. Shaw, Michael F. Clark, Dave Wayne, John Gilbert, Robert E. Parks, Shawn Bryant",2007
FDA-2007-P-0118-0013_Dwight_G__Castle___Citizen_Petition_2.pdf,9/4/07,"Dwight G. Castle. Rebecca Gilbert, James Whalen, Thomas J. Quinn, Michael E. Masterman, Jeffrey P. Frontier, John W. Shaw, Michael F. Clark, Dave Wayne, John Gilbert, Robert E. Parks, Shawn Bryant",2007
FDA-2007-P-0118-0014_Dave_Wayne___Citizen_Petition_3.pdf,9/3/07,"Dwight G. Castle. Rebecca Gilbert, James Whalen, Thomas J. Quinn, Michael E. Masterman, Jeffrey P. Frontier, John W. Shaw, Michael F. Clark, Dave Wayne, John Gilbert, Robert E. Parks, Shawn Bryant",2007
FDA-2007-P-0118-0015_John_Gilbert___Citizen_Petition_4.pdf,9/12/07,"Dwight G. Castle. Rebecca Gilbert, James Whalen, Thomas J. Quinn, Michael E. Masterman, Jeffrey P. Frontier, John W. Shaw, Michael F. Clark, Dave Wayne, John Gilbert, Robert E. Parks, Shawn Bryant",2007
FDA-2007-P-0118-0016_Michael_E__Masterman___Citizen_Petition_5.pdf,9/16/07,"Dwight G. Castle. Rebecca Gilbert, James Whalen, Thomas J. Quinn, Michael E. Masterman, Jeffrey P. Frontier, John W. Shaw, Michael F. Clark, Dave Wayne, John Gilbert, Robert E. Parks, Shawn Bryant",2007
FDA-2007-P-0118-0017_John_W__Shaw___Citizen_Petition_6.pdf,9/16/07,"Dwight G. Castle. Rebecca Gilbert, James Whalen, Thomas J. Quinn, Michael E. Masterman, Jeffrey P. Frontier, John W. Shaw, Michael F. Clark, Dave Wayne, John Gilbert, Robert E. Parks, Shawn Bryant",2007
FDA-2007-P-0118-0018_Rebecca_Gilbert___Citizen_Petition_7.pdf,9/17/07,"Dwight G. Castle. Rebecca Gilbert, James Whalen, Thomas J. Quinn, Michael E. Masterman, Jeffrey P. Frontier, John W. Shaw, Michael F. Clark, Dave Wayne, John Gilbert, Robert E. Parks, Shawn Bryant",2007
FDA-2007-P-0118-0019_Jeffrey_P__Frontier___Citizen_Petition_8.pdf,9/25/07,"Dwight G. Castle. Rebecca Gilbert, James Whalen, Thomas J. Quinn, Michael E. Masterman, Jeffrey P. Frontier, John W. Shaw, Michael F. Clark, Dave Wayne, John Gilbert, Robert E. Parks, Shawn Bryant",2007
FDA-2007-P-0118-0020_Michael_F__Clark_Citizen_Petition_9.pdf,10/10/07,"Dwight G. Castle. Rebecca Gilbert, James Whalen, Thomas J. Quinn, Michael E. Masterman, Jeffrey P. Frontier, John W. Shaw, Michael F. Clark, Dave Wayne, John Gilbert, Robert E. Parks, Shawn Bryant",2007
FDA-2007-P-0118-0021_Shawn_Bryant___Citizen_Petition_11.pdf,11/8/07,"Dwight G. Castle. Rebecca Gilbert, James Whalen, Thomas J. Quinn, Michael E. Masterman, Jeffrey P. Frontier, John W. Shaw, Michael F. Clark, Dave Wayne, John Gilbert, Robert E. Parks, Shawn Bryant",2007
FDA-2007-P-0118-0022_James_Whalen___Citizen_Petition_12.pdf,11/8/07,"Dwight G. Castle. Rebecca Gilbert, James Whalen, Thomas J. Quinn, Michael E. Masterman, Jeffrey P. Frontier, John W. Shaw, Michael F. Clark, Dave Wayne, John Gilbert, Robert E. Parks, Shawn Bryant",2007
FDA-2007-P-0118-0023_Robert_E__Parks___Citizen_Petition_10.pdf,10/17/07,"Dwight G. Castle. Rebecca Gilbert, James Whalen, Thomas J. Quinn, Michael E. Masterman, Jeffrey P. Frontier, John W. Shaw, Michael F. Clark, Dave Wayne, John Gilbert, Robert E. Parks, Shawn Bryant",2007
FDA-2007-P-0119-0003_Citizen_Petition_from_Cancer_Prevention_Coalition_.pdf,2/20/07,"Cancer Prevention Coalition, Et Al",2007
FDA-2007-P-0126-0003_Akorn_Strides__LLC___Citizen_Petition.pdf,4/27/07,"Akorn-Strides, Llc",2007
FDA-2007-P-0128-0002_King_Pharmaceuticals__Inc____Citizen_Petition.pdf,9/26/07,"King Pharmaceuticals, Inc.",2007
FDA-2007-P-0129-0003_Alcon_Research__Ltd____Citizen_Petition.pdf,4/19/07,"Alcon Research, Ltd.",2007
FDA-2007-P-0168-0011_CareToLive___Citizen_Petition.pdf,6/26/07,Caretolive,2007
FDA-2007-P-0168-0014_CareToLive___Supplement_Citizen_Petition_2_.pdf,6/26/07,Caretolive,2007
FDA-2007-P-0168-0015_CareToLive___Supplement_to_Citizen_Petition.pdf,6/26/07,Citizen Petition,2007
FDA-2007-P-0168-0017_CareToLive___Supplement_to_Citizen_Petition.pdf,6/26/07,Citizen Petition,2007
FDA-2007-P-0169-0002_Unimed_Pharmaceuticals__Inc____Citizen_Petition.pdf,10/28/07,"Unimed Pharmaceuticals, Inc.",2007
FDA-2007-P-0170-0002_Teva_Pharmaceuticals_USA___Citizen_Petition.pdf,8/5/07,Teva Pharmaceuticals Usa,2007
FDA-2007-P-0171-0004_Warner_Chilcott_Inc____Citizen_Petition.pdf,4/9/07,Warner Chilcott Inc.,2007
FDA-2007-P-0172-0002_Thunder_Bay_Seafood_Co___Inc___Petition_for_Stay.pdf,9/19/07,"Thunder Bay Seafood Co., Inc",2007
FDA-2007-P-0174-0002_Thunder_Bay_Seafood_Co___Inc____Petition_for_Stay.pdf,"September 27, 2007",Thunder Bay Seafood Co   Inc,2007
FDA-2007-P-0175-0002_VCU_School_of_Medicine___Citizen_Petition.pdf,10/17/07,Vcu School Of Medicine,2007
FDA-2007-P-0177-0003_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,2/28/07,"Lachman Consultant Services, Inc.",2007
FDA-2007-P-0178-0002_John_Edward_Erb___Citizen_Petition.pdf,12/26/07,John Edward Erb,2007
FDA-2007-P-0179-0004_Petition_for_Stay_of_Action_from_Pfizer_Inc_.pdf,3/21/07,Pfizer Inc.,2007
FDA-2007-P-0181-0005_Citizen_Petition_from_Charles_E__Weber.pdf,2/23/07,Charles E. Weber,2007
FDA-2007-P-0182-0003_sanofi_aventis___Citizen_Petition.pdf,5/16/07,Sanofi Aventis,2007
FDA-2007-P-0183-0006_Petition_for_Reconsideration___Philip_C__Strassbur.pdf,4/1/08,Purdue Pharma L.P. and Rhodes Technologies,2007
FDA-2007-P-0184-0002_Judy_Slome_Cohain___Citizen_Petition.pdf,12/12/07,Judy Slome Cohain,2007
FDA-2007-P-0185-0002_Lupin_Pharmaceuticals__Inc____Citizen_Petition.pdf,10/18/07,"Lupin Pharmaceuticals, Inc.",2007
FDA-2007-P-0186-0006_Citizen_Petition_from_Perdue_Pharma_LP.pdf,3/13/07,Purdue Pharma L.P.,2007
FDA-2007-P-0186-0007_Petition_for_Stay_of_Action_from_Purdue_Pharma_L_P.pdf,5/2/07,Purdue Pharma L.P.,2007
FDA-2007-P-0187-0003_Alston___Bird_LLP___Citizen_Petition.pdf,12/10/07,Synthetic Organic Chemical Manufacturers Association,2007
FDA-2007-P-0188-0002_Citizen_Petition_from_Beckloff_Associates_Inc.pdf,12/27/07,"Beckloff Associates, Inc.",2007
FDA-2007-P-0189-0004_Acorda_Therapeutics__Inc____Citizen_Petition.pdf,4/12/07,"Acorda Therapeutics, Inc.",2007
FDA-2007-P-0192-0004_Aurobindo_Pharmaceuticals_Ltd____Citizen_Petition.pdf,5/1/07,Aurobindo Pharmaceuticals Ltd.,2007
FDA-2007-P-0234-0002_Terence_J_Mix_Esq_Citizen_Petition.pdf,11/29/07,"Terence J. Mix, Esq.",2007
FDA-2007-P-0234-0008_Terence_J_Mix_Esq_Petition_for_Reconsideration.pdf,10/5/09,"Terence J. Mix, Esq.",2007
FDA-2007-P-0235-0002_Citizen_Petition_from_Mutual_Pharmaceutical_Compan.pdf,12/20/07,"Mutual Pharmaceutical Company, Inc.",2007
FDA-2007-P-0236-0004_Citizen_Petition_from_Three_Laboratory_Consortium.pdf,3/23/07,Three-Laboratory Consortium,2007
FDA-2007-P-0241-0002_B__Braun_Medical__Inc____CItizen_Petition.pdf,7/31/07,"B. Braun Medical, Inc.",2007
FDA-2007-P-0242-0003_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,1/20/07,"Lachman Consultant Services, Inc.",2007
FDA-2007-P-0243-0002_Michael_J__Dochniak___Citizen_Petition.pdf,12/19/07,Michael J. Dochniak,2007
FDA-2007-P-0246-0003_Sandoz_Inc____Citizen_Petition.pdf,5/22/07,Sandoz Inc.,2007
FDA-2007-P-0247-0007_Citizen_Petition_from_Regulus_Pharmaceutical_Consu.pdf,2/20/07,"Regulus Pharmaceutical Consulting, Inc.",2007
FDA-2007-P-0248-0002_Citizen_Petition_from_Cornerstone_Regulatory.pdf,8/10/07,Cornerstone Regulatory,2007
FDA-2007-P-0250-0002_Sun_Pharmaceuticals__Ltd____Citizen_Petition.pdf,9/13/07,"Sun Pharmaceuticals, Ltd.",2007
FDA-2007-P-0250-0005_FDA_to_Kendle_International___Petition_Partial_App.pdf,"September 13,2007","Sun Pharmaceuticals, Ltd.",2007
FDA-2007-P-0286-0004_Citizen_Petition_Index_Cover.pdf,4/23/07,"Immunotec, Inc.",2007
FDA-2007-P-0286-0005_Immunotec__Inc____Tab_1__Citizen_Petition.pdf,4/23/07,"Immunotec, Inc.",2007
FDA-2007-P-0290-0004_Dawn_Densmore___Citizen_Petition.pdf,7/13/07,Dawn Densmore,2007
FDA-2007-P-0292-0002_Prolacta_Bioscience___Citizen_Petition.pdf,10/29/07,Prolacta Bioscience,2007
FDA-2007-P-0293-0005_Citizen_Petition_from_David_K_Richardson.pdf,3/4/07,David K. Richardson,2007
FDA-2007-P-0293-0006_Supplement_to_Citizen_Petition_from_David_K__Richa.pdf,"May 14, 2007",David K  Richa,2007
FDA-2007-P-0293-0007_Supplement_to_Citizen_Petition_from_David_K_Richar.pdf,"September 12, 2007",David K Richar,2007
FDA-2007-P-0296-0003_Citizen_Petition_from_Sovereign_Pharmaceuticals__L.pdf,3/1/07,"Sovereign Pharmaceuticals, Ltd",2007
FDA-2007-P-0299-0003_Citizen_Petition_from_Clinical_and_Laboratory_Stan.pdf,7/3/07,Clinical And Laboratory Standards Institute (CLSI),2007
FDA-2007-P-0300-0002_AAIPharma___Citizen_Petition______________________.pdf,8/20/07,AAIPharma,2007
FDA-2007-P-0301-0004_Citizen_Petition_from_Jennifer_McGinn.pdf,3/12/07,Jennifer Mcginn,2007
FDA-2007-P-0339-0002_Anil_K__Mandal__M_D____Citizen_Petition.pdf,8/16/07,"Anil K. Mandal, M.D.",2007
FDA-2007-P-0344-0004_Arbor_Hill___Citizen_Petition.pdf,1/22/07,Arbor Hill,2007
FDA-2007-P-0345-0003_HellerEhrman_LLP___Citizen_Petition.pdf,9/20/07,Hellerehrman Llp,2007
FDA-2007-P-0346-0039_Richard_Sauerheber_Palomar_College___Petition_for_.pdf,"November 17, 2010",Richard Sauerheber Palomar College,2007
FDA-2007-P-0348-0002_King_and_Spalding_LLP___Citizen_Petition.pdf,10/30/07,King And Spalding Llp,2007
FDA-2007-P-0349-0005_Engel___Novitt__LLP___Petition_for_Stay_of_Action.pdf,"September 17, 2007",Engel   Novitt  LLP,2007
FDA-2007-P-0349-0006_Engel___Novitt__LLP___Citizen_Petition.pdf,9/18/07,"Engel & Novitt, Llp",2007
FDA-2007-P-0350-0004_Citizen_Petition_from_Pfizer_Inc.pdf,3/21/07,Pfizer Inc,2007
FDA-2007-P-0351-0003_Randall_W__Lutter___Letter___PSA___Petition_Closed.pdf,"March 26, 2007","Mylan Laboratories, Inc.",2007
FDA-2007-P-0351-0004_Mylan_Laboratories__Inc____Citizen_Petition.pdf,4/27/07,"Mylan Laboratories, Inc.",2007
FDA-2007-P-0353-0002_JRRapoza_Associates__Inc____Citizen_Petition.pdf,1/23/07,"Jrrapoza Associates, Inc.",2007
FDA-2007-P-0402-0004_Petition_for_Stay_of_Action_from_Mylan_Pharmaceuti.pdf,3/26/07,Mylan Pharmaceuticals Inc.,2007
FDA-2007-P-0403-0004_Norbrook__Inc____ANADA_Suitability_Petition.pdf,5/2/07,Norbrook Inc.,2007
FDA-2007-P-0404-0003_Ellen_M_Ashworth_Citizen_Petition_Redacted.pdf,1/23/07,Ellen M. Ashworth,2007
FDA-2007-P-0405-0002_Matrix_Laboratories__Inc____Citizen_Petition.pdf,11/5/07,"Matrix Laboratories, Inc.",2007
FDA-2007-P-0406-0002_Sandoz__Inc____Citizen_Petition.pdf,5/24/07,"Sandoz, Inc.",2007
FDA-2007-P-0407-0005_Citizen_Petition_from_Hikma_Farmaceutica_of_Portug.pdf,2/9/07,Hikma Farmaceutica Of Portugal,2007
FDA-2007-P-0408-0003_Citizen_Petition_from_PFI_LLC.pdf,3/30/07,Pfi Llc,2007
FDA-2007-P-0409-0003_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,3/1/07,"Lachman Consultant Services, Inc.",2007
FDA-2007-P-0410-0002_Medicure_Pharma__Inc____Citizen_Petition.pdf,11/30/07,"Medicure Pharma, Inc.",2007
FDA-2007-P-0412-0003_Letter_re_Receipt_of_Petition.pdf,4/3/07,C Smith,2007
FDA-2007-P-0412-0004_Citizen_Petition_from_C_Smith.pdf,4/3/07,C Smith,2007
FDA-2007-P-0413-0005_Citizen_Petition_from_Pharmacists_Planning_Service.pdf,2/21/07,"Pharmacists Planning Service, Inc.",2007
FDA-2007-P-0413-0006_Supplement_to_Petition_from_Pharmacists_Planning_S.pdf,"February 14,2007",Pharmacists Planning S,2007
FDA-2007-P-0414-0006_Victor_L__Yu__M_D____Citizen_Petition.pdf,1/15/07,Victor L. Yu. M.D.,2007
FDA-2007-P-0416-0003_Citizen_Petition_from_Sapna_Lohiya__Royal_Medical_.pdf,11/16/07,Sapna Lohiya (Royal Medical Group),2007
FDA-2007-P-0417-0002_Consumers_Union___Citizen_Petition.pdf,12/17/07,Consumers Union,2007
FDA-2007-P-0464-0001_Ralph_D__Childs___Citizen_Petition.pdf,10/3/07,Ralph D. Childs,2007
FDA-2007-P-0477-0001_Citizen_Petition_Lachman_Consultant_Services__Inc_.pdf,2/1/07,"Lachman Consultant Services, Inc.",2007
FDA-2007-P-0483-0001_Matrix_Laboratories__Inc____Citizen_Petition.pdf,9/5/07,"Matrix Laboratories, Inc.",2007
FDA-2007-P-0497-0001_Norbrook_Inc____Citizen_Petition.pdf,5/2/07,Norbrook Inc.,2007
FDA-2008-P-0284-0001_Bedford_Laboratories___Citizen_Petition.pdf,"March 27, 2008",Bedford Laboratories,2008
FDA-2008-P-0291-0001_PRN_Publishing___Citizen_Petition.pdf,"May 1, 2008",PRN Publishing,2008
FDA-2008-P-0296-0001_Public_Citizen___Citizen_Petition.pdf,"May 8, 2008",Public Citizen,2008
FDA-2008-P-0300-0001_Salix_Pharmaceuticals__Inc____Citizen_Petition.pdf,"May 14, 2008",Salix Pharmaceuticals  Inc,2008
FDA-2008-P-0304-0001_King_Pharmaceuticals___Citizen_Petition.pdf,"May 16, 2008",King Pharmaceuticals,2008
FDA-2008-P-0318-0001_Mylan_Pharmaceuticals__Inc____Citizen_Petition.pdf,"May 23, 2008",Mylan Pharmaceuticals  Inc,2008
FDA-2008-P-0319-0001_Lauranell_H__Burch___Citizen_Petition.pdf,"May 19, 2008",Lauranell H  Burch   Petition Denial,2008
FDA-2008-P-0325-0001_Kendle_Regulatory_Affairs___Citizen_Petition.pdf,"May 30, 2008",Kendle Regulatory Affairs   Petition A,2008
FDA-2008-P-0327-0001_Kendle_Regulatory_Affairs___Citizen_Petition.pdf,"May 30, 2008",Kendle Regulatory Affairs   Petition A,2008
FDA-2008-P-0329-0001_Osmotica_Pharmaceutical_Corp____Citizen_Petition.pdf,6/11/08,Osmotica Pharmaceutical Corp.,2008
FDA-2008-P-0333-0001_Citizen_Petition_from_Michael_Weber.pdf,6/11/08,Michael Weber,2008
FDA-2008-P-0336-0001_Patton_Boggs_LLP___Citizen_Petition.pdf,6/12/08,Patton Boggs Llp,2008
FDA-2008-P-0340-0001_Citizen_Petition_from_Lupin_Pharmaceuticals__Inc_.pdf,6/12/08,Lupin Pharmaceuticals  Inc,2008
FDA-2008-P-0343-0001_Novo_Nordisk_Inc____Citizen_Petition.pdf,"June 
9,2008",Novo Nordisk Inc,2008
FDA-2008-P-0343-0010_Novo_Nordisk_Inc____Petition_for_Reconsideration.pdf,"June 
9,2008",Novo Nordisk Inc,2008
FDA-2008-P-0343-0012_Novo_Nordisk_Inc____Petition_for_Stay_of_Action.pdf,"June 
9,2008",Novo Nordisk Inc,2008
FDA-2008-P-0346-0001_Jacob_S__Briskman___Citizen_Petition.pdf,6/17/08,Jacob S. Briskman,2008
FDA-2008-P-0348-0001_Olsson_Frank_Weeda___Citizen_Petition.pdf,6/18/08,Olsson Frank Weeda,2008
FDA-2008-P-0353-0001_Fuerst_Humphrey_Ittleman_PL___Citizen_Petition.pdf,"Feb 09,2009",Fuerst Humphrey Ittleman PL,2008
FDA-2008-P-0353-0003_Fuerst__Humphrey__Ittleman__PL___Citizen_Petition_.pdf,"Feb 09,2009",Fuerst  Humphrey  Ittleman  PL,2008
FDA-2008-P-0353-0004_Fuerst_Humphrey_Ittleman_PL___Petition_for_Reconsi.pdf,"Feb 09,2009",Fuerst Humphrey Ittleman PL,2008
FDA-2008-P-0353-0006_Fuerst_Humphrey_Ittleman_PL___Petition_for_Stay_of.pdf,"Feb 09,2009",Fuerst Humphrey Ittleman PL,2008
FDA-2008-P-0358-0004_James_P__Reichmann_Citizen_Petition__Redacted_.pdf,6/26/08,James P. Reichmann,2008
FDA-2008-P-0363-0001_Nordic_Cryobank_ApS___Citizen_Petition_.pdf,7/1/08,Nordic Cryobank Aps,2008
FDA-2008-P-0365-0001_ISTA_Pharmaceuticals___Citizen_Petition.pdf,"June 23,2008",ISTA Pharmaceuticals   Petition Denied,2008
FDA-2008-P-0365-0003_FDA_to_ISTA_Pharmaceuticals___Petition_Denied.pdf,"June 23,2008",ISTA Pharmaceuticals   Petition Denied,2008
FDA-2008-P-0366-0001_Purdue_Pharm_L_P____Citizen_Petition.pdf,"June 23, 2008",Purdue Pharma L P    Petition Denial,2008
FDA-2008-P-0366-0005_Purdue_Pharm_L_P____Supplement_Citizen_Petition_.pdf,"June 23, 2008",Purdue Pharma L P    Petition Denial,2008
FDA-2008-P-0368-0001_ISTA_Pharmaceuticals___Citizen_Petition_.pdf,7/1/08,Ista Pharmaceuticals,2008
FDA-2008-P-0384-0001_Laurie_L__Rentas___Citizen_Petition_.pdf,7/3/08,Laurie L. Rentas,2008
FDA-2008-P-0404-0001_Strides_Arcolab_Ltd___Citizen_Petition.pdf,7/16/08,Strides Arcolab Ltd,2008
FDA-2008-P-0405-0001_Strides_Arcolab_Ltd___Citizen_Petition.pdf,7/16/08,Strides Arcolab Ltd,2008
FDA-2008-P-0408-0001_Foley___Lardner_LLP___Citizen_Petition.pdf,7/23/08,Foley & Lardner Llp,2008
FDA-2008-P-0411-0007_Novo_Nordisk_Inc____Petition_for_Reconsideration.pdf,"June 9, 2008",Caraco Pharmaceuticals Laboratories  L,2008
FDA-2008-P-0411-0009_Novo_Nordisk_Inc____Petition_for_Stay_of_Action.pdf,"June 9, 2008",Caraco Pharmaceuticals Laboratories  L,2008
FDA-2008-P-0412-0001_Foley___Lardner_LLP___Citizen_Petition.pdf,7/18/08,Foley & Lardner Llp,2008
FDA-2008-P-0431-0001_Crixmor_LLC___Citizen_Petition.pdf,7/29/08,Crixmor Llc,2008
FDA-2008-P-0443-0001_PharmaForce__Inc____Citizen_Petition.pdf,8/8/08,"Pharmaforce, Inc.",2008
FDA-2008-P-0444-0001_Codonics_Inc____Citizen_Petition.pdf,11/7/08,Codonics Inc.,2008
FDA-2008-P-0445-0001_CPT_Pulp___Paper__LLC___Citizen_Petition.pdf,8/8/08,"Cpt Pulp & Paper, Llc",2008
FDA-2008-P-0452-0001_Citizen_Petition_from_The_Weston_A__Price_Foundati.pdf,"August 8, 2008",The Weston A  Price Foundati,2008
FDA-2009-P-0003-0001_Organic_Pastures_Dairy_Company___Citizen_Petition.pdf,1/9/09,Organic Pastures Dairy Company,2009
FDA-2009-P-0004-0001_Therapeutic_Proteins__Inc____Citizen_Petition.pdf,1/9/09,"Therapeutic Proteins, Inc.",2009
FDA-2009-P-0040-0001_King_Pharmaceuticals__Inc_____Citizen_Petition.pdf,"September 26, 2007",King Pharmaceuticals  Inc    Petition Parti,2009
FDA-2009-P-0040-0006_FDA_to_King_Pharmaceuticals__Inc____Petition_Parti.pdf,"September 26, 2007",King Pharmaceuticals  Inc    Petition Parti,2009
FDA-2009-P-0045-0001_Gastroenterology_Institute___Citizen_Petition.pdf,,Gastroenterology Institute Petition Deni,2009
FDA-2009-P-0045-0003_FDA_OP_to_Gastroenterology_Institute_Petition_Deni.pdf,,Gastroenterology Institute Petition Deni,2009
FDA-2009-P-0055-0001_APP_Pharmaceuticals__LLC___Citizen_Petition_1_.pdf,"April 24, 2009",APP Pharmaceuticals  LLC,2009
FDA-2009-P-0055-0003_APP_Pharmaceuticals__LLC___Citizen_Petition_2_.pdf,"April 24, 2009",APP Pharmaceuticals  LLC,2009
FDA-2009-P-0055-0005_APP_Pharmaceuticals_LLC___Supplement_Petition__32_.pdf,"April 24, 2009",,2009
FDA-2009-P-0055-0006_APP_Pharmaceuticals_LLC___Supplement_Petition__16_.pdf,"April 24, 2009",,2009
FDA-2009-P-0059-0001_Eurand_Pharmaceuticals__Inc____Citizen_Petition.pdf,"February 6, 2009",Eurand Pharmaceuticals  Inc,2009
FDA-2009-P-0067-0001_APP_Pharmaceuticals__LLC___Citizen_Petition_.pdf,"February 9, 2009",APP Pharmaceuticals  LLC,2009
FDA-2009-P-0068-0001_APP_Pharmaceuticals__LLC____Citizen_Petition_.pdf,"February 9, 2009",APP Pharmaceuticals LLC    Petition A,2009
FDA-2009-P-0068-0003_APP_Pharmaceuticals_LLC___Supplement_Petition.pdf,"April 24, 2009",,2009
FDA-2009-P-0068-0004_FDA_CDER__to_APP_Pharmaceuticals_LLC____Petition_A.pdf,"February 9, 2009",APP Pharmaceuticals LLC    Petition A,2009
FDA-2009-P-0069-0001_APP_Pharmaceuticals__LLC___Citizen_Petition.pdf,2/17/09,"App Pharmaceuticals, Llc",2009
FDA-2009-P-0069-0003_APP_Pharmaceuticals_LLC___Supplement_Petition.pdf,"April 24, 2009",,2009
FDA-2009-P-0069-0004_APP_Pharmaceuticals__LLC___Amendment_to_Petition.pdf,"June 10, 2009",Petition,2009
FDA-2009-P-0070-0001_APP_Pharmaceuticals__LLC___Citizen_Petition.pdf,"June 2, 2009",APP Pharmaceuticals  LLC,2009
FDA-2009-P-0074-0001_E__Douglas_Kramer___Citizen_Petition.pdf,2/19/09,E. Douglas Kramer,2009
FDA-2009-P-0080-0001_APP_Pharmaceuticals__LLC___Citizen_Petition.pdf,"February 17,2009",APP Pharmaceuticals  LLC   Petition Ap,2009
FDA-2009-P-0082-0001_APP_Pharmaceuticals__LLC___Citizen_Petition.pdf,2/20/09,"App Pharmaceuticals, Llc",2009
FDA-2009-P-0085-0001_APP_Pharmaceuticals__LLC___Citizen_Petition.pdf,"February 17, 2009",APP Pharmaceuticals  LLC   Petition Ap,2009
FDA-2009-P-0089-0001_Novo_Nordisk_Inc____Citizen_Petition.pdf,2/20/09,Novo Nordisk Inc.,2009
FDA-2009-P-0094-0001_Citizen_Petition_from_American_Association_for_Hea.pdf,2/23/09,American Association for Hea,2009
FDA-2009-P-0105-0001_Exhibit_A____Medtronic_Citizen_Petitioners___Willi.pdf,2/26/09,"Williams Kherkher Hart Boundas, Llp",2009
FDA-2009-P-0107-0001_APP_Pharmaceuticals__LLC___Citizen_Petition.pdf,2/26/09,"App Pharmaceuticals, Llc",2009
FDA-2009-P-0107-0003_APP_Pharmaceuticals_LLC___Supplement_Petition.pdf,"April 24, 2009",,2009
FDA-2009-P-0108-0001_APP_Pharmaceuticals__LLC___Citizen_Petition.pdf,"February 23, 2009",APP Pharmaceuticals  LLC,2009
FDA-2009-P-0109-0001_APP_Pharmaceuticals__LLC___Citizen_Petition.pdf,"February 23, 2009",APP Pharmaceuticals  LLC,2009
FDA-2009-P-0109-0003_APP_Pharmaceuticals_LLC___Supplement_Petition.pdf,"April 24, 2009",,2009
FDA-2009-P-0110-0001_PetMedicus_Laboratories__Inc____Citizen_Petition.pdf,2/26/09,"Petmedicus Laboratories, Inc.",2009
FDA-2009-P-0111-0001_Thomas_J__Quinn___Citizen_Petition.pdf,3/4/09,Thomas J. Quinn,2009
FDA-2009-P-0116-0001_Vistaurum_Corporation___Citizen_Petition.pdf,3/4/09,Vistaurum Corporation,2009
FDA-2009-P-0117-0001_Kimberly_Clark_Health_Care___Citizen_Petition.pdf,3/4/09,Kimberly-Clark Health Care,2009
FDA-2009-P-0121-0001_PE_PharmEng_Technology__Inc____Citizen_Petition.pdf,3/4/09,"Pe Pharmeng Technology, Inc.",2009
FDA-2009-P-0122-0001_K__Paul_Stoller__MD___Citizen_Petition.pdf,3/9/09,"K. Paul Stoller, Md",2009
FDA-2009-P-0123-0009_Auxilium_Pharmaceuticals__Inc____Citizen_Petition_.pdf,3/11/09,"Auxilium Pharmaceuticals, Inc.",2009
FDA-2010-P-0012-0001_Patrick_Foster___Citizen_Petition.pdf,"December 21, 2009",Patrick Foster,2010
FDA-2010-P-0017-0001_Foley___Lardner_LLP___Citizen_Petition.pdf,"January 6, 2010",Foley   Lardner LLP,2010
FDA-2010-P-0060-0001_Virgilian__LLC____Citizen_Petition.pdf,"January 11, 2010",Virgilian  LLC,2010
FDA-2010-P-0069-0001_Foley___Lardner__LLP___Citizen_Petition.pdf,"January 6, 2010",Foley   Lardner  LLP,2010
FDA-2010-P-0072-0001_Arent_Fox__LLP___Citizen_Petition.pdf,"January 27, 2010",Arent Fox  LLP,2010
FDA-2010-P-0087-0001_Sandoz__Inc____Citizen_Petition.pdf,"February 9, 2010",Sandoz  Inc,2010
FDA-2010-P-0091-0001_Citizen_Petition_from_Emily_Robin_et_al.pdf,3/1/10,Emily Robin et al,2010
FDA-2010-P-0096-0001_OncoTherapies_Limited___Citizen_Petition.pdf,"February 15, 2010",OncoTherapies Limited,2010
FDA-2010-P-0105-0001_National_Chicken_Council__NCC____Citizen_Petition.pdf,"February 19,2010",National Chicken Council  NCC,2010
FDA-2010-P-0111-0001_Warner_Chilcott_Company__LLC___Citizen_Petition.pdf,"February 22, 2010",Warner Chilcott Company  LLC,2010
FDA-2010-P-0111-0012_Shire_Pharmaceuticals__Inc____Petition_for_Reconsi.pdf,"September 16, 2010",Shire Pharmaceuticals  Inc,2010
FDA-2010-P-0114-0001_McGuff_Pharmaceuticals__Inc____Citizen_Petition.pdf,"February 19, 2010",McGuff Pharmaceuticals  Inc,2010
FDA-2010-P-0116-0001_Watson_Laboratories__Inc____Citizen_Petition.pdf,"February 24, 2010",Watson Laboratories  Inc,2010
FDA-2011-P-0018-0001_Dwayne_A__Ratleff___Citizen_Petition_.pdf,"December 22, 2010",Dwayne A  Ratleff,2011
FDA-2011-P-0022-0009_Petition_for_Reconsideration_from_Waxler_Consultan.pdf,"July 22, 2014",Waxler Consultan,2011
FDA-2011-P-0032-0001_Anika_Therapeutics__Inc____Petition_for_Reconsider.pdf,"January 10,2011",Anika Therapeutics  Inc,2011
FDA-2011-P-0045-0001_Purdue_Pharma_L_P___Purdue____Citizen_petition.pdf,"January 14, 2411",,2011
FDA-2011-P-0047-0001_InvaGen_Pharmaceuticals__Inc____Citizen_Petition_.pdf,"January 14, 2011",InvaGen Pharmaceuticals  Inc,2011
FDA-2011-P-0059-0001_Citizen_Petition_from_Hospira_Inc_.pdf,"January 25, 2011",Hospira Inc,2011
FDA-2011-P-0064-0001_Barbara_L__Maw__P_C____Citizen_Petition_.pdf,"January 20,2011",Barbara L  Maw  P C,2011
FDA-2011-P-0078-0004_FDA_CVM_to_Ceva_Animal_Health_LLC___Petition_Denia.pdf,MAY 18 2011,Ceva Animal Health LLC   Petition Denia,2011
FDA-2011-P-0081-0001_Armenpharm__Ltd____Citizen_Petition.pdf,"February 7, 2011",Armenpharm  Ltd,2011
FDA-2011-P-0087-0001_Navinta__LLC___Citizen_Petition.pdf,"February 9, 2011",Navinta  LLC,2011
FDA-2011-P-0115-0001_Cypress_Pharmaceutical__Inc____Citizen_Petition.pdf,"February 24, 2011",Cypress Pharmaceutical  Inc,2011
FDA-2011-P-0150-0001_SureTek_Medical___Citizen_Petition.pdf,"March 7, 2011",SureTek Medical,2011
FDA-2011-P-0151-0001_Brian_C__Mandingo___Citizen_Petition_.pdf,"March 4, 2011",Brian C  Mandingo,2011
FDA-2011-P-0173-0001_Hospira__Inc____Citizen_Petition.pdf,"March 17,2011",Hospira  Inc,2011
FDA-2011-P-0182-0001_Watson_Laboratories__Inc____Citizen_Petition.pdf,"March 21, 2011",Watson Laboratories  Inc,2011
FDA-2011-P-0186-0001_Nexus_Pharmaceuticals__Inc____Citizen_Petition.pdf,"March 17, 2011",Nexus Pharmaceuticals  Inc,2011
FDA-2011-P-0209-0001_K_L_Gates__LLP___Citizen_Petition.pdf,"March 25, 2011",K L Gates  LLP,2011
FDA-2011-P-0213-0001_CSL_Behring___Citizen_Petition.pdf,"March 25, 2011",CSL Behring,2011
FDA-2011-P-0226-0001_Hyman__Phelps___McNamara__P_C____Citizen_Petition.pdf,"March 30, 2011",Hyman  Phelps   McNamara  P C,2011
FDA-2011-P-0291-0001_Actavis_Inc____Citizen_Petition.pdf,"April 20, 2011",Actavis Inc,2011
FDA-2011-P-0292-0001_Actavis_Inc____Citizen_Petition.pdf,"September 28, 2010",Actavis Inc,2011
FDA-2011-P-0335-0001_Norbrook_Laboratories__Inc____Citizen_Petition.pdf,"May 3, 2011",Norbrook Laboratories  Inc,2011
FDA-2011-P-0337-0001_Precision_Nuclear__LLC___Citizen_Petition.pdf,"May 5, 2011",Precision Nuclear  LLC,2011
FDA-2011-P-0337-0005_FDA_CDER__to_Precision_Nuclear__LLC___Petition_App.pdf,"May 6, 2011",Precision Nuclear  LLC   Petition App,2011
FDA-2011-P-0339-0001_Leydig__Voit___Mayer__LTD___Citizen_Petition.pdf,"May 5, 2011",Leydig  Voit   Mayer  LTD,2011
FDA-2011-P-0347-0005_Medicis_Pharmaceutical_Corporation__Petition_for_R.pdf,"March 7, 2013",Medicis Pharmaceutical Corporation,2011
FDA-2011-P-0355-0001_MELA_Sciences_Inc_Citizen_Petition.pdf,"May 10, 2011",MELA Sciences Inc,2011
FDA-2011-P-0368-0001_Academic_Pharmaceuticals___Citizen_Petition.pdf,"May 4, 2011",Academic Pharmaceuticals,2011
FDA-2011-P-0397-0001_NewMarket_Pharmaceuticals__LLC____Citizen_Petition.pdf,May 2011,NewMarket Pharmaceuticals  LLC,2011
FDA-2011-P-0437-0001_Cancer_Action_NY___Citizen_Petition.pdf,"FEBRUARY 24, 2011",Cancer Action NY,2011
FDA-2011-P-0437-0003_Closure_of_Citizen_Petition_from_Donald_Hassig.pdf,"January 24, 2024",Donald Hassig,2011
FDA-2011-P-0450-0001_MSMB_Capital_Management_LLC___Citizen_Petition.pdf,June 20084,MSMB Capital Management LLC,2011
FDA-2011-P-0460-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,6/26/11,Lachman Consultant Services,2011
FDA-2011-P-0479-0001_Citizen_Petition_from_Dr__S__Albert_Edwards_Redact.pdf,"June 6,2011",Dr  S  Albert Edwards Redact,2011
FDA-2011-P-0482-0001_Novo_Nordisk__Inc____Citizen_Petition.pdf,"June 17, 2011",Novo Nordisk  Inc,2011
FDA-2011-P-0488-0001_Sandoz__Inc____Citizen_Petition.pdf,7/18/11,"Sandoz, Inc.",2011
FDA-2011-P-0497-0001_Washington_Legal_Foundation___Citizen_Petition.pdf,"June 28,2011",Washington Legal Foundation,2011
FDA-2011-P-0512-0011_Petition_to_Stay_and_for_Reconsideration.pdf,"February 8, 2017",Stay and for Reconsideration,2011
FDA-2011-P-0540-0001_Pharmgate__LLC___Citizen_Petition.pdf,"August 14, 2009",Pharmgate  LLC,2011
FDA-2011-P-0550-0001_B__Braun_Medical__Inc____Citizen_Petition.pdf,"June 27, 2011",B  Braun Medical  Inc,2011
FDA-2011-P-0551-0001_B__Braun_Medical__Inc____Citizen_Petition.pdf,"June 27, 2011",B  Braun Medical  Inc,2011
FDA-2011-P-0552-0001_Robert_Wagner___Citizen_Petition_2_.pdf,"July 11,2011",Robert Wagner,2011
FDA-2011-P-0575-0001_Warner_Chilcott_Company__LLC____Citizen_Petition.pdf,"July 29, 2011",Warner Chilcott Company  LLC,2011
FDA-2011-P-0578-0001_Academic_Pharmaceuticals__Inc____Citizen_Petition.pdf,"July 27, 2011",Academic Pharmaceuticals  Inc,2011
FDA-2011-P-0580-0001_Charles_Watson___Citizen_Petition__Redacted_.pdf,"MAY 19, 2011",Charles Watson,2011
FDA-2011-P-0590-0001_Kim_Witczak_and_William_Vaughn___Citizen_Petition_.pdf,"August 5, 2011",Kim Witczak and William Vaughn,2011
FDA-2011-P-0596-0010_Dr_Richard_M_Fleming_Petition_for_Reconsideration_.pdf,September 2012,Dr Richard M Fleming,2011
FDA-2011-P-0606-0001_Actavis__Inc__Citizen_Petition.pdf,"August 17, 2011",Actavis  Inc,2011
FDA-2011-P-0609-0001_Elizabeth_Kohler___Citizen_Petition.pdf,"September 6, 201",Elizabeth Kohler,2011
FDA-2011-P-0637-0001_Alliance_for_Natural_Health_USA___Citizen_Petition.pdf,"August 11, 2011",Alliance for Natural Health USA,2011
FDA-2011-P-0646-0008_Amended_Citizen_Petition_from_City_of_Philadelphia.pdf,"September 8, 2015",City of Philadelphia,2011
FDA-2011-P-0654-0001_Acorda_Therapeutics__Inc____Citizen_Petition.pdf,"September 6, 2011",Acorda Therapeutics  Inc,2011
FDA-2011-P-0657-0001_Citizen_Petition_from_the_National_Organization_fo.pdf,"September 2, 2011",the National Organization fo,2011
FDA-2011-P-0660-0001_RegulatoryPro_com___Citizen_Petition.pdf,"August 31, 2011",RegulatoryPro com,2011
FDA-2011-P-0662-0001_AstraZeneca_Pharmaceuticals_LP___Citizen_Petition.pdf,"September 2, 2011",AstraZeneca Pharmaceuticals LP,2011
FDA-2011-P-0663-0001_AstraZeneca_Pharmaceuticals_LP___Citizen_Petition.pdf,"September 2, 2011",AstraZeneca Pharmaceuticals LP,2011
FDA-2011-P-0701-0001_KVK_Tech__Inc____Citizen_Petition.pdf,"September 22, 2011",KVK Tech  Inc,2011
FDA-2011-P-0709-0001_Jennifer_Kuzdzal_Citizen_Petition1.pdf,10/7/11,Jennifer Kuzdzal,2011
FDA-2011-P-0717-0001_Cooley_LLP___Citizen_Petition.pdf,"September 29, 2011",Cooley LLP,2011
FDA-2011-P-0727-0001_12TH_Man_Technologies___Citizen_Petition.pdf,"October 4, 2011",12TH Man Technologies,2011
FDA-2011-P-0728-0001_WraSer_Pharmaceuticals__LLC___Cititzen_Petition.pdf,"October 5, 2011",,2011
FDA-2011-P-0734-0001_Richard_J__Miller___Citizen_Petition.pdf,"October 3, 2011",Richard J  Miller,2011
FDA-2011-P-0740-0001_Allan_M__Green__M_D___LLC__Citizen_Petition.pdf,October 2011,Allan M  Green  M D   LLC,2011
FDA-2011-P-0756-0001_Lupin_Pharmaceuticals_Inc_Citizen_Petition.pdf,"October 14, 2011",Lupin Pharmaceuticals Inc,2011
FDA-2011-P-0767-0001_Somaxon_Pharmaceuticals__Inc____Citizen_Petition.pdf,"October 20, 2011",Somaxon Pharmaceuticals  Inc,2011
FDA-2011-P-0798-0001_Dr_S_Albert_Edwards__Citizen_Petition.pdf,11/4/11,Dr. S. Albert Edwards,2011
FDA-2011-P-0801-0001_Holland_and_Knight_LLP___Citizen_Petition.pdf,"November 1, 2011",Holland and Knight LLP,2011
FDA-2011-P-0818-0001_Jubilant_HollisterStier_LLC__Citizen_Petition.pdf,"November 9, 2011",Jubilant HollisterStier LLC,2011
FDA-2011-P-0820-0001_G_Scott_Crowther_PE_Citizen_Petition.pdf,"November 8, 2011",G Scott Crowther PE,2011
FDA-2011-P-0821-0001_Lachman_Consultant_Services_Inc_Citizen_Petition.pdf,"November 10, 2011",Lachman Consultant Services Inc,2011
FDA-2011-P-0822-0001_Lupin_Pharmaceuticals_Inc__Citizen_Petition.pdf,"November 10, 2011",Lupin Pharmaceuticals Inc,2011
FDA-2011-P-0823-0001_AstraZeneca_Pharmaceuticals_LP__Citizen_Petition.pdf,"November 14, 2011",AstraZeneca Pharmaceuticals LP,2011
FDA-2011-P-0840-0001_Perrigo_Company_Citizen_Petition.pdf,"November 17, 2011",Perrigo Company,2011
FDA-2011-P-0846-0001_Citizen_Petition_from_Jubilant_HollisterStier__For.pdf,"November 9, 2011",Jubilant HollisterStier  For,2011
FDA-2011-P-0852-0001_Dr_S_Albert_Edwards___Citizen_Petition.pdf,"November 17, 2011",Dr S Albert Edwards,2011
FDA-2011-P-0869-0001_Hyman_Phelps_and_McNamara_PC__Citizen_Petition.pdf,"December 2, 2011",Hyman Phelps and McNamara PC,2011
FDA-2011-P-0884-0001_Lenard_Thylan___Citizen_Petition.pdf,"December 2, 2011",Lenard Thylan,2011
FDA-2011-P-0888-0001_Foley___Lardner_LLP___Citizen_Petition.pdf,"December 7, 2011",Foley   Lardner LLP,2011
FDA-2011-P-0913-0001_KVKTech_Inc__Citizen_Petition.pdf,"December 15, 2011",KVKTech Inc,2011
FDA-2011-P-0924-0001_Atavis_Inc_Citizen_Petition.pdf,"December 14, 2011",Atavis Inc,2011
FDA-2012-P-0050-0001_Arent_Fox_LLP_Citizen_Petition.pdf,"January 10, 2012",Arent Fox LLP,2012
FDA-2012-P-0052-0001_Lannett_Company_Inc__Citizen_Petition.pdf,"January 10, 2012",Lannett Company Inc,2012
FDA-2012-P-0061-0001_Lannett_Company_Inc__Citizen_Petition.pdf,"January 16, 2012",Lannett Company Inc,2012
FDA-2012-P-0119-0001_Mario_Morais_Citizen_Petition.pdf,"DECEMBER 05, 2011",Mario Morais,2012
FDA-2012-P-0142-0001_Lannett_Company_Inc_Citizen_Petition.pdf,"February 3, 2012",Lannett Company Inc,2012
FDA-2012-P-0153-0001_Intertek_Citizen_Petition.pdf,Feb 2012,Intertek,2012
FDA-2012-P-0200-0001_PharmaForce_Inc_Citizen_Petition.pdf,"February 29, 2012",PharmaForce Inc,2012
FDA-2012-P-0226-0001_AIDS_Healthcare_Foundation_Citizen_Petition.pdf,"March 5, 2012",AIDS Healthcare Foundation,2012
FDA-2012-P-0260-0001_Fisher_Wallace_Laboratories_LLC_Citizen_Petition.pdf,"March 8, 2012",Fisher Wallace Laboratories LLC,2012
FDA-2012-P-0270-0001_Neuro_Fitness_LLC___Citizen_Petition.pdf,"March 1, 2012",Neuro Fitness LLC,2012
FDA-2012-P-0271-0001_Lachman_Consultant_Services_Inc__Citizen_Petition.pdf,"March 14, 2012",Lachman Consultant Services Inc,2012
FDA-2012-P-0272-0001_Actavis_Inc__Attachments_1_and_2__Citizen_Petition.pdf,"March 14, 2012",Actavis Inc  Attachments 1 and 2,2012
FDA-2012-P-0275-0001_William_H_Lamont_Citizen_Petition.pdf,"March 15, 2012",William H Lamont,2012
FDA-2012-P-0279-0001_Lupin_Pharmaceutical__Inc____Citizen_Petition.pdf,"March 16, 2012",Lupin Pharmaceutical  Inc,2012
FDA-2012-P-0292-0001_Lachman_Consultant_Services_Inc_Citizen_Petition.pdf,"March 22, 2012",Lachman Consultant Services Inc,2012
FDA-2012-P-0387-0001_ABT_Molecular_Imaging_Inc_Citizen_Petition.pdf,"April 18, 2012",ABT Molecular Imaging Inc,2012
FDA-2012-P-0431-0001_Alcon_Research_Ltd_Citizen_Petition.pdf,"May 1, 2012",Alcon Research Ltd,2012
FDA-2012-P-0436-0001_Lupin_Pharmaceuticals_Inc_Citizen_Petition.pdf,"May 03, 2012",Lupin Pharmaceuticals Inc,2012
FDA-2012-P-0458-0001_Lachman_Consultant_Services_Inc_Citizen_Petition.pdf,"May 7, 2012",Lachman Consultant Services Inc,2012
FDA-2012-P-0462-0001_Douglass_Oeller_Consulting_Inc_Citizen_Petition.pdf,"May 7, 2012",Douglass Oeller Consulting Inc,2012
FDA-2012-P-0478-0001_Xspire_Pharma_LLC_Citizen_Petition.pdf,"January 14, 2011",Xspire Pharma LLC,2012
FDA-2012-P-0479-0001_Natco_Pharma_Limited__Citizen_Petition.pdf,"May 08, 2012",Natco Pharma Limited,2012
FDA-2012-P-0492-0001_Med_Pharmex_Inc_Citizen_Petition.pdf,"May 5, 2012",Med Pharmex Inc,2012
FDA-2012-P-0496-0001_Cumberland_Pharmaceuticals_Inc_Citizen_Petition.pdf,"May 17,2012",Cumberland Pharmaceuticals Inc,2012
FDA-2012-P-0497-0001_Piedmont_Animal_Health_Citizen_Petition.pdf,"May 17, 2012",Piedmont Animal Health,2012
FDA-2012-P-0497-0003_FDA_CVM_to_Piedmont_Animal_Health__Petition_Approv.pdf,"May 17, 2012",Piedmont Animal Health  Petition Approv,2012
FDA-2012-P-0499-0001_Jazz_Pharmaceuticals_Inc_Citizen_Petition.pdf,"May 18,2012",Jazz Pharmaceuticals Inc,2012
FDA-2012-P-0545-0001_Pfizer_Inc_Citizen_Petition.pdf,"May 31,2012",Pfizer Inc,2012
FDA-2012-P-0554-0001_Lupin_Pharmaceuticals_Inc__Citizen_Petition.pdf,"June 1,2012",Lupin Pharmaceuticals Inc,2012
FDA-2012-P-0566-0001_Citizen_Petition_Empire_State_Consumer_Project_Inc.pdf,"June 3, 2012",,2012
FDA-2012-P-0583-0001_Pfizer_Inc_Citizen_Petition.pdf,"June 6, 2012",Pfizer Inc,2012
FDA-2012-P-0607-0001_AIDS_Healthcare_Foundation_AHF_Citizen_Petition.pdf,"June 8, 2012",AIDS Healthcare Foundation AHF,2012
FDA-2012-P-0632-0001_Citizen_Petition_from_Par_Pharmaceutical.pdf,"June 1, 2012",Par Pharmaceutical,2012
FDA-2012-P-0637-0001_KV_Pharmaceutical_Company_Citizen_Petition.pdf,"June 15, 2012",KV Pharmaceutical Company,2012
FDA-2012-P-0649-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"June 18, 2012",Lachman Consultant Services,2012
FDA-2012-P-0661-0001_Citizen_Petition_from_Sandoz_Inc_.pdf,"June 19, 2012",Sandoz Inc,2012
FDA-2012-P-0695-0001_Lorillard_Tobacco_Company__Citizen_Petition.pdf,"June 26, 2012",Lorillard Tobacco Company,2012
FDA-2012-P-0695-0012_Lorillard_Tobacco_Company_Petition_for_Reconsidera.pdf,"November 13, 2013",Lorillard Tobacco Company,2012
FDA-2012-P-0698-0001_Lachman_Consultant_Services_Inc_Citizen_Petition.pdf,"June 27, 2012",Lachman Consultant Services Inc,2012
FDA-2012-P-0733-0001_Jazz_Pharmaceuticals_Citizen_Petition.pdf,"July 10, 2012",Jazz Pharmaceuticals,2012
FDA-2012-P-0737-0001_Actient_Pharmaceuticals_Citizen_Petition.pdf,"July 9, 2012",Actient Pharmaceuticals,2012
FDA-2012-P-0738-0001_The_Joseph_Dedvukaj_Firm_PC_Citizen_Petition.pdf,"July 9, 2012",The Joseph Dedvukaj Firm PC,2012
FDA-2012-P-0747-0001_Leroy_Leslie_Hamilton_PhD_Citizen_Petition.pdf,"July 3, 2012",Leroy Leslie Hamilton PhD,2012
FDA-2012-P-0764-0001_The_Joseph_Dedvukaj_Firm_PC_Citizen_Petition.pdf,"July 12, 2012",The Joseph Dedvukaj Firm PC,2012
FDA-2012-P-0775-0001_Xspire_Pharma_LLC_Citizen_Petition.pdf,"July 12, 2012",Xspire Pharma LLC,2012
FDA-2012-P-0794-0001_Piedmont_Animal_Health_Citizen_Petition.pdf,"July 19, 2012",Piedmont Animal Health,2012
FDA-2012-P-0794-0003_FDA_CVM_to_Piedmont_Animal_Health__Petition_Approv.pdf,8/1/12,Piedmont Animal Health  Petition Approv,2012
FDA-2012-P-0826-0001_Lachman_Consultant_Services_Inc__Citizen_Petition.pdf,"July 27, 2012",Lachman Consultant Services Inc,2012
FDA-2012-P-0854-0001_B_Braun_Medical_Inc__Citizen_Petition.pdf,"August 2, 2012",B Braun Medical Inc,2012
FDA-2012-P-0857-0001_Citizen_Petition_from_Sheller_P_C_Law_Offices.pdf,"July 27, 2012",Sheller P C Law Offices,2012
FDA-2012-P-0895-0001_Endo_Pharmaceuticals_Inc_Citizen_Petition.pdf,"August 10, 2012",Endo Pharmaceuticals Inc,2012
FDA-2012-P-0904-0001_Citizen_for_Health_Citizen_Petition.pdf,"August 15, 2012",Citizen for Health,2012
FDA-2012-P-0932-0001_Noven_Pharmaceuticals_Inc_Citizen_Petition.pdf,"August 24, 2012",Noven Pharmaceuticals Inc,2012
FDA-2012-P-0935-0001_Lachman_Consultant_Services_Inc_Citizen_Petition.pdf,"February 8, 2011",Lachman Consultant Services Inc,2012
FDA-2012-P-0947-0001_Mallinckrodt_Inc__Citizen_Petition.pdf,"August 31, 2012",Mallinckrodt Inc,2012
FDA-2012-P-0951-0001_Endo_Pharmaceuticals_Inc_Citizen_Petition.pdf,"August 31, 2012",Endo Pharmaceuticals Inc,2012
FDA-2012-P-0963-0001_Charles_J_Zimmerer_Citizen_Petition.pdf,"August 31, 2012",Charles J Zimmerer,2012
FDA-2012-P-0964-0001_Lannett_Company_Inc_Citizen_Petition.pdf,"September 5, 2012",Lannett Company Inc,2012
FDA-2012-P-0986-0005_Second_Amendment_to_ANDA_Suitability_Petition_from.pdf,"March 2, 2018",ANDA Suitability Petition from,2012
FDA-2012-P-1000-0001_CUSTOpharm_Inc_Citizen_Petition.pdf,"September 11, 2012",CUSTOpharm Inc,2012
FDA-2012-P-1007-0001_Public_Citizen_Citizen_Petition.pdf,"September 19, 2012",Public Citizen,2012
FDA-2012-P-1029-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"September 24, 2012",Lachman Consultant Services,2012
FDA-2012-P-1034-0001_Lachman_Consultant_Sevices_Inc_Citizen_Petition.pdf,"September 27, 2012",Lachman Consultant Sevices Inc,2012
FDA-2012-P-1043-0001_Foley_Lardner_LLP_Citizen_Petition.pdf,"October 2, 2012",Foley Lardner LLP,2012
FDA-2012-P-1053-0001_Citizen_Petition_from_Public_Citizen.pdf,"October 4, 2012",Public Citizen,2012
FDA-2012-P-1058-0001_Lachman_Consultant_Sevices_Inc_Citizen_Petition.pdf,"October 10, 2012",Lachman Consultant Sevices Inc,2012
FDA-2012-P-1068-0001_Ben_Venue_Laboratories_Inc_Citizen_Petition.pdf,"February 1, 2007",Ben Venue Laboratories Inc,2012
FDA-2012-P-1071-0001_Law_Office_of_Alvin_J_Lorman_Citizen_Petition.pdf,"October 12, 2012",Law Office of Alvin J Lorman,2012
FDA-2012-P-1087-0001_Warner_Chilcott_Company_LLC_Citizen_Petition.pdf,"October 24, 2012",Warner Chilcott Company LLC,2012
FDA-2012-P-1095-0001_Resveratrol_Partners_LLC_Citizen_Petition.pdf,April 2012,Resveratrol Partners LLC,2012
FDA-2012-P-1104-0001_Lachman_Consultant_Services_Inc_Citizen_Petition.pdf,"November 2, 2012",Lachman Consultant Services Inc,2012
FDA-2012-P-1107-0001_FzioMed_Inc_Hogan_Lovells_US_LLP_Citizen_Petition.pdf,"November 5, 2012",FzioMed Inc Hogan Lovells US LLP,2012
FDA-2012-P-1107-0033_Oxiplex__SP_Gel__FzioMed__Incorporated_s_Petition_.pdf,"May 14, 2014",,2012
FDA-2012-P-1107-0039_OXIPLEX_SP_Gel__FzioMed__Incorporated_s_Petition_f.pdf,"June 10, 2014",,2012
FDA-2012-P-1112-0001_Nobel_Laboratories_LLC_Citizen_Petition.pdf,"October 21,2012",Nobel Laboratories LLC,2012
FDA-2012-P-1112-0011_Petition_For_Reconsideration_From_Nobel_Laboratori.pdf,"January 22,2015",Nobel Laboratori,2012
FDA-2012-P-1128-0001_Dechra_Ltd_Citizen_Petition.pdf,"October 23, 2012",Dechra Ltd,2012
FDA-2012-P-1128-0003_Dechra_Ltd_Citizen_Petition.pdf,"October 23, 2012",Dechra Ltd,2012
FDA-2012-P-1147-0001_Foley_Lardner_LLP_Citizen_Petition.pdf,"November 13, 2012",Foley Lardner LLP,2012
FDA-2012-P-1158-0001_Milagros_Demier_Citizen_Petition.pdf,"November 20, 2012",Milagros Demier,2012
FDA-2012-P-1160-0001_Steven_A_Zecola_Citizen_Petition_Redacted_Version.pdf,"November 15, 2012",Steven A Zecola,2012
FDA-2012-P-1170-0001_Cephazone_Pharma_LLC_Citizen_Petition.pdf,"November 12, 2012",Cephazone Pharma LLC,2012
FDA-2012-P-1179-0001_Jack_M_Saroyan_DDS_Citizen_Petition.pdf,"November 24, 2012",Jack M Saroyan DDS,2012
FDA-2012-P-1180-0001_Lannett_Company_Inc_Citizen_Petition.pdf,"November 26, 2012",Lannett Company Inc,2012
FDA-2012-P-1180-0003_Lannett_Co_Inc_Amendment_to_Suitability_Petition.pdf,"December 17, 2012",Suitability Petition,2012
FDA-2012-P-1252-0001_Center_for_Food_Safety_CFS_Citizen_Petition.pdf,"December 20, 2012",Center for Food Safety CFS,2012
FDA-2012-P-1259-0001_Hyman_Phelps_McNamara_PC_Citizen_Petition.pdf,"December 21, 2012",Hyman Phelps McNamara PC,2012
FDA-2012-P-1265-0001_Indicus_Pharma_LLC_Citzen_Petition.pdf,"December 17, 2012",,2012
FDA-2012-P-1267-0001_Xspire_Pharma_LLC_Citizen_Petition.pdf,"December 26, 2012",Xspire Pharma LLC,2012
FDA-2013-P-0025-0001_Citizen_Petition_from_Teva_Pharmaceutical_Industri.pdf,"December 31, 2012",Teva Pharmaceutical Industri,2013
FDA-2013-P-0028-0001_Custo_Pharm_Inc_Citizen_Petition.pdf,"December 28, 2012",Pharm Inc Citizen Petition,2013
FDA-2013-P-0028-0003_CustoPharm_Inc_Amendment_to_Citizen_Petition.pdf,"December 28, 
2012",Citizen Petition,2013
FDA-2013-P-0761-0001_Poly_Cell_Technologies_LLC___Health_Claim_Petition.pdf,"January 31, 2013",Poly Cell Technologies LLC,2013
FDA-2013-P-0766-0001_Amedra_Pharmaceuticals_LLC_Citizen_Petition.pdf,"June 18, 2013",Amedra Pharmaceuticals LLC,2013
FDA-2014-P-0038-0001_Riverain_Technologies_Reclassification_Petition.pdf,"December 18, 2013",,2014
FDA-2014-P-0073-0001_Citizen_Petition_From_Jubilant_Life_Sciences_Limit.pdf,"January 03, 2014",Jubilant Life Sciences Limit,2014
FDA-2014-P-0076-0001_Citizen_Petition_From_Lannett_Company_Inc.pdf,"January 8, 2014",Lannett Company Inc,2014
FDA-2014-P-0077-0001_Citizen_Petition_From_Janssen_Pharmaceutical_Compa.pdf,"January 7, 2014",Janssen Pharmaceutical Compa,2014
FDA-2014-P-0099-0001_Citizen_Petition_From_Apotex_Corp.pdf,"January 10, 2014",Apotex Corp,2014
FDA-2014-P-0111-0001_Reclassification_Petition_From_LeMaitre_Vascular_I.pdf,"January 9, 2014",LeMaitre Vascular I,2014
FDA-2014-P-0112-0001_Citizen_Petition_From_NadaChair.pdf,"January 3, 2014",NadaChair,2014
FDA-2014-P-0123-0001_Citizen_Petition_From_Consumer_Reports.pdf,"January 21,2014",Consumer Reports,2014
FDA-2014-P-0142-0001_Citizen_Petition_From_Emcure_Pharmaceuticals_USA_I.pdf,"January 21, 2014",Emcure Pharmaceuticals USA I,2014
FDA-2014-P-0143-0001_Citizen_Petition_From_Gail_Gudmundsen_Redacted.pdf,"January 16, 2014",Gail Gudmundsen Redacted,2014
FDA-2014-P-0144-0001_Citizen_Petition_From_Sucampo_Pharma_Americas_LLC.pdf,"January 17, 2014",Sucampo Pharma Americas LLC,2014
FDA-2014-P-0158-0001_Citizen_Petition_From_Christohper_Schweitzer_Redac.pdf,1/31/14,Christohper Schweitzer Redac,2014
FDA-2014-P-0159-0001_Electronic_Citizen_Petition_From_Mead_Killion_Reda.pdf,"January 28, 2014",Mead Killion Reda,2014
FDA-2014-P-0169-0001_Citizen_Petition_From_Strides_Inc_A_Mylan_Company.pdf,"January 29, 2014",Strides Inc A Mylan Company,2014
FDA-2014-P-0181-0001_Citizen_Petition_From_Imagenetix_Inc_Kotchen_and_L.pdf,"January 31, 2014",Imagenetix Inc Kotchen and L,2014
FDA-2014-P-0196-0001_Citizen_Petition_from_Lannett_Company_Inc.pdf,"January 8, 2014",Lannett Company Inc,2014
FDA-2014-P-0205-0001_Citizen_Petition_From_Purdue_Pharma_LP_Kleinfeld_K.pdf,"September 10, 
2013",Purdue Pharma LP Kleinfeld K,2014
FDA-2014-P-0205-0005_150617_Purdue_Pharma_petition_supplement.pdf,"June 17, 2015",,2014
FDA-2014-P-0206-0001_Citizen_Petition_From_Roger_Cady_et_al_Redacted.pdf,2/25/14,Roger Cady et al Redacted,2014
FDA-2014-P-0209-0001_Citizen_Petition_From_Horizon_Pharma_Inc.pdf,"February 03, 2014",Horizon Pharma Inc,2014
FDA-2014-P-0210-0001_Citizen_Petition_From_Greenblum_Bernstein_PLC.pdf,"February 11, 2014",Greenblum Bernstein PLC,2014
FDA-2014-P-0230-0001_Citizen_Petition_From_Lachman_Consultant_Services_.pdf,"February 11, 2014",Lachman Consultant Services,2014
FDA-2014-P-0231-0001_Citizen_Petition_From_Adaptive_Engineering_Inc.pdf,"Dec. 2, 2013",Adaptive Engineering Inc,2014
FDA-2014-P-0241-0001_Citizen_Petition_From_Public_Citizen.pdf,"February 25, 2014",Public Citizen,2014
FDA-2014-P-0245-0001_Citizen_Petition_From_The_Sugar_Association_Inc.pdf,"February 18, 2014",The Sugar Association Inc,2014
FDA-2014-P-0251-0001_Citizen_Petition_From_Gordon_Johnston_Regulatory_C.pdf,"February 24, 2014",Gordon Johnston Regulatory C,2014
FDA-2014-P-0258-0001_Citizen_Petition_From_Public_Citizen.pdf,"February 25, 2014",Public Citizen,2014
FDA-2014-P-0259-0001_Citizen_Petition_From_Sabra_Dipping_Co_LLC.pdf,3/7/14,Sabra Dipping Co LLC,2014
FDA-2014-P-0263-0001_Citizen_Petition_From_Ferrero_USA_Inc_Hogan_Lovell.pdf,"March 4, 2014",Ferrero USA Inc Hogan Lovell,2014
FDA-2014-P-0282-0001_Citizen_Petition_From_Custo_Pharm_Inc.pdf,3/12/14,Custo Pharm Inc,2014
FDA-2014-P-0283-0001_Citizen_Petition_From_Leroy_L_Hamilton_Redacted.pdf,"March 3, 2014",Leroy L Hamilton Redacted,2014
FDA-2014-P-0284-0001_Citizen_Petition_From_Lachman_Consultant_Services_.pdf,"March 5, 2014",Lachman Consultant Services,2014
FDA-2014-P-0290-0001_Citizen_Petition_From_Leroy_L_Hamilton_Redacted.pdf,"February 27, 2014",Leroy L Hamilton Redacted,2014
FDA-2014-P-0311-0001_Citizen_Petition_From_Shepperd_Mullen_Richter_Hamp.pdf,"March 13, 2014",Shepperd Mullen Richter Hamp,2014
FDA-2014-P-0312-0001_Citizen_Petition_From_Grocery_Manufacturers_Associ.pdf,"March 14, 2014",Grocery Manufacturers Associ,2014
FDA-2014-P-0315-0001_Citizen_Petition_From_Lachman_Consultant_Services_.pdf,"March 18, 2014",Lachman Consultant Services,2014
FDA-2014-P-0318-0001_Citizen_Petition_from_Antares_Pharma_Inc.pdf,3/28/14,Antares Pharma Inc,2014
FDA-2014-P-0328-0001_Citizen_Petition_From_Hyman_Phelps_and_McNamara_PC.pdf,"March 19, 2014",Hyman Phelps and McNamara PC,2014
FDA-2014-P-0367-0001_Citizen_Petition_From_Hyman_Phelps_and_McNamara_PC.pdf,"March 28, 2014",Hyman Phelps and McNamara PC,2014
FDA-2014-P-0377-0001_Citizen_Petition_From_Hyman_Phelps_and_McNamara.pdf,"November 6,2013",Hyman Phelps and McNamara,2014
FDA-2014-P-0404-0001_Citizen_Petition_From_Teva_Pharmaceutical_Inc_Teva.pdf,"April 3, 2014",Teva Pharmaceutical Inc Teva,2014
FDA-2014-P-0405-0001_Citizen_Petition_from_Ken_Surprenant_Redacted.pdf,"April 6, 2014",Ken Surprenant Redacted,2014
FDA-2014-P-0407-0001_Citizen_Petition_from_Almatica_Pharma_Inc.pdf,4/3/14,"Almatica Pharma, Inc.",2014
FDA-2014-P-0422-0001_Citizen_Petition_from_Jason_Williams_Redacted.pdf,4/10/14,Jason R. Williams,2014
FDA-2014-P-0427-0002_Citizen_Petition_From_Medicem_Technology.pdf,3/26/14,Medicem Technology,2014
FDA-2014-P-0445-0001_Citizen_Petition_From_Robert_L_Lytle_Redacted.pdf,4/2/14,Robert L. Lytle,2014
FDA-2014-P-0446-0001_Citizen_Petition_from_Starkist_Company_Pisani_and_.pdf,4/11/14,Starkist Company (Pisani And Roll Llp),2014
FDA-2014-P-0461-0001_Citizen_Petition_From_Wiley_Rein_LLP.pdf,4/14/14,Wiley Rein Llp,2014
FDA-2014-P-0462-0001_Citizen_Petition_From_Wiley_Rein_LLP.pdf,4/14/14,Wiley Rein Llp,2014
FDA-2014-P-0496-0001_Citizen_Petition_From_Pharmacists_Planning_Service.pdf,4/9/14,Pharmacists Planning Service Inc,2014
FDA-2014-P-0497-0001_Citizen_Petition_from_Ken_Surprenant_Redacted.pdf,4/19/14,Ken Surprenant,2014
FDA-2014-P-0511-0001_Citizen_Petition_From_Agila_Specialties_Inc_.pdf,4/21/14,Agila Specialties Inc.,2014
FDA-2014-P-0513-0001_Citizen_Petition_from_University_of_TX_MD_Anderson.pdf,4/21/14,University Of Tx Md Anderson Cancer Center,2014
FDA-2014-P-0534-0001_Citizen_Petition_From_Neurelis_Inc__Pacific_Link_C.pdf,4/24/14,Neurelis Inc. (Pacific Link Consulting),2014
FDA-2014-P-0549-0001_Citizen_Petition_From_Emcure_Pharmaceuticals_Inc.pdf,"April 28, 2014",Emcure Pharmaceuticals Inc,2014
FDA-2014-P-0585-0001_Citizen_Petition_from_A__Haggag_Capstone_Law_APC.pdf,5/1/14,A. Haggag (Capstone Law),2014
FDA-2014-P-0594-0001_Citizen_Petition_From_Hyman_Phelps_McNamara_PC.pdf,5/5/14,Hyman Phelps Mcnamara P.C.,2014
FDA-2014-P-0603-0001_Citizen_Petition_from_Pacific_Link_Consulting.pdf,5/7/14,Pacific Link Consulting,2014
FDA-2014-P-0628-0001_Citizen_Petition_from_Shauce_Co.pdf,5/1/14,Shauce Company,2014
FDA-2014-P-0637-0001_Citizen_Petition_From_Lachman_Consultant_Services_.pdf,5/15/14,"Lachman Consultant Services, Inc.",2014
FDA-2014-P-0646-0001_Citizen_Petition_From_Kamat_Pharmatech.pdf,5/22/14,Kamat Pharmatech,2014
FDA-2014-P-0647-0001_Citizen_Petition_From_Kamat_Pharmatech.pdf,5/16/14,Kamat Pharmatech,2014
FDA-2014-P-0654-0001_Citizen_Petition_From_Edwards_Life_Sciences_LLC_RE.pdf,5/6/14,Edwards Lifesciences Llc,2014
FDA-2014-P-0687-0001_Citizen_PetitionFrom_Margaret_Moline_Redacted.pdf,5/20/14,Margaret Moline,2014
FDA-2014-P-0699-0001_Citizen_Petition_From_Jason_WIlliams__Redacted.pdf,5/22/14,Jason Williams,2014
FDA-2014-P-0700-0001_Citizen_Petition_From_Qilu_Pharma__Inc_.pdf,5/23/14,"Qilu Pharma, Inc. (Qilu Pharmaceutical Co., Ltd.)",2014
FDA-2014-P-0724-0001_Citizen_Petition_From_Barbara_Spohn_Lillo.pdf,10/27/14,Barbara Spohn-Lillo,2014
FDA-2014-P-0737-0001_Citizen_Petition_from_Pfizer_Ropes_and_Gray_LLP.pdf,5/30/14,Pfizer Inc (Ropes And Gray Llp),2014
FDA-2014-P-0748-0001_Citizen_Petition_From_Piedmont_Animal_Health.pdf,"May 30, 2014",Piedmont Animal Health,2014
FDA-2014-P-0752-0002_Citizen_Petition_From_Pharmacist_s_Planning_Servic.pdf,"June 4, 2014",Pharmacist s Planning Servic,2014
FDA-2014-P-0772-0001_Citizen_Petition_from_Piedmont_Animal_Health.pdf,"June 4, 2014",Piedmont Animal Health,2014
FDA-2014-P-0794-0001_Citizen_Petition_from_E5_Pharma_LLC.pdf,"June 11, 2014",E5 Pharma LLC,2014
FDA-2014-P-0802-0001_Citizen_Petition_From_Moon_T_Kwon_Redacted.pdf,1/22/14,Moon T. Kwon,2014
FDA-2014-P-0813-0001_Citizen_Petition_From_Lachman_Consultant_Services_.pdf,6/17/14,"Lachman Consultant Services, Inc.",2014
FDA-2014-P-0814-0001_Citizen_Petition_from_the_Center_for_Responsible_S.pdf,6/18/14,The Center For Responsible Science,2014
FDA-2014-P-0823-0001_Citizen_Petition_From_Richard_Burk_Redacted.pdf,6/12/14,Richard D. Burk,2014
FDA-2014-P-0825-0001_Citizen_Petition_From_Orthofix_Inc_.pdf,6/19/14,Orthofix Inc.,2014
FDA-2014-P-0830-0001_Citizen_Petition_From_Merz_North_America__Buchanan.pdf,6/19/14,"Merz North America (Buchanan, Ingersoll And Rooney Pc)",2014
FDA-2014-P-0831-0001_Citizen_Petition_From_Orthofix_Inc_.pdf,August 2011,Orthofix Inc,2014
FDA-2014-P-0856-0001_Citizen_Petition_from_the_Southern_Network_on_Adve.pdf,6/18/14,The Southern Network On Adverse Reactions,2014
FDA-2014-P-0861-0001_Citizen_Petition_From_Clinipace_Worldwide.pdf,6/20/14,Clinipace Worldwide,2014
FDA-2014-P-0862-0001_Citizen_Petition_from_the_Alliance_for_Natural_Hea.pdf,6/23/14,The Alliance For Natural Health Usa,2014
FDA-2014-P-0878-0001_Citizen_Petition_From_Amarin_Pharma_Inc.pdf,"June 24, 2014",Amarin Pharma Inc,2014
FDA-2014-P-0907-0001_Citizen_Petition_from_Citizens_for_Health_et_al_Sw.pdf,"June 30, 2014",Citizens for Health et al Sw,2014
FDA-2014-P-0908-0001_Citizen_Petition_from_Mothers_Against_Mercury_Titu.pdf,"January 27, 2015",Mothers Against Mercury Titu,2014
FDA-2014-P-0916-0001_Citizen_Petition_From_Hope_Pharmaceuticals.pdf,"June 18, 2014",Hope Pharmaceuticals,2014
FDA-2014-P-0919-0001_Citizen_Petition_From_Daniel_Schumaier_PhD_Redacte.pdf,"June 18, 2014",Daniel Schumaier PhD Redacte,2014
FDA-2014-P-0933-0001_Citizen_Petition_From_Teva_Neuroscience_Inc_Redact.pdf,7/2/14,Teva Neuroscience,2014
FDA-2014-P-0935-0001_Citizen_Petition_from_The_Juice_Products_Associati.pdf,"July 2, 2014",The Juice Products Associati,2014
FDA-2014-P-0979-0001_Citizen_Petition_from_Emcure_Pharmaceuticals_USA_I.pdf,"July 03, 2014",Emcure Pharmaceuticals USA I,2014
FDA-2014-P-0980-0001_Citizen_Petition_From_Lachman_Consultant_Services_.pdf,"July 07, 2014",Lachman Consultant Services,2014
FDA-2014-P-0984-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"July 7, 2014",Lachman Consultant Services,2014
FDA-2014-P-1038-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"July 16, 2014",Lachman Consultant Services,2014
FDA-2014-P-1044-0001_Citizen_Petition_from_Zydus_Pharmaceuticals_Inc.pdf,"July 14, 2014",Zydus Pharmaceuticals Inc,2014
FDA-2014-P-1057-0001_Citizen_Petition_from_Pharmacists_Planning_Service.pdf,"July 18, 2014",Pharmacists Planning Service,2014
FDA-2014-P-1065-0001_Citizen_Petition_from_Zydus_Pharmaceuticals_Inc.pdf,"July 08, 2014",Zydus Pharmaceuticals Inc,2014
FDA-2014-P-1101-0001_Citizen_Petition_From_Lachman_Consultant_Services_.pdf,"July 25, 2014",Lachman Consultant Services,2014
FDA-2014-P-1102-0001_Citizen_Petition_From_Lachman_Consultant_Services_.pdf,"July 25, 2014",Lachman Consultant Services,2014
FDA-2014-P-1256-0001_Citizen_Petition_from_Public_Citizen.pdf,"July 28, 2014",Public Citizen,2014
FDA-2014-P-1258-0001_Citizen_Petition_from_SolRX_Global_Inc.pdf,"August 7, 2014",SolRX Global Inc,2014
FDA-2014-P-1281-0001_Citizen_Petition_from_Arnall_Golden_Gregory_LLP.pdf,"july 3, 2014",Arnall Golden Gregory LLP,2014
FDA-2014-P-1282-0001_Citizen_Petition_from_Morgan_Lewis_and_Bockius_LLP.pdf,"July 17, 2014",Morgan Lewis and Bockius LLP,2014
FDA-2014-P-1282-0005_Suitability_Petition_Amendment_from_Morgan_Lewis__.pdf,"October 19, 2016",Morgan Lewis,2014
FDA-2014-P-1293-0001_Citizen_Petition_from_Hyman_Phelps_and_McNamara_PC.pdf,"August 13, 2014",Hyman Phelps and McNamara PC,2014
FDA-2014-P-1343-0001_Citizen_Petition_from_American_Society_of_Interven.pdf,"September 3, 2014",American Society of Interven,2014
FDA-2014-P-1353-0001_Citizen_Petition_from_International_Formula_Counci.pdf,"September 5, 2014",International Formula Counci,2014
FDA-2014-P-1354-0001_Citizen_Petition_from_Otsuka_Pharmaceutical_Compan.pdf,"September 9, 2014",Otsuka Pharmaceutical Compan,2014
FDA-2014-P-1383-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"August 27, 2014",Lachman Consultant Services,2014
FDA-2014-P-1429-0001_Citizen_Petition_from_Oliver_Boudreaux_Redacted.pdf,"August 25, 2014",Oliver Boudreaux Redacted,2014
FDA-2014-P-1470-0001_Citizen_Petition_from_Hyman_Phelps___McNamara_PC.pdf,"August 21, 2014",Hyman Phelps   McNamara PC,2014
FDA-2014-P-1472-0001_Citizen_Petition_from_Strides_Arcolab_Limited_Indi.pdf,"September 29, 2014",Strides Arcolab Limited Indi,2014
FDA-2014-P-1483-0001_Citizen_Petition_from_Sean_Mahoney_Upsher_Smith_La.pdf,"September 30, 2014",Sean Mahoney Upsher Smith La,2014
FDA-2014-P-1562-0001_Citizen_Petition_from_the_Institute_for_Safe_Medic.pdf,"October 8, 2014",the Institute for Safe Medic,2014
FDA-2014-P-1569-0002_Citizen_Petition_from_Pharmacists_Planning_Service.pdf,"October 9, 2014",Pharmacists Planning Service,2014
FDA-2014-P-1570-0001_Citizen_Petition_From_the_Natural_Solutions_Founda.pdf,"September 23, 2014",the Natural Solutions Founda,2014
FDA-2014-P-1576-0001_Citizens_Petition_from_Gordon_Johnston_Regulatory_.pdf,10/10/14,Gordon Johnston Regulatory,2014
FDA-2014-P-1593-0002_Citizen_Petition_From_Buchanan_Ingersoll_and_Roone.pdf,"September 15,2014",Buchanan Ingersoll and Roone,2014
FDA-2014-P-1603-0001_Citizen_Petition_from_Zydus_Pharmaceuticals_USA_In.pdf,"July 30, 2014",Zydus Pharmaceuticals USA In,2014
FDA-2014-P-1611-0001_Citizen_Petition_from_Southern_Network_on_Adverse_.pdf,"September 8, 2014",Southern Network on Adverse,2014
FDA-2014-P-1615-0001_Citizen_Petition_from_Spectrum_Pharmaceuticals_Inc.pdf,"October 13, 2014",Spectrum Pharmaceuticals Inc,2014
FDA-2014-P-1622-0001_Citizen_Petition_from_Genesee_Health_System.pdf,"September 3, 2014",Genesee Health System,2014
FDA-2014-P-1649-0001_Citizen_Petition_from_Spectrum_Pharmaceuticals_Inc.pdf,"September 30, 2014",Spectrum Pharmaceuticals Inc,2014
FDA-2014-P-1650-0001_Citizen_Petition_from_Consumers_Union_et_al.pdf,"June 26, 2014",Consumers Union et al,2014
FDA-2014-P-1656-0001_Citizen_Petition_from_Alaska_Seafood_Marketing_Ins.pdf,"October 7, 2014",Alaska Seafood Marketing Ins,2014
FDA-2014-P-1657-0001_Citizen_Petition_from_Gordon_Johnston_Regulatory_C.pdf,"October 17, 2014",Gordon Johnston Regulatory C,2014
FDA-2014-P-1660-0001_Citizen_Petition_from_Teva_Pharmaceutical_Industri.pdf,"October 20, 2014",Teva Pharmaceutical Industri,2014
FDA-2014-P-1670-0001_Citizen_Petition_from_Gordon_Johnston_Regulatory_C.pdf,"September 24, 2014",Gordon Johnston Regulatory C,2014
FDA-2014-P-1673-0001_Citizen_Petition_From_Tia_Gonnella_redacted.pdf,"April 1, 2014",Tia Gonnella redacted,2014
FDA-2014-P-1685-0001_Citizen_Petition_from_Larry_R__Pilot.pdf,"September 19, 2014",Larry R  Pilot,2014
FDA-2014-P-1694-0001_Suitability_Citizen_Petition_from_Parnell_Corporat.pdf,"October 22, 2014",Parnell Corporat,2014
FDA-2014-P-1752-0001_Citizen_Petition_From_Dara_Biosciences.pdf,"October 22, 2014",Dara Biosciences,2014
FDA-2014-P-1753-0001_Citizen_Petition_From_Angela_A_Stanton_PHD_signed_.pdf,"April 1, 2014",Angela A Stanton PHD signed,2014
FDA-2014-P-1753-0004_Citizen_Petition_From_Angela_A_Stanton_PHD.pdf,"April 1, 2014",Angela A Stanton PHD,2014
FDA-2014-P-1771-0001_Citizen_Petition_From_Amgen_Sidley_Austin_LLP.pdf,"October 29, 2014",Amgen Sidley Austin LLP,2014
FDA-2014-P-1773-0001_Citizen_Petition_From_Pharmacists_Planning_Service.pdf,"September 4, 2014",Pharmacists Planning Service,2014
FDA-2014-P-1784-0001_Citizen_Petition_From_the_Wood_Burditt_Group.pdf,"August 14, 2014",the Wood Burditt Group,2014
FDA-2014-P-1796-0001_Citizen_Petition_From_Omthera_Pharmaceuticals_Hoga.pdf,"October 31, 2014",Omthera Pharmaceuticals Hoga,2014
FDA-2014-P-1802-0001_Citizen_Petition_from_e5_Pharma_LLC.pdf,11/3/14,e5 Pharma LLC,2014
FDA-2014-P-1844-0001_Citizen_Petition_Request_from_Lachman_Consultant_S.pdf,"November 4, 201",Lachman Consultant S,2014
FDA-2014-P-1844-0005_Request_to_Withdraw_Petition.pdf,"January 23, 2017",Withdraw Petition,2014
FDA-2014-P-1882-0001_Citizen_Petition_From_Isabella_Gujardo_Redacted.pdf,11/10/14,Isabella Gujardo Redacted,2014
FDA-2014-P-1883-0001_Citizen_Petition_From_Lannett_Holdings_Inc_.pdf,"November 7, 2014",Lannett Holdings Inc,2014
FDA-2014-P-1896-0001_Citizen_Petition_From_TechReg_Services_Inc.pdf,"November 12, 2014",TechReg Services Inc,2014
FDA-2014-P-1930-0001_Citizen_Petition_From_Apotex_Inc_.pdf,"November 4, 2014",Apotex Inc,2014
FDA-2014-P-1975-0001_Citizen_Petition_From_e5_Pharma_LLC.pdf,"November 14,2014",e5 Pharma LLC,2014
FDA-2014-P-2035-0001_Citizen_Petition_From_Dr_Carla_M_Davis_et_al.pdf,"November 18, 2014",Dr Carla M Davis et al,2014
FDA-2014-P-2058-0001_Citizen_Petition_From_Lachman_Consultant_Services_.pdf,"November 24, 2014",Lachman Consultant Services,2014
FDA-2014-P-2140-0001_Citizen_Petition_From_Lachman_Consulting_Services_.pdf,"September 19, 2014",Lachman Consulting Services,2014
FDA-2014-P-2168-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"December 9, 2014",Lachman Consultant Services,2014
FDA-2014-P-2169-0001_Citizen_Petition_Request_from_Lachman_Consultant_S.pdf,"December 9, 2014",Lachman Consultant S,2014
FDA-2014-P-2188-0001_Citizen_Petition_from_Acura_Pharmaceuticals_Inc.pdf,"December 10, 2014",Acura Pharmaceuticals Inc,2014
FDA-2014-P-2193-0001_Citizen_Petition_From_Acorda_Therapeutics.pdf,"December 12, 2014",Acorda Therapeutics,2014
FDA-2014-P-2243-0001_Citizen_Petition_Request_from_Apotex_Inc.pdf,"December 17, 2014",Apotex Inc,2014
FDA-2014-P-2276-0001_Citizen_Petition_From_Alan_Laboratories__Inc_.pdf,"December 22, 2014",Alan Laboratories  Inc,2014
FDA-2014-P-2301-0001_Citizen_Petition_From_Probiomed_S_A__de_C_V__Mexic.pdf,"February 25, 2014",Probiomed S A  de C V  Mexic,2014
FDA-2015-P-0014-0001_Citizen_Petition_From_Edward_Boshnick__O_D_.pdf,"December 24, 2014",Edward Boshnick  O D,2015
FDA-2015-P-0051-0001_Citizen_Petition_Request_from_Inrange_Systems_Inc.pdf,"December 26, 2014",Inrange Systems Inc,2015
FDA-2015-P-0059-0003_Citizen_Petition_from_the_Center_for_Science_in_th.pdf,"December 9, 2014",the Center for Science in th,2015
FDA-2015-P-0065-0001_Citizen_Petition_From_Allergan__Inc_.pdf,1/16/15,Allergan  Inc,2015
FDA-2015-P-0095-0008_Citizen_Petition_From_DuVal_and_Associates__Leonha.pdf,"January 8, 2015",DuVal and Associates  Leonha,2015
FDA-2015-P-0181-0001_Citizen_Petition_From_Mylan_Specialty__L_P_.pdf,"January 16, 2015",Mylan Specialty  L P,2015
FDA-2015-P-0181-0007_Petition_Supplement_from_Mylan_Specialty_LP.pdf,"April 28, 2015",Mylan Specialty LP,2015
FDA-2015-P-0233-0001_Citizen_Petition_From_the_Madison_Company.pdf,"January 22, 2015",the Madison Company,2015
FDA-2015-P-0335-0001_Citizen_Petition_From_Chrai_Associates__Inc_.pdf,January 2015,Chrai Associates  Inc,2015
FDA-2015-P-0403-0001_Citizen_Petition_Request_from_LACHMAN_CONSULTANT_S.pdf,"February 4, 2015",LACHMAN CONSULTANT S,2015
FDA-2015-P-0464-0001_Citizen_Petition_from_Colgate_Palmolive_Company.pdf,"February 10, 2015",Colgate Palmolive Company,2015
FDA-2015-P-0543-0001_Citizen_Petition_From_Gland_Pharma_Ltd_.pdf,"February 19, 2015",Gland Pharma Ltd,2015
FDA-2015-P-0547-0001_Citizen_Petition_From_Gland_Pharma__Inc_.pdf,"February 19, 2015",Gland Pharma  Inc,2015
FDA-2015-P-0569-0001_Citizen_Petition_From_Koch_Parafinczuk_and_Wolf__P.pdf,"February 20, 2015",Koch Parafinczuk and Wolf  P,2015
FDA-2015-P-0578-0001_Citizen_Petition_From_Public_Citizen_s_Health_Rese.pdf,"February 24, 2015",Public Citizen s Health Rese,2015
FDA-2015-P-0596-0001_Citizen_Petition_Request_from_LACHMAN_CONSULTANT_S.pdf,"February 24, 2015",LACHMAN CONSULTANT S,2015
FDA-2015-P-0613-0001_Citizen_Petition_From_Qilu_Pharma__Inc_.pdf,"February 25, 2015",Qilu Pharma  Inc,2015
FDA-2015-P-0633-0001_Citizen_Petition_From_Jonathan_Smith.pdf,"February 24, 2015",Jonathan Smith,2015
FDA-2015-P-0703-0001_Citizen_Petition_Sarah_Salem_Robinson_1__Redacted.pdf,"March 4, 2015",,2015
FDA-2015-P-0711-0001_Citizen_Petition_From_L__Garner_Redacted.pdf,March 2015,L  Garner Redacted,2015
FDA-2015-P-0720-0001_Citizen_Petition_request_from_Zydus_Pharmaceutical.pdf,"March 03,2015",Zydus Pharmaceutical,2015
FDA-2015-P-0732-0001_Citizen_Petition_from_Arnold___Porter_LLP__Celgene.pdf,"March 6, 2015",Arnold   Porter LLP  Celgene,2015
FDA-2015-P-0762-0001_Citizen_Petition_From_Pharmacists_Planning_Service.pdf,"March 4, 2015",Pharmacists Planning Service,2015
FDA-2015-P-0840-0001_Citizen_Petition_From_Dr__Richard_Sherman.pdf,"March 17, 2015",Dr  Richard Sherman,2015
FDA-2015-P-0876-0001_Citizen_Petition_From_The_Escher_Fund_For_Autism.pdf,"March 16, 2015",The Escher Fund For Autism,2015
FDA-2015-P-0989-0001_Citizen_Petition_From_Organic_Pastures_Dairy_Compa.pdf,3/30/15,Organic Pastures Dairy Compa,2015
FDA-2015-P-1003-0001_Citizen_Petition_From_Lachman_Consultant_Services_.pdf,"March 26, 2015",Lachman Consultant Services,2015
FDA-2015-P-1004-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"March 26, 2015",Lachman Consultant Services,2015
FDA-2015-P-1050-0001_Citizen_Petition_From_Teva_Pharmaceuticals.pdf,"April 1, 2015",Teva Pharmaceuticals,2015
FDA-2015-P-1090-0001_Citizen_Petition_from_Baker_Hostetler_LLP.pdf,"April 1, 2015",Baker Hostetler LLP,2015
FDA-2015-P-1094-0001_Citizen_Petition_from_Food_and_Water_Watch.pdf,"April 2, 2015",Food and Water Watch,2015
FDA-2015-P-1103-0001_Citizen_Petition_from_Hyman_Phelps_McNamara_PC.pdf,"April 3,2015",Hyman Phelps McNamara PC,2015
FDA-2015-P-1153-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"April 7, 2015",Lachman Consultant Services,2015
FDA-2015-P-1187-0001_Citizen_Petition_from_U_S_Right_To_Know_US_RTK.pdf,"April 9, 2015",U S Right To Know US RTK,2015
FDA-2015-P-1197-0001_Citizen_Petition_from_Stryker_Medical.pdf,"October 9, 2015",Stryker Medical,2015
FDA-2015-P-1201-0001_Citizen_Petition_from_Tate_and_Lyle.pdf,"April 10, 2015",Tate and Lyle,2015
FDA-2015-P-1218-0001_Citizen_Petition_from_Hogan_Lovells_US_LLP.pdf,4/15/15,Hogan Lovells US LLP,2015
FDA-2015-P-1279-0001_Citizen_Petition_From_Cigar_Rights_of_America.pdf,4/20/15,Cigar Rights of America,2015
FDA-2015-P-1279-0003_Citizen_Petition_From_Cigar_Rights_of_America_Rega.pdf,"April 25, 2014",Cigar Rights of America Rega,2015
FDA-2015-P-1279-0005_Citizen_Petition_from_Cigar_Rights_of_America.pdf,4/20/15,Cigar Rights of America,2015
FDA-2015-P-1279-0008_Citizen_Petition_from_Cigar_Rights_of_America.pdf,"April 25, 2014",Cigar Rights of America,2015
FDA-2015-P-1279-0011_Citizen_Petition_5_from_Cigar_Rights_of_America.pdf,"April 25, 2014",Cigar Rights of America,2015
FDA-2015-P-1279-0018_Citizen_Petition_from_Cigar_Rights_of_America.pdf,"April 25, 2014",Cigar Rights of America,2015
FDA-2015-P-1279-0020_Citizen_Petition_from_Cigar_Rights_of_America.pdf,"April 25, 2014",Cigar Rights of America,2015
FDA-2015-P-1296-0001_Citizen_Petition_From_LeClairRyan_PC_Jubilant_Drax.pdf,"April 17, 2015",LeClairRyan PC Jubilant Drax,2015
FDA-2015-P-1404-0001_Citizen_Petition_from_Physical_Pharmaceutica_LLC.pdf,June 2013,Physical Pharmaceutica LLC,2015
FDA-2015-P-1431-0001_Citizen_Petition_from_Teva_Pharmaceuticals_Cephalo.pdf,"February 26, 2008",Teva Pharmaceuticals Cephalo,2015
FDA-2015-P-1433-0001_Citizen_Petition_from_Michael_Welber__Redacted.pdf,4/30/15,Michael Welber  Redacted,2015
FDA-2015-P-1449-0001_Citizen_Petition_from_REGCON_Solutions_LLC_Akorn_I.pdf,5/8/15,REGCON Solutions LLC Akorn I,2015
FDA-2015-P-1503-0001_Citizen_Petition_from_eVenus_Pharmaceutical_Labora.pdf,"April 30, 2015",eVenus Pharmaceutical Labora,2015
FDA-2015-P-1553-0001_Citizen_Petition_from_3M_Drug_Delivery_Systems.pdf,"May 4, 2015",3M Drug Delivery Systems,2015
FDA-2015-P-1590-0001_Suitability_Petition_from_Qilu_Pharmaceutical_Co_L.pdf,"May 5, 2015",Qilu Pharmaceutical Co L,2015
FDA-2015-P-1595-0001_Citizen_Petition_from_Cubist_Pharmaceuticals__Inc.pdf,May 2015,Cubist Pharmaceuticals  Inc,2015
FDA-2015-P-1669-0001_Citizen_Petition_from_RegCon_Solutions.pdf,"May 7, 2015",RegCon Solutions,2015
FDA-2015-P-1674-0001_Citizen_Petition_from_Globus_Medical_Inc.pdf,August 2011,Globus Medical Inc,2015
FDA-2015-P-1721-0001_Citizen_Petition_from_Hogan_Lovells_US_LLP_Helsinn.pdf,"May 13, 2015",Hogan Lovells US LLP Helsinn,2015
FDA-2015-P-1722-0001_Citizen_Petition_from_Hogan_Lovells_US_LLP_Helsinn.pdf,"May 13, 2015",Hogan Lovells US LLP Helsinn,2015
FDA-2015-P-1752-0001_Citizen_Petition_from_Wiley_Rein_LLP.pdf,"May 14, 2015",Wiley Rein LLP,2015
FDA-2015-P-1757-0001_Citizen_Petition_from_the_Organic_and_Natural_Heal.pdf,"May 14, 2015",the Organic and Natural Heal,2015
FDA-2015-P-1898-0001_Citizen_Petition_from_Hyman_Phelps_and_McNamara_PC.pdf,"May 27, 2015",Hyman Phelps and McNamara PC,2015
FDA-2015-P-1899-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"May 22, 2015",Lachman Consultant Services,2015
FDA-2015-P-1900-0001_Citizen_Petition_from_Heidi_Jones.pdf,"May 27,2015",Heidi Jones,2015
FDA-2015-P-1903-0001_Citizen_Petition_from_Matawan_Pharmaceuticals_LLC.pdf,"May 26, 2015",Matawan Pharmaceuticals LLC,2015
FDA-2015-P-1924-0001_Citizen_Petition_from_Hunton_and_Williams_LLP.pdf,"May 28, 2015",Hunton and Williams LLP,2015
FDA-2015-P-1977-0001_Citizen_Petition_from_Gerald_Steel.pdf,"June 1, 2015",Gerald Steel,2015
FDA-2015-P-1977-0248_Citizen_Petition_for_Reconsideration__from_Gerald_.pdf,"December 5, 2018",Gerald,2015
FDA-2015-P-2000-0001_Citizen_Petition_from_AbbVie_Inc.pdf,"June 2, 2015",AbbVie Inc,2015
FDA-2015-P-2000-0007_Supplement_to_Citizen_Petition_from_AbbVie_Inc.pdf,"August 10, 2015",AbbVie Inc,2015
FDA-2015-P-2120-0001_Citizen_Petition_from_Kleinfeld_Kaplan_and_Becker_.pdf,"June 9, 2015",Kleinfeld Kaplan and Becker,2015
FDA-2015-P-2141-0001_Citizen_Petition_from_Heritage_Pharma_Labs_Inc.pdf,"June 9, 2015",Heritage Pharma Labs Inc,2015
FDA-2015-P-2142-0001_Citizen_Petition_from_Public_Citizen.pdf,"June 11, 2015",Public Citizen,2015
FDA-2015-P-2149-0001_Citizen_Petition_from_the_Natural_Solutions_Founda.pdf,6/15/15,the Natural Solutions Founda,2015
FDA-2015-P-2230-0001_Citizen_Petition_from_Hyman_Phelps_and_McNamara_PC.pdf,"June 16, 2015",Hyman Phelps and McNamara PC,2015
FDA-2015-P-2231-0001_Citizen_Petition_from_Cross_Vetpharm_Group_Ltd_Bim.pdf,"June 11, 2015",Cross Vetpharm Group Ltd Bim,2015
FDA-2015-P-2247-0001_Citizen_Petition_from_Tricia_Spencer_Redacted.pdf,"June 12, 2015",Tricia Spencer Redacted,2015
FDA-2015-P-2344-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"June 29,2015",Lachman Consultant Services,2015
FDA-2015-P-2373-0001_Citizen_Petition_from_David_K_Cundiff_MD_Redacted.pdf,"July 2, 2015",David K Cundiff MD Redacted,2015
FDA-2015-P-2374-0001_Citizen_Petition_from_Hyman_Phelps_and_McNamara_PC.pdf,"July 6,2015",Hyman Phelps and McNamara PC,2015
FDA-2015-P-2375-0001_Citizen_Petition_from_Public_Citizen.pdf,"July 7, 2015",Public Citizen,2015
FDA-2015-P-2413-0001_Citizen_Petition_from_Acura_Pharmaceuticals_Inc.pdf,"July 7, 2015",Acura Pharmaceuticals Inc,2015
FDA-2015-P-2481-0001_Reclassification_Petition_from_SweetSpot_Diabetes_.pdf,July 10 2015,SweetSpot Diabetes,2015
FDA-2015-P-2482-0001_Citizen_Petition_from_Otsuka_Pharmaceutical_Develo.pdf,"July 13, 2015",Otsuka Pharmaceutical Develo,2015
FDA-2015-P-2482-0011_SECOND_SUPPLEMENT_TO_CITIZEN_PETITION_from_Venable.pdf,"August 5, 2015",Venable,2015
FDA-2015-P-2626-0001_Citizen_Petition_from_US_WorldMeds_LLC.pdf,7/21/2015,US WorldMeds LLC,2015
FDA-2015-P-2678-0001_Citizen_Petition_from_Brian_C__Weiner__Marlboro_Ga.pdf,"July 24, 2015",Brian C  Weiner  Marlboro Ga,2015
FDA-2015-P-2736-0001_Suitability_Petition_from_Comodo_Health__Inc_.pdf,"July 24, 2015",Comodo Health  Inc,2015
FDA-2015-P-2807-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"July 29, 2015",Lachman Consultant Services,2015
FDA-2015-P-2820-0001_Citizen_Petition_from_Alston_and_Bird__the_Center_.pdf,"July 31, 2015",Alston and Bird  the Center,2015
FDA-2015-P-2830-0001_Citizen_Petition_from_Supernus_Pharmaceuticals_Rop.pdf,"July 31, 2015",Supernus Pharmaceuticals Rop,2015
FDA-2015-P-2854-0001_Citizen_Petition_from_Olsson_Frank_Weeda_Terman_Ma.pdf,"August 3, 2015",Olsson Frank Weeda Terman Ma,2015
FDA-2015-P-2867-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"August 5, 2015",Lachman Consultant Services,2015
FDA-2015-P-2962-0001_Citizen_Petition_From_Regcon_Solutions_LLC.pdf,"April 22, 2015",Regcon Solutions LLC,2015
FDA-2015-P-3009-0001_Citizen_Petition_from_the_Physicians_Committee_for.pdf,"August 14, 2015",the Physicians Committee for,2015
FDA-2015-P-3020-0001_Citizen_Petition_from_Women_s_Voices_for_the_Earth.pdf,"August 18, 2015",Women s Voices for the Earth,2015
FDA-2015-P-3053-0001_Citizen_Petition_from_Florek___Endres_PLLC.pdf,"August 20, 2015",Florek   Endres PLLC,2015
FDA-2015-P-3085-0001_Citizen_Petition_From_Mid_Atlantic_BioTherapeutics.pdf,August 2015,Mid Atlantic BioTherapeutics,2015
FDA-2015-P-3107-0001_Citizen_Petition_from_Ferrosan_Medical_Devices__Du.pdf,"August 20, 2015",Ferrosan Medical Devices  Du,2015
FDA-2015-P-3108-0001_Citizen_Petition_from_Ferrosan_Medical_Devices__Du.pdf,"August 20, 2015",Ferrosan Medical Devices  Du,2015
FDA-2015-P-3139-0001_Citizen_Petition_from_Kimberly_Kideckel_Redacted.pdf,"August 26, 2015",Kimberly Kideckel Redacted,2015
FDA-2015-P-3299-0001_Citizen_Petition_from_Clinipace_Worldwide.pdf,"December 20,1988",Clinipace Worldwide,2015
FDA-2015-P-3319-0001_Citizen_Petition_from_Winifred_Begley_Redacted.pdf,"September 10,2015",Winifred Begley Redacted,2015
FDA-2015-P-3364-0001_Citizen_Petition_from_Dr__Leroy_Hamilton___Redacte.pdf,"September 8, 2015",Dr  Leroy Hamilton   Redacte,2015
FDA-2015-P-3365-0001_Citizen_Petition_from_Inrange_Systems.pdf,"September 4, 2015",Inrange Systems,2015
FDA-2015-P-3391-0001_Citizen_Petition_from_Ashley_Franz__Patricia_Syver.pdf,"September 16, 2015",Ashley Franz  Patricia Syver,2015
FDA-2015-P-3400-0001_Citizen_Petition_from_Lupin_Pharmaceuticals__Inc_.pdf,October 2014,Lupin Pharmaceuticals  Inc,2015
FDA-2015-P-3404-0001_Citizen_Petition_from_Lupin_Pharmaceuticals__Inc_.pdf,9/25/15,Lupin Pharmaceuticals  Inc,2015
FDA-2015-P-3407-0001_Citizen_Petition_RegCon_Solutions_LLC.pdf,"September 23, 2015",,2015
FDA-2015-P-3408-0001_Citizen_Petition_from_David_Cundiff.pdf,"September 25, 2015",David Cundiff,2015
FDA-2015-P-3410-0001_Citizen_Petition_from_David_K_Cundiff.pdf,"September 25, 2015",David K Cundiff,2015
FDA-2015-P-3485-0001_Citizen_Petition_from_the_National_Chicken_Council.pdf,"September 29, 2015",the National Chicken Council,2015
FDA-2015-P-3540-0001_Citizen_Petition_from_Lachman_Consultant_Services.pdf,"October 2, 2015",Lachman Consultant Services,2015
FDA-2015-P-3621-0001_Citizen_Petition_from_Hospira.pdf,"October 5, 2015",Hospira,2015
FDA-2015-P-3739-0001_Citizen_Petition_from_Bryan_Kutz_Redacted.pdf,"October 14, 2015",Bryan Kutz Redacted,2015
FDA-2015-P-3778-0001_Citizen_Petition_from_Orthofix.pdf,"October14,2015",Orthofix,2015
FDA-2015-P-3794-0001_Citizen_Petition_From_Lawrence_R__Savage_Redacted.pdf,10/16/15,Lawrence R  Savage Redacted,2015
FDA-2015-P-3876-0001_Citizen_Petition_from_World_Alliance_for_Mercury_F.pdf,October 2015,World Alliance for Mercury F,2015
FDA-2015-P-3942-0001_Citizen_Petition_from_REGCON_Solutions.pdf,"October 26, 2015",REGCON Solutions,2015
FDA-2015-P-3959-0001_Citizen_Petition_from_Daniel_F__Kripke__MD__The_We.pdf,12/16/15,Daniel F  Kripke  MD  The We,2015
FDA-2015-P-3980-0001_Citizen_Petition_from_Teva_Pharmaceutical_Industri.pdf,"October 26, 2015",Teva Pharmaceutical Industri,2015
FDA-2015-P-3991-0001_Citizen_Petition_from_The_Take_Back_America_Campai.pdf,10/30/15,The Take Back America Campai,2015
FDA-2015-P-4019-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"October 30, 2015",Hyman  Phelps   McNamara  P,2015
FDA-2015-P-4131-0001_Citizen_Petition_from_the_University_of_Florida.pdf,"November 4, 2015",the University of Florida,2015
FDA-2015-P-4131-0007_Supplement_to_Oral_Phenylephrine_Citizen_Petition_.pdf,May 2022,Oral Phenylephrine Citizen Petition,2015
FDA-2015-P-4224-0001_Citizen_Petition_from_Flamingo_Pharmaceuticals_Ltd.pdf,"November 4, 2015",Flamingo Pharmaceuticals Ltd,2015
FDA-2015-P-4231-0001_Citizen_Petition_from_REGCON_Solutions.pdf,"November 11, 2015",REGCON Solutions,2015
FDA-2015-P-4237-0001_Citizen_Petition_from_Gland_Pharma_Limited.pdf,"November 06, 2015",Gland Pharma Limited,2015
FDA-2015-P-4307-0001_Citizen_Petition_from_Guy_Aliotta_Redacted.pdf,"November 18, 2015",Guy Aliotta Redacted,2015
FDA-2015-P-4529-0001_Citizen_Petition_from_UAW_Retiree_Medical_Benefits.pdf,"November 23, 2015",UAW Retiree Medical Benefits,2015
FDA-2015-P-4564-0001_Citizen_Petition_from_KIND_LLC.pdf,"December 1, 2015",KIND LLC,2015
FDA-2015-P-4566-0001_Citizen_Petition_from_Concordia_Pharmaceuticals__B.pdf,"December 1, 2015",Concordia Pharmaceuticals  B,2015
FDA-2015-P-4582-0001_Citizen_Petition_from_Margaret_Moustafa_Redacted.pdf,"December 2, 2015",Margaret Moustafa Redacted,2015
FDA-2015-P-4600-0001_Citizen_Petition_from_Bayer_HealthCare_LLC.pdf,"December 3, 2015",Bayer HealthCare LLC,2015
FDA-2015-P-4601-0001_Citizen_Petition_from_Frier_Levitt.pdf,"December 
45  2013",Frier Levitt,2015
FDA-2015-P-4664-0001_Citizen_Petition_from_Richard_Fife_Redacted.pdf,"December 07, 2015",Richard Fife Redacted,2015
FDA-2015-P-4916-0001_Citizen_Petition_from_REGCON_Solutions.pdf,"December 16, 2015",REGCON Solutions,2015
FDA-2015-P-4935-0001_Citizen_Petition_from_AbbVie_Inc_.pdf,"December 16, 2015",AbbVie Inc,2015
FDA-2015-P-4945-0001_Citizen_Petition_from_Ryszard_Rokicki_Redacted.pdf,"December 14, 2015",Ryszard Rokicki Redacted,2015
FDA-2015-P-4946-0001_Citizen_Petition_from_Zydus_Pharmaceuticals__USA__.pdf,December 2015,Zydus Pharmaceuticals  USA,2015
FDA-2015-P-4959-0001_Citizen_Petition_from_Cardinal_Health_Regulatory_S.pdf,"December 17, 2015",Cardinal Health Regulatory S,2015
FDA-2015-P-5022-0001_Citizen_Petition_from_Pharmaceutical_Research_and_.pdf,"December 22, 2015",Pharmaceutical Research and,2015
FDA-2015-P-5108-0001_Citizen_Petition_from_Purdue_Pharma_L_P___Kleinfel.pdf,"December 22, 2015",Purdue Pharma L P   Kleinfel,2015
FDA-2016-P-0031-0001_Citizen_Petition_from_Indoco_Remedies_Limited.pdf,"December 30, 2015",Indoco Remedies Limited,2016
FDA-2016-P-0040-0001_Citizen_Petition_from_Troutman_Sanders_LLP.pdf,1/22/16,Troutman Sanders LLP,2016
FDA-2016-P-0134-0001_Citizen_Petition_from_Summit_Pharmaceuticals__Inc_.pdf,"January 19,2016",Summit Pharmaceuticals  Inc,2016
FDA-2016-P-0145-0001_Citizen_Petition_from_Med_Pharmex__Inc_.pdf,"January 05, 2016",Med Pharmex  Inc,2016
FDA-2016-P-0147-0001_Citizen_Petition_from_Bumble_Bee_Foods__LLC__et_al.pdf,"September 3, 2015",Bumble Bee Foods  LLC  et al,2016
FDA-2016-P-0159-0001_Citizen_Petition_from_Biorex_Labs_LLC.pdf,"January 01,2016",Biorex Labs LLC,2016
FDA-2016-P-0187-0001_Citizen_Petition_from_United_Therapeutics_Corporat.pdf,"January 14, 2016",United Therapeutics Corporat,2016
FDA-2016-P-0214-0001_Citizen_Petition_from_Rosalind_Advisors__Inc_.pdf,"January 16, 2016",Rosalind Advisors  Inc,2016
FDA-2016-P-0378-0001_Citizen_Petition_from_The_Weinberg_Group__Inc_.pdf,"January 28, 2016",The Weinberg Group  Inc,2016
FDA-2016-P-0383-0001_Citizen_Petition_from_Fish___Richardson_P__C___Dep.pdf,"January 29, 2016",Fish   Richardson P  C   Dep,2016
FDA-2016-P-0540-0001_Citizen_Petition_from_Gordon_Johnston_Regulatory_C.pdf,"February 10, 2016",Gordon Johnston Regulatory C,2016
FDA-2016-P-0541-0001_Citizen_Petition_from_Gordon_Johnston_Regulatory_C.pdf,"February 10, 2016",Gordon Johnston Regulatory C,2016
FDA-2016-P-0542-0001_Citizen_Petition_from_Gordon_Johnston_Regulatory_C.pdf,"February 10, 2016",Gordon Johnston Regulatory C,2016
FDA-2016-P-0618-0001_Citizen_Petition_from_Emily_Conner__Redacted.pdf,"February 16, 2016",Emily Conner  Redacted,2016
FDA-2016-P-0621-0001_Citizen_Petition_from_Hogan_Lovells_US_LLP__Helsin.pdf,"February 18, 2016",Hogan Lovells US LLP  Helsin,2016
FDA-2016-P-0644-0001_Citizen_Petition_from_Gordon_Johnston_Regulatory_C.pdf,"February 22, 2016",Gordon Johnston Regulatory C,2016
FDA-2016-P-0645-0001_Citizen_Petition_from_Pharmaceutical_Manufacturing.pdf,"February 19,2016",Pharmaceutical Manufacturing,2016
FDA-2016-P-0656-0001_Citizen_Petition_from_Steven_Zecola___Redacted.pdf,"January 30, 2015",Steven Zecola   Redacted,2016
FDA-2016-P-0689-0001_Citizen_Petition_from_Leana_Wen__M_D___M_Sc___Comm.pdf,"February 22, 2016",Leana Wen  M D   M Sc   Comm,2016
FDA-2016-P-0713-0001_Citizen_Petition_from_Pernix_Therapeutics.pdf,"February 25, 2016",Pernix Therapeutics,2016
FDA-2016-P-0769-0001_Citizen_Petition_from_Empire_State_Consumer_Projec.pdf,"February 26, 2016",Empire State Consumer Projec,2016
FDA-2016-P-0770-0001_Citizen_Petition_from_International_Isotopes_Inc_.pdf,8/25/16,International Isotopes Inc,2016
FDA-2016-P-0974-0001_Citizen_Petition_from_Gordon_Johnston_Regulatory_C.pdf,"March 15, 2016",Gordon Johnston Regulatory C,2016
FDA-2016-P-1026-0001_Citizen_Petition_from_Germaine_Laboratories__Inc_.pdf,"March 18, 2016",Germaine Laboratories  Inc,2016
FDA-2016-P-1027-0001_Citizen_Petition_from_Gland_Pharma_Limited.pdf,"March 21, 2016",Gland Pharma Limited,2016
FDA-2016-P-1037-0001_Citizen_Petition_from_Rose_Zhao__Emprise_Pharma.pdf,"March 18, 2016",Rose Zhao  Emprise Pharma,2016
FDA-2016-P-1073-0001_Citizen_Petition_from_PAR_Pharmaceutical.pdf,"March 22, 2016",PAR Pharmaceutical,2016
FDA-2016-P-1085-0001_Citizen_Petition_from_Frontage_Laboratories_Inc.pdf,"March 23, 2016",Frontage Laboratories Inc,2016
FDA-2016-P-1088-0001_Citizen_Petition_from_ABHAI_LLC_c_o_KVK_Tech__Inc.pdf,"March 23,2016",ABHAI LLC c o KVK Tech  Inc,2016
FDA-2016-P-1088-0007_Amendment_to_Suitability_Petition_for_Oxybutynin_C.pdf,"September 19, 2019",Suitability Petition for Oxybutynin C,2016
FDA-2016-P-1090-0004_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"March 24, 2016",Lachman Consultant Services,2016
FDA-2016-P-1104-0001_Citizen_Petition_from_Gordon_Johnston_Regulatory_C.pdf,"March 30, 2016",Gordon Johnston Regulatory C,2016
FDA-2016-P-1105-0001_Citizen_Petition_from_Gordon_Johnston_Regulatory_C.pdf,"March 30, 2016",Gordon Johnston Regulatory C,2016
FDA-2016-P-1106-0001_Citizen_Petition_from_Gordon_Johnston_Regulatory_C.pdf,"March 30, 2016",Gordon Johnston Regulatory C,2016
FDA-2016-P-1107-0001_Citizen_Petition_from_Gordon_Johnston_Regulatory_C.pdf,"March 30, 2016",Gordon Johnston Regulatory C,2016
FDA-2016-P-1108-0001_Citizen_Petition_from_Gordon_Johnston_Regulatory_C.pdf,"March 30, 2016",Gordon Johnston Regulatory C,2016
FDA-2016-P-1115-0001_Citizen_Petition_from_Mostyn_Law_Firm.pdf,"March 31, 2016",Mostyn Law Firm,2016
FDA-2016-P-1128-0001_Citizen_Petition_from_Melissa_Schilling___Redacted.pdf,"April 6, 2016",Melissa Schilling   Redacted,2016
FDA-2016-P-1158-0001_Citizen_Petition_from_Amanda_Williams_Redacted.pdf,"April 15, 2016",Amanda Williams Redacted,2016
FDA-2016-P-1163-0001_Citizen_Petition_from_Foley_Hoag_LLP__Vifor_Fresen.pdf,"April 15, 2016",Foley Hoag LLP  Vifor Fresen,2016
FDA-2016-P-1163-0098_Petition_for_Reconsideration_and_Stay_from_SIDLEY_.pdf,"June 25, 2021",SIDLEY,2016
FDA-2016-P-1169-0001_Citizen_Petition_from_e5_Pharma_LLC.pdf,"April 6, 2016",e5 Pharma LLC,2016
FDA-2016-P-1169-0006_Citizen_Petition_for_Reconsideration_from_e5_Pharm.pdf,"July 08, 2016",e5 Pharm,2016
FDA-2016-P-1169-0011_Petition_for_Reconsideration___Decision_Request.pdf,"September 20, 2018",,2016
FDA-2016-P-1171-0001_Citizen_Petition_from_Breast_Cancer_Fund__Center_f.pdf,"April 19, 2016",Breast Cancer Fund  Center f,2016
FDA-2016-P-1171-0013_Petition_for_Reconsideration_from_Earthjustice.pdf,"June 21, 2022",Earthjustice,2016
FDA-2016-P-1180-0001_Citizen_Petition_from_Top_Health_Ingredients_Inc_R.pdf,"April 9, 2016",Top Health Ingredients Inc R,2016
FDA-2016-P-1180-0044_Supplement_to_Citizens_Petition_from_Top_Health_In.pdf,"April 20, 2016",Top Health In,2016
FDA-2016-P-1180-0045_Supplement_to_Citizen_Petition_of_Top_Health_Ingr_.pdf,"March 20, 2018",Citizen Petition of Top Health Ingr,2016
FDA-2016-P-1211-0001_Citizen_Petition_from_Medtech_Products_Inc_.pdf,April 2016,Medtech Products Inc,2016
FDA-2016-P-1212-0001_Citizen_Petition_from_Medtech_Products_Inc_.pdf,April 2016,Medtech Products Inc,2016
FDA-2016-P-1213-0001_Citizen_Petition_from_Medtech_Products_Inc_.pdf,"Jan 14, 1998",Medtech Products Inc,2016
FDA-2016-P-1246-0001_Citizen_Petition__from_the_Working_Group_on_Women_.pdf,"May 12, 2016",the Working Group on Women,2016
FDA-2016-P-1246-0005_FDA_Citizen_Petition_06_13_2016.pdf,"May12,2016",FDA,2016
FDA-2016-P-1247-0001_Citizen_Petition_from_ABHAI__LLC.pdf,"May 03, 2016",ABHAI  LLC,2016
FDA-2016-P-1249-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"July 27, 2012",Hyman  Phelps   McNamara  P,2016
FDA-2016-P-1250-0001_Citizen_Petition_from_PTS_Consulting.pdf,"May 4, 2016",PTS Consulting,2016
FDA-2016-P-1251-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"May 9, 2016",Lachman Consultant Services,2016
FDA-2016-P-1285-0001_Citizen_Petition_from_Mylan_Pharmaceuticals_Inc.pdf,"May 12,2016",Mylan Pharmaceuticals Inc,2016
FDA-2016-P-1286-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"May 13, 2016",Lachman Consultant Services,2016
FDA-2016-P-1287-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"May 13, 2016",Lachman Consultant Services,2016
FDA-2016-P-1288-0001_Citizen_Petition_from_Fluoride_Action_Network.pdf,"May 16, 2016",Fluoride Action Network,2016
FDA-2016-P-1303-0001_Citizen_Petition_from_Consumers_for_Dental_Choice.pdf,May 2016,Consumers for Dental Choice,2016
FDA-2016-P-1314-0001_Citizen_Petition_from_Center_for_Responsible_Scien.pdf,"May	
 9,	
 2016",Center for Responsible Scien,2016
FDA-2016-P-1319-0001_Citizen_Petition_from_Florek___Endres_PLLC.pdf,"May 23, 2016",Florek   Endres PLLC,2016
FDA-2016-P-1363-0001_Citizen_Petition_from_Gordon_Johnston_Regulatory_C.pdf,"May 25, 2016",Gordon Johnston Regulatory C,2016
FDA-2016-P-1364-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"May 25, 2016",Lachman Consultant Services,2016
FDA-2016-P-1398-0001_Citizen_Petition_from_Dr__Hooman_Noorchashm_Redact.pdf,"April 7, 2016",Dr  Hooman Noorchashm Redact,2016
FDA-2016-P-1547-0001_Citizens_Petition_from_Baxter_Healthcare_Corporati.pdf,"June 9, 2016",Baxter Healthcare Corporati,2016
FDA-2016-P-1650-0001_Citizen_Petition_from_Lannett_Company__Inc_.pdf,"June 14, 2016",Lannett Company  Inc,2016
FDA-2016-P-1667-0001_Citizen_Petition_from_Zydus_Pharmaceutical__USA__I.pdf,June 2016,Zydus Pharmaceutical  USA  I,2016
FDA-2016-P-1674-0001_Citizen_Petition_from_Tate___Lyle_Ingredients_Amer.pdf,"June 15, 2016",Tate   Lyle Ingredients Amer,2016
FDA-2016-P-1676-0001_Citizen_Petition_from_JR_Rapoza_Associates__Inc_.pdf,"June 16,2016",JR Rapoza Associates  Inc,2016
FDA-2016-P-1725-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"June 20, 2016",Lachman Consultant Services,2016
FDA-2016-P-1825-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"June 23, 2016",Lachman Consultant Services,2016
FDA-2016-P-1826-0001_Citizen_Petition_from_NuTek_Food_Science_LLC.pdf,"June 27, 2016",NuTek Food Science LLC,2016
FDA-2016-P-1852-0001_Citizen_Petition_from_Farm_To_Consumer_Legal_Defen.pdf,"June 22, 2016",Farm To Consumer Legal Defen,2016
FDA-2016-P-1873-0001_Citizen_Petition_from_Teva_Pharmaceuticals.pdf,"June 28, 2016",Teva Pharmaceuticals,2016
FDA-2016-P-1874-0001_Citizen_Petition_from_Public_Citizen_Health_Resear.pdf,"June 29, 2016",Public Citizen Health Resear,2016
FDA-2016-P-1875-0001_Citizen_Petition_from_Pacific_Link_Consulting__Ada.pdf,June 2016,Pacific Link Consulting  Ada,2016
FDA-2016-P-1946-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__PC.pdf,"July 1,2016",Hyman  Phelps   McNamara  PC,2016
FDA-2016-P-1952-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC.pdf,"July 5, 2016",Fresenius Kabi USA  LLC,2016
FDA-2016-P-1955-0001_Citizen_Petition_from_Mallinckrodt_Pharmaceuticals.pdf,June 2016,Mallinckrodt Pharmaceuticals,2016
FDA-2016-P-1962-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__PC.pdf,"July 6,2016",Hyman  Phelps   McNamara  PC,2016
FDA-2016-P-1963-0001_Citizen_Petition_from_SmartVet_Holdings_Inc.pdf,"July 1, 2016",SmartVet Holdings Inc,2016
FDA-2016-P-1991-0001_Citizen_Petition_from_Douglass_Oeller_Consulting__.pdf,"July 11, 2016",Douglass Oeller Consulting,2016
FDA-2016-P-2029-0001_Citizen_Petition_from_Buchanan_Ingersoll___Rooney_.pdf,"July 11,2016",Buchanan Ingersoll   Rooney,2016
FDA-2016-P-2030-0001_Citizen_Petition_from_The_Food_Lawyers.pdf,"July 12, 2016",The Food Lawyers,2016
FDA-2016-P-2072-0001_Citizen_Petition_from_Pacific_Link_Consulting__Ada.pdf,July 2016,Pacific Link Consulting  Ada,2016
FDA-2016-P-2091-0001_Citizen_Petition_from_ANDA_Consultants_Furosemide_.pdf,"July 14, 2016",ANDA Consultants Furosemide,2016
FDA-2016-P-2337-0001_Citizen_Petition_from_Lachman_Consulting_Services_.pdf,"July 18, 2016",Lachman Consulting Services,2016
FDA-2016-P-2342-0001_Citizen_Petition_from_Sovereign_Pharmaceuticals__L.pdf,"July 18, 2016",Sovereign Pharmaceuticals  L,2016
FDA-2016-P-2375-0001_Citizen_Petition_from_AKORN_Specialty_Generics.pdf,"July 26, 2016",AKORN Specialty Generics,2016
FDA-2016-P-2376-0001_Citizen_Petition_from_Latham___Watkins_LLP_on_beha.pdf,"August 1, 2016",Latham   Watkins LLP on beha,2016
FDA-2016-P-2377-0001_Citizen_Petition_from_Archer_Daniels_Midland_Compa.pdf,"July 22, 2016",Archer Daniels Midland Compa,2016
FDA-2016-P-2467-0001_Citizen_Petition_from_Actavis_LLC.pdf,"August 5, 2016",Actavis LLC,2016
FDA-2016-P-2469-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"August 3,2016",Hyman  Phelps   McNamara  P,2016
FDA-2016-P-2478-0001_Citizen_Petition_from_Hogan_Lovells_US_LLP__United.pdf,"August 10, 2016",Hogan Lovells US LLP  United,2016
FDA-2016-P-2497-0001_Citizen_Petition_from_Clinical_Decision_Support_Co.pdf,"August 16, 2016",Clinical Decision Support Co,2016
FDA-2016-P-2515-0001_Citizen_Petition_from_Eli_Lilly_and_Company.pdf,"August 18, 2016",Eli Lilly and Company,2016
FDA-2016-P-2532-0001_Citizen_Petition_from_David_K__Cundiff___Redacted.pdf,"August 25, 2016",David K  Cundiff   Redacted,2016
FDA-2016-P-2558-0001_Citizen_Petition_from_Similasan_Corporation.pdf,"August 25, 2016",Similasan Corporation,2016
FDA-2016-P-2559-0001_Citizen_Petition_from_Emord_and_Associates__P_C_.pdf,"August 24, 2016",Emord and Associates  P C,2016
FDA-2016-P-2559-0030_Meeting_Regarding_Citizen_Petition_FDA_Minutes_31_.pdf,"July 31, 2017",Meeting Regarding,2016
FDA-2016-P-2568-0001_Citizen_Petition_from_Fresenius_Kabi_USA.pdf,August 2016,Fresenius Kabi USA,2016
FDA-2016-P-2654-0001_Citizen_Petition_from_Vanda_Pharmaceuticals__Inc_.pdf,"September 7, 2016",Vanda Pharmaceuticals  Inc,2016
FDA-2016-P-2672-0001_Citizen_Petition_from_Jazz_Pharmaceuticals_Inc_.pdf,"September 2, 2016",Jazz Pharmaceuticals Inc,2016
FDA-2016-P-2674-0001_Citizen_Petition_from_Heritage_Pharma__Inc_.pdf,"August 31, 2016",Heritage Pharma  Inc,2016
FDA-2016-P-2675-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"September 7, 2016",Foley   Lardner LLP,2016
FDA-2016-P-2676-0001_Citizen_Petition_from_Joshua_Schroeder__redacted.pdf,8/31/2016,Joshua Schroeder  redacted,2016
FDA-2016-P-2713-0001_Citizen_Petition_from_Strides_Pharma__Inc_.pdf,"September 12, 2016",Strides Pharma  Inc,2016
FDA-2016-P-2736-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"September 12, 2016",Hyman  Phelps   McNamara  P,2016
FDA-2016-P-2737-0001_Citizen_Petition_from_Natural_Resources_Defense_Co.pdf,"September 13, 2016",Natural Resources Defense Co,2016
FDA-2016-P-2737-0135_Supplement_to_Citizen_Petition_from_Natural_Resour.pdf,"May 29, 2020",Natural Resour,2016
FDA-2016-P-2738-0001_Citizen_Petition_from_Metabolic_Therapy_Inc_.pdf,"September 12, 2016",Metabolic Therapy Inc,2016
FDA-2016-P-2781-0001_Citizen_Petition_from_Alcon_Pharmaceuticals__Ltd__.pdf,"September 14, 2016",Alcon Pharmaceuticals  Ltd,2016
FDA-2016-P-2782-0001_Citizen_Petition_from_Alcon_Pharmaceuticals__Ltd__.pdf,"September 14, 2016",Alcon Pharmaceuticals  Ltd,2016
FDA-2016-P-2860-0001_Citizen_Petition_from_General_Mills__Inc_.pdf,"September 16, 2016",General Mills  Inc,2016
FDA-2016-P-2863-0001_Citizen_Petition_from_General_Mills__Inc__1.pdf,"September 16, 2016",General Mills  Inc  1,2016
FDA-2016-P-2955-0001_Citizen_Petition_from_Nicholas_Isel___redacted_2.pdf,"August 31,2016",Nicholas Isel   redacted 2,2016
FDA-2016-P-2955-0087_Petition_to_Reconsider_from_Rozovics_Law_Firm_LLC_.pdf,"September 8, 2018",Rozovics Law Firm LLC,2016
FDA-2016-P-3015-0001_Citizen_Petition_from_Douglass_Oeller_Consulting__.pdf,"September 23, 2016",Douglass Oeller Consulting,2016
FDA-2016-P-3052-0001_Citizen_Petition_from_Foley___Lardner_LLP__Lehigh_.pdf,"September 28, 2016",Foley   Lardner LLP  Lehigh,2016
FDA-2016-P-3070-0001_Citizen_s_Petition_from_DuPont_Nutrition___Health.pdf,"September 27, 2016",DuPont Nutrition   Health,2016
FDA-2016-P-3082-0001_Citizen_Petition_from_Ropes___Gray_LLP__Pfizer_Inc.pdf,"September 30, 2016",Ropes   Gray LLP  Pfizer Inc,2016
FDA-2016-P-3089-0001_Citizen_Petition_from_Aleon_Pharma_International__.pdf,"September 30, 2016",Aleon Pharma International,2016
FDA-2016-P-3112-0001_Citizen_Petition_from_Mario_Morais.pdf,"SEPTEMBER  15, 2016",Mario Morais,2016
FDA-2016-P-3162-0001_Citizen_Petition_from_ANDA_Consultants.pdf,"October 5, 2016",ANDA Consultants,2016
FDA-2016-P-3195-0001_Citizen_Petition_from_Wood__Herron___Evans__LLP_.pdf,"October 6, 2016",Wood  Herron   Evans  LLP,2016
FDA-2016-P-3311-0001_Citizen_Petition_from_Tate___Lyle_Ingredients_Amer.pdf,"October 7, 2016",Tate   Lyle Ingredients Amer,2016
FDA-2016-P-3312-0003_Request_to_Withdraw_Citizen_Petition_from_Gilead_S.pdf,"January 30, 2017",Gilead S,2016
FDA-2016-P-3313-0001_Citizen_Petition_from_Kleinfeld__Kaplan_and_Becker.pdf,"October 12, 2016",Kleinfeld  Kaplan and Becker,2016
FDA-2016-P-3356-0001_Citizen_Petition_from_Sandoz_Inc.pdf,"October 13, 2016",Sandoz Inc,2016
FDA-2016-P-3418-0001_Citizen_Petition_from_Baker___Hostetler__LLP__Sali.pdf,"May 
14 2008",Baker   Hostetler  LLP  Sali,2016
FDA-2016-P-3426-0001_Citizen_Petition_from_Novitium_Pharma_LLC.pdf,"October 14, 2016",Novitium Pharma LLC,2016
FDA-2016-P-3427-0001_Suitability_Petition_from_Douglass_Oeller_Consulti.pdf,"October 12, 2016",Douglass Oeller Consulti,2016
FDA-2016-P-3428-0001_Suitability_Petition_from_Douglass_Oeller_Consulti.pdf,"October 12, 2016",Douglass Oeller Consulti,2016
FDA-2016-P-3428-0005_Amendment_to_Suitability_Petition_from_Douglass_Oe.pdf,"November 16, 2016",Douglass Oe,2016
FDA-2016-P-3463-0002_Suitability_Petition_from_Axinn__Veltrop___Harkrid.pdf,"October 19, 2016",Axinn  Veltrop   Harkrid,2016
FDA-2016-P-3465-0001_Citizen_Petition_from_Novitium_Pharma_LLC.pdf,"October 19, 2016",Novitium Pharma LLC,2016
FDA-2016-P-3482-0001_Citizen_Petition_from_Zydus_Pharmaceuticals__USA__.pdf,"October 17, 2016",Zydus Pharmaceuticals  USA,2016
FDA-2016-P-3509-0001_Citizen_Petition_from_Metabolic_Therapy_Inc.pdf,"October 18, 2016",Metabolic Therapy Inc,2016
FDA-2016-P-3510-0001_Citizen_Petition_from_Aleon_Pharma_International__.pdf,"October 24, 2016",Aleon Pharma International,2016
FDA-2016-P-3560-0001_Citizen_Petition_from_Orchid_Healthcare___A_Divisi.pdf,"April 5, 2017",Orchid Healthcare   A Divisi,2016
FDA-2016-P-3578-0001_Citizen_Petition_from_Association_for_TruthinPetFo.pdf,"October 27, 2016",Association for TruthinPetFo,2016
FDA-2016-P-3578-0004_Addendum_to_Citizen_Petition_FDA_2016_P_3578__from.pdf,10/27/2016,Citizen Petition FDA 2016 P 3578  from,2016
FDA-2016-P-3578-0007_Petition_for_Reconsideration_from_Association_for_.pdf,"June 17, 2019",Association for,2016
FDA-2016-P-3598-0001_Citizen_Petition_from_Axinn__Veltrop___Harkrider_L.pdf,"October 27, 2016",Axinn  Veltrop   Harkrider L,2016
FDA-2016-P-3620-0001_Citizen_Petition_from_MGP_Ingredients__Inc_CP.pdf,"October 28, 2016",MGP Ingredients  Inc CP,2016
FDA-2016-P-3674-0001_Citizen_Petition_from_Consumers_for_Dental_Choice.pdf,November 2016,Consumers for Dental Choice,2016
FDA-2016-P-3696-0001_Citizen_Petition_from_ANDA_Consultants.pdf,"October 12, 2016",ANDA Consultants,2016
FDA-2016-P-3753-0001_Citizen_Petition_from_MaCLeods_Pharmaceuticals_Lim.pdf,"November 07,2016",MaCLeods Pharmaceuticals Lim,2016
FDA-2016-P-3912-0001_Citizen_Petition_from_Adapt_Pharma_Operations_Ltd_.pdf,November 2016,Adapt Pharma Operations Ltd,2016
FDA-2016-P-3968-0001_Citizen_Petition_from_International_Probiotics_Ass.pdf,"February 2, 2018",International Probiotics Ass,2016
FDA-2016-P-4047-0001_Citizen_Petitions_from_Mayne_Pharma_lnternational_.pdf,"November 18, 2016",Mayne Pharma lnternational,2016
FDA-2016-P-4093-0001_Citizen_Petition_from_Ferring_Pharmaceuticals_Inc.pdf,"November 22, 2016",Ferring Pharmaceuticals Inc,2016
FDA-2016-P-4094-0001_Citizen_Petition_from_Adapt_Pharma_Operations_Lts.pdf,November 2016,Adapt Pharma Operations Lts,2016
FDA-2016-P-4095-0001_Citizen_Petition_from_Mapi_USA__Inc_.pdf,"November 24, 2016",Mapi USA  Inc,2016
FDA-2016-P-4095-0004_Amendment_to_Citizen_Petition_from_Mapi_USA__Inc__.pdf,"January 18, 2019",Mapi USA  Inc,2016
FDA-2016-P-4141-0001_Citizen_Petition_from_Hyman_Phelps___McNamara__P_C.pdf,"November 22, 2016",Hyman Phelps   McNamara  P C,2016
FDA-2016-P-4164-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"November 22, 2016",Lachman Consultant Services,2016
FDA-2016-P-4186-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"December 1, 2016",Lachman Consultant Services,2016
FDA-2016-P-4233-0002_Citizen_Petition_from_KFSU_Ltd.pdf,December 2016,KFSU Ltd,2016
FDA-2016-P-4274-0001_Citizen_Petition_from_Teligent__Inc_.pdf,"December 8, 2016",Teligent  Inc,2016
FDA-2016-P-4275-0001_Citizen_Petition_from_BioNeutra_North_America_Inc.pdf,"December 5, 2016",BioNeutra North America Inc,2016
FDA-2016-P-4341-0001_Citizen_Petition_from_Osmotica_Pharmaceutical_US_L.pdf,"December 9, 2016",Osmotica Pharmaceutical US L,2016
FDA-2016-P-4388-0001_Citizen_Petition_from_Dr__S__Varghese.pdf,12/21/16,Dr  S  Varghese,2016
FDA-2016-P-4584-0001_Citizen_Petition_from_Public_Citizens_Health_Resea.pdf,"December 21, 2016",Public Citizens Health Resea,2016
FDA-2016-P-4585-0001_Citizen_Petition_from_Acorda_Therapeutics__Inc.pdf,"December 26, 2016",Acorda Therapeutics  Inc,2016
FDA-2016-P-4587-0001_Citizen_Petition_from_Mallinckrodt_Pharmaceuticals.pdf,"December 27, 2016",Mallinckrodt Pharmaceuticals,2016
FDA-2016-P-4591-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__PC.pdf,"December 28, 2016",Hyman  Phelps   McNamara  PC,2016
FDA-2017-P-0052-0001_Citizen_Petition_from_Donor_Sibling_Registry.pdf,"January 1, 2017",Donor Sibling Registry,2017
FDA-2017-P-0115-0001_Citizen_Petition_from_Jubilant_Generics_Limited.pdf,"Dec 22, 2016",Jubilant Generics Limited,2017
FDA-2017-P-0137-0001_Citizen_Petition_from_Macleods_Pharmaceuticals_Lim.pdf,"January 09,2017",Macleods Pharmaceuticals Lim,2017
FDA-2017-P-0176-0001_Citizen_Petition_from_American_Herbal_Products_Ass.pdf,"January 9, 2017",American Herbal Products Ass,2017
FDA-2017-P-0290-0001_Citizen_Petition_from_Malaysian_Rubber_Export_Prom.pdf,January 2017,Malaysian Rubber Export Prom,2017
FDA-2017-P-0398-0001_Citizen_Petition_from_Florek___Endres_PLLC.pdf,"January 18, 2017",Florek   Endres PLLC,2017
FDA-2017-P-0428-0001_Citizen_Petition_From_Mucodel_Pharma_LLC.pdf,"January 20, 2017",Mucodel Pharma LLC,2017
FDA-2017-P-0494-0001_Citizen_Petition_From_Navinta_LLC.pdf,"February 18, 2005",Navinta LLC,2017
FDA-2017-P-0495-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"January 25, 2017",Lachman Consultant Services,2017
FDA-2017-P-0508-0001_Citizen_Petition_from_the_Union_of_Concerned_Scien.pdf,"January 25, 2017",the Union of Concerned Scien,2017
FDA-2017-P-0662-0001_Citizen_Petition_from_Impax_Laboratories__Inc_.pdf,"January 31, 2017",Impax Laboratories  Inc,2017
FDA-2017-P-0663-0001_Citizen_Petition_from_Mucodel_Pharma__LLC.pdf,"January 31, 2017",Mucodel Pharma  LLC,2017
FDA-2017-P-0757-0001_Citizen_Petition_from_Beck___Thomas.pdf,"February 10, 2017",Beck   Thomas,2017
FDA-2017-P-0840-0001_Citizen_Petition_from_The_Weinberg_Group.pdf,"February 8, 2017",The Weinberg Group,2017
FDA-2017-P-0863-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC_2.pdf,"February 8, 2017",Fresenius Kabi USA  LLC 2,2017
FDA-2017-P-0864-0001_Citizen_Petition_from_Hyman_Phelps___McNamara_PC.pdf,"February 8, 2017",Hyman Phelps   McNamara PC,2017
FDA-2017-P-0866-0001_Citizen_Petition_from_Hyman_Phelps___McNamara.pdf,"February 8,2017",Hyman Phelps   McNamara,2017
FDA-2017-P-0867-0001_Citizen_Petition_from_Public_Citizen.pdf,"February 8, 2017",Public Citizen,2017
FDA-2017-P-0868-0001_Citizen_Petition_From_David_Wong.pdf,"February 8, 2017",David Wong,2017
FDA-2017-P-0970-0001_Citizen_Petition_from_RiceBran_Technologies.pdf,"February 12, 2017",RiceBran Technologies,2017
FDA-2017-P-1002-0001_Citizen_Petition_from_Inrange_Systems__Inc_.pdf,"February 13, 2017",Inrange Systems  Inc,2017
FDA-2017-P-1039-0001_Citizen_Petition_from_Beck___Thomas.pdf,"February 10, 2017",Beck   Thomas,2017
FDA-2017-P-1077-0001_Citizen_Petition_from_Recordati_Rare_Diseases_INC.pdf,"March 2, 2017",Recordati Rare Diseases INC,2017
FDA-2017-P-1096-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"February 17, 2017",Hyman  Phelps   McNamara  P,2017
FDA-2017-P-1104-0001_Citizen_Petition_from_Gator_Pharmaceuticals__Inc_.pdf,"February 17, 2017",Gator Pharmaceuticals  Inc,2017
FDA-2017-P-1108-0001_Citizen_Petition_from_Orbicular_Pharmaceutical_Tec.pdf,"February 22, 2017",Orbicular Pharmaceutical Tec,2017
FDA-2017-P-1221-0001_Suitability_Petition_from_Aurora_Pharmaceutical_LL.pdf,February 2017,Aurora Pharmaceutical LL,2017
FDA-2017-P-1221-0005_Suitability_Petition_Amendment_from_Aurora_Pharmac.pdf,"February 23, 2017",Aurora Pharmac,2017
FDA-2017-P-1225-0001_Suitability_Petition_from_Aurora_Pharmaceutical_LL.pdf,February 2017,Aurora Pharmaceutical LL,2017
FDA-2017-P-1226-0001_Citizen_Petition_from_INRange_Systems__Inc.pdf,"February 24, 2017",INRange Systems  Inc,2017
FDA-2017-P-1230-0001_Citizen_Petition_from_Regcon_Solutions.pdf,"February 27, 2017",Regcon Solutions,2017
FDA-2017-P-1251-0001_Citizen_Petition_from_American_Feed_Industry_Assoc.pdf,"February 27, 2017",American Feed Industry Assoc,2017
FDA-2017-P-1252-0001_Citizen_Petition_from_Xiromed__LLC_on_behalf_of_Li.pdf,"February 26, 2017",Xiromed  LLC on behalf of Li,2017
FDA-2017-P-1278-0001_Citizen_Petition_from_Gilead_Sciences__Inc_.pdf,"January 24, 2017",Gilead Sciences  Inc,2017
FDA-2017-P-1297-0001_Citizen_Petition_from_Regcon_Solutions.pdf,"March 1,2017",Regcon Solutions,2017
FDA-2017-P-1298-0001_Citizen_Petition_from_The_Good_Food_Institute.pdf,"March 2, 2017",The Good Food Institute,2017
FDA-2017-P-1359-0001_Citizen_Petition_from_Pharmaceutical__Manufacturin.pdf,3/7/17,Pharmaceutical  Manufacturin,2017
FDA-2017-P-1391-0001_Citizen_Petition_from_Epstein_Becker___Green_P_C_.pdf,"March 3, 2017",Epstein Becker   Green P C,2017
FDA-2017-P-1392-0001_Citizen_Petition_from_Latham___Watkins__LLP__Par_S.pdf,"March 7, 2017",Latham   Watkins  LLP  Par S,2017
FDA-2017-P-1459-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"March 8, 2017",Foley   Lardner LLP,2017
FDA-2017-P-1460-0001_Citizen_Petition_from_Covington___Burling_LLP.pdf,"October 11, 2013",Covington   Burling LLP,2017
FDA-2017-P-1461-0001_Citizen_Petition_from_FOLEY___LARDNER_LLP.pdf,"March 8, 2017",FOLEY   LARDNER LLP,2017
FDA-2017-P-1463-0001_Citizen_Petition_from_Tate___Lyle_Ingredients_Amer.pdf,"March 8, 2017",Tate   Lyle Ingredients Amer,2017
FDA-2017-P-1495-0001_Citizen_Petition_from_Sandoz_Inc.pdf,"March 10, 2017",Sandoz Inc,2017
FDA-2017-P-1573-0001_Citizen_Petition_from_Hospira_Inc.pdf,"March 13, 2017",Hospira Inc,2017
FDA-2017-P-1911-0001_Citizen_Petition_from_Kleinfeld__Kaplan_and_Becker.pdf,"March 27, 2017",Kleinfeld  Kaplan and Becker,2017
FDA-2017-P-1990-0001_Citizen_Petition_from_AIDP__Inc.pdf,"May 27, 2016",AIDP  Inc,2017
FDA-2017-P-2043-0001_Citizen_Petition_from_Yiling_Pharmaceutical__Ltd.pdf,"March 31, 2017",Yiling Pharmaceutical  Ltd,2017
FDA-2017-P-2044-0001_Citizen_Petition_from_Nirsum_Pharmaceuticals__LLC.pdf,"March 31, 2017",Nirsum Pharmaceuticals  LLC,2017
FDA-2017-P-2092-0001_Citizen_Petition_from_Wilson_Sonsini_Goodrich___Ro.pdf,"April 3, 2017",Wilson Sonsini Goodrich   Ro,2017
FDA-2017-P-2128-0001_Citizen_Petition_from_Jubilant_Generics_Limited.pdf,"April 04, 2017",Jubilant Generics Limited,2017
FDA-2017-P-2129-0001_Citizen_Petition_from_Jubilant_Generics_Limited.pdf,"April 04,2017",Jubilant Generics Limited,2017
FDA-2017-P-2131-0001_Citizen_Petition_from_Menn_Law_Firm_LTD.pdf,"Jan 1, 1982",Menn Law Firm LTD,2017
FDA-2017-P-2162-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"April 5,2017",Hyman  Phelps   McNamara  P,2017
FDA-2017-P-2164-0001_Citizen_Petition_from_Steptoe___Johnson__LLP__Nati.pdf,"April 5, 2017",Steptoe   Johnson  LLP  Nati,2017
FDA-2017-P-2229-0001_Citizen_Petition_from_Covington___Burling__LLP_and.pdf,"April 7, 2017",Covington   Burling  LLP and,2017
FDA-2017-P-2230-0001_Citizen_Petition_from_Kleinfeld__Kaplan_and_Becker.pdf,"March 27, 2017",Kleinfeld  Kaplan and Becker,2017
FDA-2017-P-2231-0001_Citizen_Petition_from_Qilu_Pharma__Inc__as_the_US_.pdf,"April 7, 2017",Qilu Pharma  Inc  as the US,2017
FDA-2017-P-2233-0001_Citizen_Petition_from_Consumers_for_Dental_Choice.pdf,March 2017,Consumers for Dental Choice,2017
FDA-2017-P-2365-0001_Citizen_Petition_from_Senators_Schumer___Gillibran.pdf,"April 14, 2017",Senators Schumer   Gillibran,2017
FDA-2017-P-2460-0001_Citizen_Petition_from_AuroMedics_Pharma_LLC__Aurob.pdf,"April 18, 2017",AuroMedics Pharma LLC  Aurob,2017
FDA-2017-P-2496-0001_Citizen_Petition_from_KVK_Tech__Inc___Abhai__LLC_.pdf,"April 19, 2017",KVK Tech  Inc   Abhai  LLC,2017
FDA-2017-P-2530-0001_Citizen_Petition_from_Lachman_Consultants_Services.pdf,"April 21, 2017",Lachman Consultants Services,2017
FDA-2017-P-2561-0001_Reclassification_Petition_from_STL_International__.pdf,"March 29, 2017",STL International,2017
FDA-2017-P-2561-0009_STL_International_Reclassification_Petition__Final.pdf,"March 29, 2017",,2017
FDA-2017-P-2563-0001_Citizen_Petition_from_The_Tatia_Oden_French_Memori.pdf,"April 24, 2017",The Tatia Oden French Memori,2017
FDA-2017-P-2626-0001_Citizen_Petition_from_Emord___Associates__P__C_.pdf,"April 26, 2017",Emord   Associates  P  C,2017
FDA-2017-P-2659-0001_Citizen_Petition_from_Jubilant_Generics.pdf,"April 27, 2017",Jubilant Generics,2017
FDA-2017-P-2660-0001_Citizen_Petition_from_Jubilant_Generics.pdf,"April 27, 2017",Jubilant Generics,2017
FDA-2017-P-2661-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"April 27, 2017",Foley   Lardner LLP,2017
FDA-2017-P-2674-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"April 27, 2017",Foley   Lardner LLP,2017
FDA-2017-P-2733-0001_Citizen_Petition_from_Esophageal_Cancer_Action_Net.pdf,"May 1, 2017",Esophageal Cancer Action Net,2017
FDA-2017-P-2803-0016_Citizen_Petition_from_Apotex_Inc_.pdf,"May 3, 2017",Apotex Inc,2017
FDA-2017-P-2836-0001_Citizen_Petition_from_VKT_Pharma_Private_Limited.pdf,"May 04, 2017",VKT Pharma Private Limited,2017
FDA-2017-P-2869-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"May 5, 2017",Lachman Consultant Services,2017
FDA-2017-P-2967-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"May 9, 2017",Lachman Consultant Services,2017
FDA-2017-P-3064-0001_Citizen_Petition_from_Pharmaceutical_Manufacturing.pdf,"May 11, 2017",Pharmaceutical Manufacturing,2017
FDA-2017-P-3065-0001_Citizen_Petition_from_NJOY_et__al_.pdf,"May 12,2017",NJOY et  al,2017
FDA-2017-P-3092-0001_Citizen_Petition_from_AstraZeneca_Pharmaceuticals_.pdf,"May 15, 2017",AstraZeneca Pharmaceuticals,2017
FDA-2017-P-3196-0001_Citizen_Petition_from_Philip_Spiller_et__al_.pdf,"May 18,2017",Philip Spiller et  al,2017
FDA-2017-P-3196-0072_Citizen_Petition_for_Reconsideration_from__Philip_.pdf,"November 13, 2017",Philip,2017
FDA-2017-P-3201-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"May 19, 2017",Foley   Lardner LLP,2017
FDA-2017-P-3202-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"May 19, 2017",Foley   Lardner LLP,2017
FDA-2017-P-3251-0001_Citizen_Petition_from_Petitioner__Redacted.pdf,April 2002,Petitioner  Redacted,2017
FDA-2017-P-3329-0001_Citizen_Petition_from_Hyman__Phelps____McNamara__P.pdf,"May 25, 2017",Hyman  Phelps    McNamara  P,2017
FDA-2017-P-3330-0001_Citizen_Petition_Regarding_PMA_K151763___REDACTED.pdf,"January 28, 2020",,2017
FDA-2017-P-3352-0001_Citizen_Petition_from_Belcher_Pharmaceuticals__LLC.pdf,May 2017,Belcher Pharmaceuticals  LLC,2017
FDA-2017-P-3405-0001_Citizen_Petition_from_Michael_Boggi_Redacted.pdf,"May 30, 2017",Michael Boggi Redacted,2017
FDA-2017-P-3413-0001_Reclassification_Petition_from__Salter_Labs.pdf,"June 2, 2017",Salter Labs,2017
FDA-2017-P-3468-0001_Citizen_Petition_from_Teligent_Pharma_Inc_.pdf,"June 1, 2017",Teligent Pharma Inc,2017
FDA-2017-P-3484-0001_Citizen_Petition_from_Glasshouse_Pharmaceuticals_L.pdf,"June 2, 2017",Glasshouse Pharmaceuticals L,2017
FDA-2017-P-3486-0001_Citizen_Petition_from_BioMedEcon__LLC.pdf,"June 2, 2017",BioMedEcon  LLC,2017
FDA-2017-P-3581-0001_Citizen_Petition_from_Alembic_Pharmaceuticals_Limi.pdf,"June 05, 2017",Alembic Pharmaceuticals Limi,2017
FDA-2017-P-3672-0001_Citizen_Petition_from_Millennium_Pharmaceuticals__.pdf,"June 8, 2017",Millennium Pharmaceuticals,2017
FDA-2017-P-3675-0001_Citizen_Petition_from__Teligent_Pharma__Inc_.pdf,"June 9, 2017",Teligent Pharma  Inc,2017
FDA-2017-P-3684-0001_Citizen_Petition_from_Goodwin_Procter_LLP__Boehrin.pdf,"June 9, 2017",Goodwin Procter LLP  Boehrin,2017
FDA-2017-P-3832-0001_Citizen_Petition_for_Reconsideration_from_Porzio__.pdf,"June 16, 2017",Porzio,2017
FDA-2017-P-3884-0001_Reclassification_Petition_from_Riverain_Technologi.pdf,"June 30, 2003",Riverain Technologi,2017
FDA-2017-P-3950-0001_Citizen_Petition_from__Amin_Talati_Upadhye_LLP__Fe.pdf,June 2017,Amin Talati Upadhye LLP  Fe,2017
FDA-2017-P-3989-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"June 29, 2017",Lachman Consultant Services,2017
FDA-2017-P-4023-0001_Citizen_Petition_from_Sidley_Austin_LLP_Vifor_Fres.pdf,"June 30, 2017",Sidley Austin LLP Vifor Fres,2017
FDA-2017-P-4027-0001_Citizen_Petition_from_Strides_Pharma_Inc.pdf,"July 01, 2017",Strides Pharma Inc,2017
FDA-2017-P-4039-0001_Citizen_Petition_from_Center_for_Lawful_Access_and.pdf,"July 3, 2017",Center for Lawful Access and,2017
FDA-2017-P-4145-0001_Citizen_Petition_from_Mylan_Pharmaceuticals__Inc.pdf,"July 11, 2017",Mylan Pharmaceuticals  Inc,2017
FDA-2017-P-4174-0001_Citizen_Petition_from_Mallinckrodt_Pharmaceuticals.pdf,"July 11, 2017",Mallinckrodt Pharmaceuticals,2017
FDA-2017-P-4194-0001_Citizen_Petition_from_Lachman_Consultants_Services.pdf,"July 12, 2017",Lachman Consultants Services,2017
FDA-2017-P-4195-0001_Citizen_Petition_from__INC_Research__LLC.pdf,"July 12, 2017",INC Research  LLC,2017
FDA-2017-P-4233-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"July 12, 2017",Lachman Consultant Services,2017
FDA-2017-P-4245-0001_Citizen_Petition_from_EAS_Consulting_Group__Jubila.pdf,July 2017,EAS Consulting Group  Jubila,2017
FDA-2017-P-4249-0001_Suitability_Petition_from_GE_Healthcare_Inc.pdf,"July 7, 2017",GE Healthcare Inc,2017
FDA-2017-P-4255-0001_Citizen_Petition_from_Kindred_Biosciences_Inc.pdf,"July 17, 2017",Kindred Biosciences Inc,2017
FDA-2017-P-4334-0001_Citizen_Petition_from_Sidley_Austin_LLP__Vifor_Fre.pdf,"June 30, 2017",Sidley Austin LLP  Vifor Fre,2017
FDA-2017-P-4335-0001_Citizen_Petition_from_William_Bonificio___redacted.pdf,7/11/2017,William Bonificio   redacted,2017
FDA-2017-P-4351-0001_Citizen_Petition_from_Hogan_Lovells_US_LLP____Rely.pdf,"July 19, 2017",Hogan Lovells US LLP    Rely,2017
FDA-2017-P-4352-0001_Citizen_Petition_from__Pharmaceutical_Manufacturin.pdf,"July 20, 2017",Pharmaceutical Manufacturin,2017
FDA-2017-P-4360-0001_Citizen_Petition_from_Mallinckrodt_Pharmaceuticals.pdf,"July 19, 2017",Mallinckrodt Pharmaceuticals,2017
FDA-2017-P-4372-0002_Citizen_Petition_from_AEGIS_Regulatory__Inc_.pdf,"January 17, 2018",AEGIS Regulatory  Inc,2017
FDA-2017-P-4388-0001_Suitability_Petition_from_Abhai__LLC.pdf,"July 21, 2017",Abhai  LLC,2017
FDA-2017-P-4389-0001_Citizen_Petition_from_Wildway_LLC.pdf,07/21/2017,Wildway LLC,2017
FDA-2017-P-4409-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__PC.pdf,"July 24, 2017",Hyman  Phelps   McNamara  PC,2017
FDA-2017-P-4500-0001_Citizen_Petition_from_Kent_Heckenlively_Redacted.pdf,"July 28, 2017",Kent Heckenlively Redacted,2017
FDA-2017-P-4575-0001_Vegetable_Oil_Health_Claim_petition_Nov_7_2016.pdf,"August 24, 2018",Unilever for a 1 year Extension,2017
FDA-2017-P-4586-0001_Citizen_Petition_from_Jubilant_DraxImage_Inc_.pdf,"July 28, 201",Jubilant DraxImage Inc,2017
FDA-2017-P-4670-0001_Citizen_Petition_from_Baxter_Healthcare_Corporatio.pdf,"August 2, 2017",Baxter Healthcare Corporatio,2017
FDA-2017-P-4736-0001_Citizen_Petition_from_American_Dental_Association.pdf,"August 4, 2017",American Dental Association,2017
FDA-2017-P-4745-0001_Citizen_Petition_from_Allergan.pdf,"August4,2017",Allergan,2017
FDA-2017-P-4791-0001_Citizen_Petition_from_Hyman__Phelps____McNamara__P.pdf,"August 8, 2017",Hyman  Phelps    McNamara  P,2017
FDA-2017-P-4852-0001_Citizen_Petition_from__EAS_Consulting_Group___Jubi.pdf,August 2017,EAS Consulting Group   Jubi,2017
FDA-2017-P-4939-0001_Citizen_Petition_from_Chul_Hi_Park_Redacted.pdf,"August 14, 2017",Chul Hi Park Redacted,2017
FDA-2017-P-5027-0001_Citizen_Petition_from_Wilson_Disease_Association.pdf,"August 17, 2017",Wilson Disease Association,2017
FDA-2017-P-5080-0001_Citizen_Petition_from_Quagen_Pharmaceuticals_LLC.pdf,June 1982,Quagen Pharmaceuticals LLC,2017
FDA-2017-P-5081-0001_Citizen_Petition_from_Pfizer__Inc_.pdf,"August 17, 2017",Pfizer  Inc,2017
FDA-2017-P-5082-0001_Citizen_Petition_from__ChromaDex__Inc_.pdf,"August 18, 2017",ChromaDex  Inc,2017
FDA-2017-P-5090-0001_Citizen_Petition_from_Macleods_Pharmaceuticals_Lim.pdf,"August 18,2017",Macleods Pharmaceuticals Lim,2017
FDA-2017-P-5114-0001_Citizen_Petition_from_Locke_Lord_LLP.pdf,"August 21, 2017",Locke Lord LLP,2017
FDA-2017-P-5118-0001_Citizen_Petition_from_Tricia_Thompson_Redacted.pdf,"August	
 18,	
 2017",Tricia Thompson Redacted,2017
FDA-2017-P-5124-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__PC.pdf,"August 22, 2017",Hyman  Phelps   McNamara  PC,2017
FDA-2017-P-5205-0001_Citizen_Petition_from_Xiromed__LLC_on_behalf_of_Li.pdf,"August 23, 2017",Xiromed  LLC on behalf of Li,2017
FDA-2017-P-5205-0004_Letter_re_Citizen_Petition_from_FDA_CDER_ORP_to_Xi.pdf,"August 24, 2017",FDA CDER ORP to Xi,2017
FDA-2017-P-5335-0001_Citizen_Petition_from_ANDA_Consultants.pdf,"August 29, 201",ANDA Consultants,2017
FDA-2017-P-5370-0001_Citizen_Petition_from_Dennis_Ryll_Redacted.pdf,"August1,2017",Dennis Ryll Redacted,2017
FDA-2017-P-5396-0001_Citizen_Petition_from_Physicians_for_Responsible_O.pdf,"September 1, 2017",Physicians for Responsible O,2017
FDA-2017-P-5435-0001_Citizen_Petition_from_Hyman__Phelps___McNamara_PC.pdf,"September 1,2017",Hyman  Phelps   McNamara PC,2017
FDA-2017-P-5477-0001_Citizen_Petition_from_Hyman__Phelps___McNamara_on_.pdf,"September 6, 2017",Hyman  Phelps   McNamara on,2017
FDA-2017-P-5592-0001_Citizens_Petition_from_International_Isotopes_Inc.pdf,"September 6, 2017",International Isotopes Inc,2017
FDA-2017-P-5787-0001_Citizen_Petition_Post__Finasteride_Syndrome_Founda.pdf,"September 18, 2017",,2017
FDA-2017-P-5787-0235_Petition_Supplement_2_Post_Finasteride_Syndrome_Fo.pdf,"December 1, 2020",,2017
FDA-2017-P-5799-0001_Citizen_Petition_from_Granules_Pharmaceuticals_Inc.pdf,"September 18, 2017",Granules Pharmaceuticals Inc,2017
FDA-2017-P-5845-0001_Citizen_Petition_from_B_H_Consulting_Services__Inc.pdf,September 2017,B H Consulting Services  Inc,2017
FDA-2017-P-5909-0001_Citizen_Petition_from_Goodwin_Procter_LLP.pdf,"September 25, 2017",Goodwin Procter LLP,2017
FDA-2017-P-5910-0001_Citizen_Petition_from_Cipla_Limited.pdf,"September 25, 2017",Cipla Limited,2017
FDA-2017-P-5921-0001_Citizen_Petition_from_Arent_Fox.pdf,"March 6, 2018",Arent Fox,2017
FDA-2017-P-5946-0001_Citizen_Petition_from_Goodwin_Procter_LLP.pdf,"September 26, 2017",Goodwin Procter LLP,2017
FDA-2017-P-5947-0001_Citizen_Petition_from_Teligent_Pharma_Inc_2.pdf,"September 25, 2017",Teligent Pharma Inc 2,2017
FDA-2017-P-5954-0001_Citizen_Petition_from_Elite_Laboratories_Inc.pdf,"September 27, 2017",Elite Laboratories Inc,2017
FDA-2017-P-5967-0001_Citizen_Petition_from_Apotex_Inc_.pdf,"September 27, 2017",Apotex Inc,2017
FDA-2017-P-5978-0001_Citizen_Petition_from_JR_Rapoza_Associates__Inc_.pdf,"September 24, 2017",JR Rapoza Associates  Inc,2017
FDA-2017-P-6020-0001_Citizen_Petition_from_Axinn__Veltrop___Harkrider_L.pdf,"October 3, 2017",Axinn  Veltrop   Harkrider L,2017
FDA-2017-P-6027-0001_Citizen_Petition_from_Axinn__Veltrop___Harkrider_L.pdf,"October 3, 2017",Axinn  Veltrop   Harkrider L,2017
FDA-2017-P-6028-0001_Citizen_Petition_from_Axinn__Veltrop___Harkrider_L.pdf,"October 3, 2017",Axinn  Veltrop   Harkrider L,2017
FDA-2017-P-6029-0001_Citizen_Petition_from_Novo_Nordisk_Inc.pdf,"October 3, 2017",Novo Nordisk Inc,2017
FDA-2017-P-6101-0001_Citizen_Petition_from_Strides_Pharma_Inc_.pdf,"October 10, 2017",Strides Pharma Inc,2017
FDA-2017-P-6108-0001_Citizen_Petition_from_Goodwin_Procter_LLP.pdf,"October 10, 2017",Goodwin Procter LLP,2017
FDA-2017-P-6116-0001_Citizen_Petition_from_King___Spalding_LLP.pdf,"October 5, 2017",King   Spalding LLP,2017
FDA-2017-P-6136-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"October 12, 2017",Foley   Lardner LLP,2017
FDA-2017-P-6208-0001_Citizen_Petition_from_INC_Research_inVentiv_Health.pdf,October 2017,INC Research inVentiv Health,2017
FDA-2017-P-6211-0001_Citizen_Petition_from_DSM_Nutritional_Products_LLC.pdf,"October 19, 2017",DSM Nutritional Products LLC,2017
FDA-2017-P-6214-0001_Citizen_Petition_from_Yabao_Pharmaceutical_Co__Ltd.pdf,"October 18, 2017",Yabao Pharmaceutical Co  Ltd,2017
FDA-2017-P-6219-0001_Citizen_Petition_from_Axinn__Veltrop___Harkrider_L.pdf,"October 19, 2017",Axinn  Veltrop   Harkrider L,2017
FDA-2017-P-6245-0001_Citizen_Petition_from_ViGuard_Health_Inc_.pdf,"October 23, 2017",ViGuard Health Inc,2017
FDA-2017-P-6274-0001_Citizen_Petition_from_Amneal_Pharmaceuticals.pdf,"October 24, 2017",Amneal Pharmaceuticals,2017
FDA-2017-P-6291-0001_CITIZEN_PETITION_FROM__LACHMAN_CONSULTANT_SERVICES.pdf,"October 26, 2017",LACHMAN CONSULTANT SERVICES,2017
FDA-2017-P-6307-0001_Citizen_Petition_from_Aurolife_Pharma_LLC.pdf,"October 26, 2017",Aurolife Pharma LLC,2017
FDA-2017-P-6316-0001_Citizen_Petition_from_Kleinfeld_Kaplan___Becker__L.pdf,"October 30, 2017",Kleinfeld Kaplan   Becker  L,2017
FDA-2017-P-6357-0001_Citizen_Petition_from_Diana_Wierzchos_Redacted.pdf,"November 2, 2017",Diana Wierzchos Redacted,2017
FDA-2017-P-6411-0001_Citizen_Petition_from__Insys_Therapeutics__Inc_.pdf,"October 27, 2017",Insys Therapeutics  Inc,2017
FDA-2017-P-6451-0001_Suitability_Petition_from_Locke_Lord_LLP.pdf,"November 8, 2017",Locke Lord LLP,2017
FDA-2017-P-6479-0001_Citizen_Petition_from_Teligent_Pharma__Inc_.pdf,"November 13, 2017",Teligent Pharma  Inc,2017
FDA-2017-P-6513-0001_Citizen_Petition_from_Public_Citizen.pdf,"November 15, 2017",Public Citizen,2017
FDA-2017-P-6631-0001_Citizen_Petition_from_Amin_Talati_Upadhye_LLP__Nat.pdf,"November 27, 2017",Amin Talati Upadhye LLP  Nat,2017
FDA-2017-P-6649-0001_Citizen_Petition_from_Greenberg_Traurig_LLP___on_b.pdf,"November 28, 2017",Greenberg Traurig LLP   on b,2017
FDA-2017-P-6663-0001_Citizen_Petition_from_Dr__Edwards_Redacted.pdf,"May 25, 2020",Dr  Edwards Redacted,2017
FDA-2017-P-6689-0001_Citizen_Petition_from_Novitium_Pharma_LLC.pdf,"November 29, 2017",Novitium Pharma LLC,2017
FDA-2017-P-6689-0007_Petition_for_Reconsideration_and_Stay_from_Arnall_.pdf,"June 7, 2019",Arnall,2017
FDA-2017-P-6692-0001_Citizen_Petition_from_Drug_Watch_International__In.pdf,"September 19, 2011",Drug Watch International  In,2017
FDA-2017-P-6692-0043_Citizen_Petition_for_Reconsideration_from_Drug_Wat.pdf,"July 2, 2018",Drug Wat,2017
FDA-2017-P-6745-0001_Citizen_Petition_from_Foley_Hoag_LLP_on_behalf_of_.pdf,"December 5, 2017",Foley Hoag LLP on behalf of,2017
FDA-2017-P-6750-0001_Citizen_Petition_from_Mylan_Inc_.pdf,"December 5, 2017",Mylan Inc,2017
FDA-2017-P-6751-0001_Citizen_Petition_from_Capstone_Law_APC_on_behalf_o.pdf,"December 5, 2017",Capstone Law APC on behalf o,2017
FDA-2017-P-6758-0001_Citizen_Petition_from_Public_Citizen_s_Health_Rese.pdf,"December 6, 2017",Public Citizen s Health Rese,2017
FDA-2017-P-6777-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"December 6, 2017",Hyman  Phelps   McNamara  P,2017
FDA-2017-P-6805-0001_Citizen_Petition_from_Bracco_Diagnostics_Inc.pdf,"December 8, 2017",Bracco Diagnostics Inc,2017
FDA-2017-P-6809-0001_Citizen_Petition_from_Freyr_Inc_.pdf,"December 08, 2017",Freyr Inc,2017
FDA-2017-P-6851-0001_Citizen_Petition_from_Shire_Development_LLC.pdf,"December 20, 2017",Shire Development LLC,2017
FDA-2017-P-6918-0001_Citizen_Petition_from_St__Jude_Children_s_Research.pdf,"December 14, 2017",St  Jude Children s Research,2017
FDA-2017-P-6922-0001_Citizen_Petition_from_Haynes_and_Boone__LLP.pdf,"December 18, 2017",Haynes and Boone  LLP,2017
FDA-2017-P-6923-0001_PUBLIC_REDACTED_VERSION_Citizen_Petition_from_Zydu.pdf,APR 1984,Zydu,2017
FDA-2017-P-6967-0001_Citizen_Petition_from_Bergstrom_Nutrition_Redacted.pdf,"December8,2017",Bergstrom Nutrition Redacted,2017
FDA-2017-P-6968-0001_Suitability_Petition_from_Ceva_Animal_Health__LLC.pdf,"December 21, 2017",Ceva Animal Health  LLC,2017
FDA-2017-P-7031-0001_Citizen_Petition_from_JRRapoza_Associates__Inc.pdf,"December 22, 2017",JRRapoza Associates  Inc,2017
FDA-2017-P-7032-0001_Citizen_Petition_from_Jubilant_Generics_Limited.pdf,"Dec. 13, 2017",Jubilant Generics Limited,2017
FDA-2017-P-7033-0001_Citizen_Petition_from_Juliant_Generics_Limited.pdf,"Dec 13, 2017",Juliant Generics Limited,2017
FDA-2017-P-7034-0001_Citizen_Petition_from_Jubilant_Generics_Limited.pdf,"Dec 19, 2017",Jubilant Generics Limited,2017
FDA-2018-P-0033-0001_Citizen_Petition_from_Hyman__Phelps___McNamara.pdf,"January 2, 2018",Hyman  Phelps   McNamara,2018
FDA-2018-P-0034-0001_Citizen_Petition_from_Hyman__Phelps___McNamara.pdf,"January 2, 2018",Hyman  Phelps   McNamara,2018
FDA-2018-P-0097-0001_Citizen_Petition_from_Hyman__Phelps___McNamara.pdf,"January 5,2018",Hyman  Phelps   McNamara,2018
FDA-2018-P-0098-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,7/18/23,Lachman Consultant Services,2018
FDA-2018-P-0130-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"January 8, 2018",Lachman Consultant Services,2018
FDA-2018-P-0131-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"January 8, 2018",Lachman Consultant Services,2018
FDA-2018-P-0258-0001_Citizen_Petition_from_Gilman_Cheese_Corporation.pdf,JANUARY 2018,Gilman Cheese Corporation,2018
FDA-2018-P-0266-0001_Citizen_Petition_from_Arent_Fox_LLP.pdf,"January 16, 2018",Arent Fox LLP,2018
FDA-2018-P-0268-0001_Citizen_Petition_from_Arent_Fox_LLP.pdf,"January 16, 2018",Arent Fox LLP,2018
FDA-2018-P-0269-0001_Citizen_Petition_from_Arent_Fox_LLP.pdf,"January 16, 2018",Arent Fox LLP,2018
FDA-2018-P-0322-0001_Petition_for_Stay_of_Action_from_Commonwealth_Bran.pdf,"January 19, 2018",Commonwealth Bran,2018
FDA-2018-P-0327-0001_Citizen_Petition_Fresenius_KabiUSA__LLC.pdf,January 2018,,2018
FDA-2018-P-0339-0001_Citizen_Petition_from_Hahn_Loeser___Parks_LLP.pdf,"January 19, 2018",Hahn Loeser   Parks LLP,2018
FDA-2018-P-0343-0001_Citizen_Petition_from_Fish___Richardson_PC.pdf,"January 23, 2018",Fish   Richardson PC,2018
FDA-2018-P-0345-0001_Citizen_Petition_from_Macleods_Pharmaceuticals_Lim.pdf,"January 23, 2018",Macleods Pharmaceuticals Lim,2018
FDA-2018-P-0564-0001_Citizen_Petition_from_Panera_LLC.pdf,"January 18, 2018",Panera LLC,2018
FDA-2018-P-0597-0001_Citizen_Petition_from_the_Alliance_for_Natural_Hea.pdf,"February 7, 2018",the Alliance for Natural Hea,2018
FDA-2018-P-0598-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__PC.pdf,"February 7, 2018",Hyman  Phelps   McNamara  PC,2018
FDA-2018-P-0599-0001_Citizen_Petition_from_National_Pediculosis_Associa.pdf,"February 6, 2018",National Pediculosis Associa,2018
FDA-2018-P-0614-0001_Citizen_Petition_from_GeneYork_Pharmaceuticals_Gro.pdf,"February 7, 2018",GeneYork Pharmaceuticals Gro,2018
FDA-2018-P-0625-0001_Citizen_Petition_from_Made_in_the_USA_Foundation.pdf,"February 1, 2018",Made in the USA Foundation,2018
FDA-2018-P-0664-0001_Citizen_Petition_from_Prinston_Pharmaceutical_Inc_.pdf,"February 9, 2018",Prinston Pharmaceutical Inc,2018
FDA-2018-P-0673-0001_Citizen_Petition_from_Justice_for_Jake.pdf,8/14/18,Justice for Jake,2018
FDA-2018-P-0674-0001_Citizen_Petition_from_Medtech_Products_Inc.pdf,February 2018,Medtech Products Inc,2018
FDA-2018-P-0829-0001_Citizen_Petition_from_Prinston_Pharmaceutical_Inc_.pdf,"February 22, 2018",Prinston Pharmaceutical Inc,2018
FDA-2018-P-0870-0001_Citizen_Petition_from_LACHMAN_CONSULTANT_SERVICES_.pdf,"FEBRUARY 26, 2018",LACHMAN CONSULTANT SERVICES,2018
FDA-2018-P-0874-0001_Citizen_Petition_from_Bonumose_LLC.pdf,"February 22, 2018",Bonumose LLC,2018
FDA-2018-P-0874-0006_Appendix_5_re_Citizen_Petition_from_Bonumose_LLC.pdf,August 2013,Bonumose LLC,2018
FDA-2018-P-0874-0023_Amended_Citizen_Petition_from_Bonumose_LLC.pdf,"April 18, 2018",Bonumose LLC,2018
FDA-2018-P-0876-0001_Citizen_Petition_from_Hyman__Phelps___McNamara.pdf,"February 23, 2018",Hyman  Phelps   McNamara,2018
FDA-2018-P-0877-0001_Citizen_Petition_from_The_Food_Lawyers.pdf,"February 24, 2018",The Food Lawyers,2018
FDA-2018-P-0877-0006_Supplement_to_Citizen_Petition_Requesting_21_CFR_1.pdf,6/14/18,Citizen Petition Requesting 21 CFR 1,2018
FDA-2018-P-0878-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"February 26, 2018",Hyman  Phelps   McNamara  P,2018
FDA-2018-P-0884-0001_Citizen_Petition_from_Buchanan_Ingersoll___Rooney_.pdf,"February 26, 2018",Buchanan Ingersoll   Rooney,2018
FDA-2018-P-0945-0001_Citizen_Petition_from_Scott_Beach_Redacted.pdf,3/5/18,Scott Beach Redacted,2018
FDA-2018-P-0964-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC___Co.pdf,"March 2, 2018",Fresenius Kabi USA  LLC   Co,2018
FDA-2018-P-0967-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC.pdf,"March 2, 2018",Fresenius Kabi USA  LLC,2018
FDA-2018-P-0998-0001_Citizen_Petition_from_Hyman_Phelps___McNamara_P_C_.pdf,"March 5,2018",Hyman Phelps   McNamara P C,2018
FDA-2018-P-1008-0001_Suitability_Petition_from_VPCI__Inc_.pdf,"March 5, 2018",VPCI  Inc,2018
FDA-2018-P-1014-0001_Citizen_Petition_from_Haynes_and_Boone_LLP.pdf,"March 6, 2018",Haynes and Boone LLP,2018
FDA-2018-P-1019-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"March 2, 2018",Lachman Consultant Services,2018
FDA-2018-P-1040-0001_Citizen_Petition_From_Joshua_Brooks_Redacted.pdf,3/8/18,Joshua Brooks Redacted,2018
FDA-2018-P-1068-0001_Citizen_Petition_from_Spear_Pharmaceuticals__Inc.pdf,"Jan. 18, 2018",Spear Pharmaceuticals  Inc,2018
FDA-2018-P-1099-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"March 12, 2018",Lachman Consultant Services,2018
FDA-2018-P-1173-0001_Citizen_Petition_from_the_Alliance_for_Natural_Hea.pdf,"March 15, 2018",the Alliance for Natural Hea,2018
FDA-2018-P-1174-0002_Citizen_Petition_from_Pharma_Regulatory_Consultant.pdf,"March 10, 2018",Pharma Regulatory Consultant,2018
FDA-2018-P-1185-0001_Suitability_Petition_from_Provetica_Animal_Health_.pdf,"March 12, 2018",Provetica Animal Health,2018
FDA-2018-P-1185-0005_Amended_Suitability_Petition_from_Provetica_Animal.pdf,"April 18, 2018",Provetica Animal,2018
FDA-2018-P-1185-0006_Amended_Suitability_Petition_from_Provetica_Animal.pdf,"May 22, 2018",Provetica Animal,2018
FDA-2018-P-1195-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__PC.pdf,"March 19, 2018",Hyman  Phelps   McNamara  PC,2018
FDA-2018-P-1195-0004_Citizen_Petition_Supplement__from_Hyman__Phelps___.pdf,"August 13, 2018",Hyman  Phelps,2018
FDA-2018-P-1195-0009_Petition_for_Reconsideration_and_Stay_Regarding_fr.pdf,"June 7, 2019",,2018
FDA-2018-P-1197-0001_Citizen_Petition_from_Exela_Pharma_Sciences.pdf,"March 19, 2018",Exela Pharma Sciences,2018
FDA-2018-P-1238-0001_Citizen_Petition_from_Lachman_Consultant_Services.pdf,"March 22, 2018",Lachman Consultant Services,2018
FDA-2018-P-1263-0001_Citizen_Petition_from_Kratz___Barry_LLP_on_behalf_.pdf,"March 26, 2018",Kratz   Barry LLP on behalf,2018
FDA-2018-P-1283-0001_Citizen_Petition_from_Sovereign_Pharmaceuticals_LL.pdf,"March 26, 2018",Sovereign Pharmaceuticals LL,2018
FDA-2018-P-1310-0001_Citizen_Petition_from_Vertice_Pharma_Management_Co.pdf,"March 28, 2018",Vertice Pharma Management Co,2018
FDA-2018-P-1335-0001_Citizen_Petition_form_Hyman__Phelps___McNamara__P_.pdf,"March 30, 2018",,2018
FDA-2018-P-1349-0001_Citizen_Petition_from_Douglass_Oeller_Consulting__.pdf,"March 19, 2018",Douglass Oeller Consulting,2018
FDA-2018-P-1349-0005_Amendments_to_Suitability_Petition__Revised_Dosage.pdf,"April 23, 2018",Suitability Petition  Revised Dosage,2018
FDA-2018-P-1351-0001_Citizen_Petition_from_Douglass_Oeller_Consulting__.pdf,"March 19, 2018",Douglass Oeller Consulting,2018
FDA-2018-P-1352-0001_Citizen_Petition_from_Douglass_Oeller_Consulting__.pdf,"March 19, 2018",Douglass Oeller Consulting,2018
FDA-2018-P-1361-0002_Citizen_Petition_from_Ajanta_Pharma_USA_Inc_.pdf,"April 02, 2018",Ajanta Pharma USA Inc,2018
FDA-2018-P-1441-0001_Citizen_Petition_from_Patients_for_Access_to_Advan.pdf,"April 8, 2018",Patients for Access to Advan,2018
FDA-2018-P-1448-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__PC.pdf,"April 9, 2018",Hyman  Phelps   McNamara  PC,2018
FDA-2018-P-1453-0001_Citizen_Petition_from_Spear_Pharmaceuticals__Inc.pdf,"April 9, 2018",Spear Pharmaceuticals  Inc,2018
FDA-2018-P-1469-0001_Citizen_Petition_from_Epstein_Becker___Green_PC___.pdf,"April 10, 2018",Epstein Becker   Green PC,2018
FDA-2018-P-1484-0001_Citizen_Petition_from_Macleods_Pharmaceuticals_Lim.pdf,"April 12, 2018",Macleods Pharmaceuticals Lim,2018
FDA-2018-P-1492-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"April 12, 2018",Lachman Consultant Services,2018
FDA-2018-P-1516-0001_Citizen_Petition_from_Encube_Ethicals_Private_Limi.pdf,"April 13, 2018",Encube Ethicals Private Limi,2018
FDA-2018-P-1531-0001_Petition_from_King___Spalding_LLP.pdf,"April 2, 2018",King   Spalding LLP,2018
FDA-2018-P-1532-0001_Petition_from_King___Spalding_LLP.pdf,"April 2, 2018",King   Spalding LLP,2018
FDA-2018-P-1593-0001_Citizen_Petition_from_Pete_and_Gerry_s_Organics_LL.pdf,"April 19, 2018",Pete and Gerry s Organics LL,2018
FDA-2018-P-1678-0001_Citizen_Petition_from__Mapi_USA__Inc.pdf,"April 27, 2018",Mapi USA  Inc,2018
FDA-2018-P-1698-0001_Suitability_Petition_from_Haynes_and_Boone__LLP.pdf,"May 1, 2018",Haynes and Boone  LLP,2018
FDA-2018-P-1719-0001_Citizen_petition_from_Sciarra_Laboratories__Inc.pdf,"May 2, 2018",Sciarra Laboratories  Inc,2018
FDA-2018-P-1720-0001_Citizen_Petition_from_Gland_Pharma_Limited.pdf,May 2018,Gland Pharma Limited,2018
FDA-2018-P-1734-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"May 3, 2018",Foley   Lardner LLP,2018
FDA-2018-P-1740-0001_Citizen_Petition_from_Provetica_Animal_Health_LLC.pdf,"May 2, 2018",Provetica Animal Health LLC,2018
FDA-2018-P-1740-0005_Amended_Citizen_Petition_from_Provetica_Animal_Hea.pdf,"July 16, 2018",Provetica Animal Hea,2018
FDA-2018-P-1751-0001_Citizen_Petition_from_RegCon_Solutions__LLC_.pdf,"May 4, 2018",RegCon Solutions  LLC,2018
FDA-2018-P-1760-0001_Citizen_Petition_from_Serenity_Pharmaceuticals__LL.pdf,May 2018,Serenity Pharmaceuticals  LL,2018
FDA-2018-P-1780-0001_Citizen_Petition_from_Pacira_Pharmaceuticals__Inc.pdf,"May 7, 2018",Pacira Pharmaceuticals  Inc,2018
FDA-2018-P-1808-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"May 8, 2018",Lachman Consultant Services,2018
FDA-2018-P-1846-0001_Citizen_Petition_from_Data_Based_Medicine_Americas.pdf,"May 10, 2018",Data Based Medicine Americas,2018
FDA-2018-P-1853-0001_Citizen_Petition_from_Aurobindo_Pharma_USA__Inc_.pdf,"May 10, 2018",Aurobindo Pharma USA  Inc,2018
FDA-2018-P-1869-0001_Citizen_Petition_from_Aurobindo_Pharma_USA_Inc.pdf,"May 11, 2018",Aurobindo Pharma USA Inc,2018
FDA-2018-P-1876-0001_Citizen_Petition_from_UIC_College_of_Pharmacy.pdf,May 2018,UIC College of Pharmacy,2018
FDA-2018-P-1877-0001_Citizen_Petition_from_Laurus_Labs.pdf,"May 14, 2018",Laurus Labs,2018
FDA-2018-P-1880-0001_Citizens_Petition_from_Louis_Morris_Aledort_MD_Red.pdf,"May 14, 2018",Louis Morris Aledort MD Red,2018
FDA-2018-P-1891-0001_Citizen_Petition_from_PuraCap_Pharmaceutical__LLC_.pdf,"May 11, 2018",PuraCap Pharmaceutical  LLC,2018
FDA-2018-P-1949-0001_Citizen_Petition_from_Avadel_Specialty_Pharmaceuti.pdf,May 2018,Avadel Specialty Pharmaceuti,2018
FDA-2018-P-1966-0001_Suitability_Petition_from_McNeely__Hare___War__LLP.pdf,"May 17, 2018",McNeely  Hare   War  LLP,2018
FDA-2018-P-1980-0001_Citizen_Petition__from_Foley___Lardner_LLP.pdf,"May 22, 2018",Foley   Lardner LLP,2018
FDA-2018-P-2025-0001_Citizen_Petition_from_Center_for_Biological_Divers.pdf,"May 24, 2018",Center for Biological Divers,2018
FDA-2018-P-2040-0001_Citizen_Petition_from_Jerry_Taylor_Reed_Redacted.pdf,"May 28, 2018",Jerry Taylor Reed Redacted,2018
FDA-2018-P-2050-0001_Citizen_Petition_from_SS_Formulations__LLC_.pdf,"May 29, 2018",SS Formulations  LLC,2018
FDA-2018-P-2073-0001_Citizen_Petition_from_LMS_Direct_Research_Foundati.pdf,"May 16, 2018",LMS Direct Research Foundati,2018
FDA-2018-P-2104-0001_Citizen_Petition_from_Nostrum_Pharmaceuticals__LLC.pdf,"May 31, 2018",Nostrum Pharmaceuticals  LLC,2018
FDA-2018-P-2175-0001_Citizen_Petition_from_Pharmalucence_Inc.pdf,"June 05, 2018",Pharmalucence Inc,2018
FDA-2018-P-2344-0001_Suitability_Petition_from_Noble_Pharma_LLC.pdf,"June 15, 2018",Noble Pharma LLC,2018
FDA-2018-P-2344-0005_Amendments_to_Suitability_Petition_from_Noble_Phar.pdf,"August 9, 2018",Noble Phar,2018
FDA-2018-P-2361-0001_Citizen_Petition_from_BF_Innovation_Inc____on_beha.pdf,June 2018,BF Innovation Inc    on beha,2018
FDA-2018-P-2362-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"June 18, 2018",Lachman Consultant Services,2018
FDA-2018-P-2407-0001_Citizen_Petition_from_Ray_Law_Firm__PLLC.pdf,"June 14, 2018",Ray Law Firm  PLLC,2018
FDA-2018-P-2408-0001_Citizen_Petition_from_Public_Citizen.pdf,"June 21, 2018",Public Citizen,2018
FDA-2018-P-2506-0001_Citizen_Petition_from_K_L_Gates_LLP.pdf,"June 27, 2016",K L Gates LLP,2018
FDA-2018-P-2720-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"July 13, 2018",Hyman  Phelps   McNamara  P,2018
FDA-2018-P-2749-0001_Citizen_Petition_from_Anne_A__Shirinian_Orlando_Re.pdf,"July 13, 2018",Anne A  Shirinian Orlando Re,2018
FDA-2018-P-2754-0001_Citizen_Petition_from_Ascend_Laboratories_LLC.pdf,"July 17,2018",Ascend Laboratories LLC,2018
FDA-2018-P-2755-0001_Citizen_Petition_from_Ascend_Laboratories__LLC.pdf,"July 18, 2018",Ascend Laboratories  LLC,2018
FDA-2018-P-2838-0001_Citizen_Petition_from_Public_Citizen_s_Health_Rese.pdf,"July 23, 2018",Public Citizen s Health Rese,2018
FDA-2018-P-2851-0001_Citizen_Petition_from_Pharmaceutical_Manufacturing.pdf,"July 23, 2018",Pharmaceutical Manufacturing,2018
FDA-2018-P-2862-0001_Citizen_Petition_from_Lupin_Pharmaceuticals__Inc.pdf,"July 23, 2018",Lupin Pharmaceuticals  Inc,2018
FDA-2018-P-2901-0001_Citizen_Petition_from_Yiling_Pharmaceutical_Ltd.pdf,"July 26, 2018",Yiling Pharmaceutical Ltd,2018
FDA-2018-P-2962-0001_Citizen_Petition_from_Americans_for_Homeopathy_Cho.pdf,"July 25, 2018",Americans for Homeopathy Cho,2018
FDA-2018-P-2985-0001_Citizen_Petition_from_Norbrook_Inc_.pdf,"July 26, 2018",Norbrook Inc,2018
FDA-2018-P-2985-0006_Amendment_to_Citizen_Petition_from_Norbrook_Inc_.pdf,"September 12, 2018",Norbrook Inc,2018
FDA-2018-P-2997-0003_Citizen_Petition_from_New_Civil_Liberties_Alliance.pdf,"July 31, 2018",New Civil Liberties Alliance,2018
FDA-2018-P-3076-0001_Citizen_Petition_from_Dr__Joseph_Purita_Redacted.pdf,"July 23, 2018",Dr  Joseph Purita Redacted,2018
FDA-2018-P-3102-0001_Citizen_Petition_From_Richard_M__Fleming_Redacted.pdf,July 2018,Richard M  Fleming Redacted,2018
FDA-2018-P-3139-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"August 10, 2018",Hyman  Phelps   McNamara  P,2018
FDA-2018-P-3176-0001_Citizen_Petition_from_Medefil_Inc_1.pdf,"August 15, 2018",Medefil Inc 1,2018
FDA-2018-P-3176-0006_Petition_Reconsideration_from_Medefil__Inc_.pdf,"January 14, 2025",Medefil  Inc,2018
FDA-2018-P-3211-0001_Citizen_Petition_from_Aurora_Pharmaceutical_LLC.pdf,August 2018,Aurora Pharmaceutical LLC,2018
FDA-2018-P-3222-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"August 17, 2018",Foley   Lardner LLP,2018
FDA-2018-P-3266-0001_Citizen_Petition_from_Haynes_and_Boone__LLP___Reda.pdf,"August 22, 201",Haynes and Boone  LLP   Reda,2018
FDA-2018-P-3281-0001_Citizen_Petition_from_Pfizer_Inc.pdf,"August 22, 2018",Pfizer Inc,2018
FDA-2018-P-3284-0001_Citizen_Petition_from_Keryx_Biopharmaceuticals__In.pdf,"August 23, 2018",Keryx Biopharmaceuticals  In,2018
FDA-2018-P-3284-0023_Petition_for_Reconsideration_from_Hogan_Lovells_US.pdf,"February 19, 2019",Hogan Lovells US,2018
FDA-2018-P-3325-0001_Citizen_Petition_from_Pfizer_Inc.pdf,"August 29, 2018",Pfizer Inc,2018
FDA-2018-P-3327-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__PC.pdf,"August 30, 2018",Hyman  Phelps   McNamara  PC,2018
FDA-2018-P-3354-0001_Citizen_Petition_from_International_Contrast_Ultra.pdf,"August 29, 2018",International Contrast Ultra,2018
FDA-2018-P-3354-0018_Citizen_Petition_from_International_Contrast_Ultra.pdf,"August 31, 2020",International Contrast Ultra,2018
FDA-2018-P-3355-0003_Citizen_Petition_from_Oregon_Pain_Guidance.pdf,"August13,2018",Oregon Pain Guidance,2018
FDA-2018-P-3372-0001_Citizen_Petition_from_Ohio_State_University.pdf,8/13/18,Ohio State University,2018
FDA-2018-P-3382-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC.pdf,"September 6, 2018",Fresenius Kabi USA  LLC,2018
FDA-2018-P-3401-0001_Citizen_Petition_from_Novo_Nordisk_Inc_.pdf,"September 05, 2018",Novo Nordisk Inc,2018
FDA-2018-P-3412-0001_Citizen_Petition_from_Aurolife_Pharma_LLC.pdf,"September 06, 2018",Aurolife Pharma LLC,2018
FDA-2018-P-3413-0001_Citizen_Petition_from_Pharmaceutical_R_D_and_QA_Co.pdf,"September 10, 2018",Pharmaceutical R D and QA Co,2018
FDA-2018-P-3422-0001_Citizen_Petition_from_Novitium_Pharma_LLC_.pdf,"September 6, 2018",Novitium Pharma LLC,2018
FDA-2018-P-3426-0001_Citizen_Petition_from_Pharmax_Group__Inc.pdf,"September 10, 2018",Pharmax Group  Inc,2018
FDA-2018-P-3535-0001_Petition_from_Norbrook_Laboratories_Limited.pdf,"September 17, 2018",Norbrook Laboratories Limited,2018
FDA-2018-P-3535-0006_Amendment_to_Suitability_Petition_FDA_2018_P_3535_.pdf,"November 12, 2018",Suitability Petition FDA 2018 P 3535,2018
FDA-2018-P-3545-0001_Citizen_Petition_from_Arnall_Golden_Gregory__LLP.pdf,"September 12, 2018",Arnall Golden Gregory  LLP,2018
FDA-2018-P-3597-0001_Citizen_Petition_from_Arent_Fox_LLP.pdf,"September 21, 2018",Arent Fox LLP,2018
FDA-2018-P-3599-0001_Citizen_Petition_from_AuroMedics_Pharma_LLC.pdf,"September 21, 2018",AuroMedics Pharma LLC,2018
FDA-2018-P-3616-0001_Citizen_Petition_from_Suven_Life_Sciences_Limited.pdf,"September 26, 2018",Suven Life Sciences Limited,2018
FDA-2018-P-3640-0001_Citizen_Petition_from_Information_Technology_and_I.pdf,"September 24, 2018",Information Technology and I,2018
FDA-2018-P-3666-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC.pdf,September 2018,Fresenius Kabi USA  LLC,2018
FDA-2018-P-3672-0001_Citizen_Petition_from_Zoetis_Inc_.pdf,"September 25, 2018",Zoetis Inc,2018
FDA-2018-P-3691-0001_Citizen_Petition_from_Avanthi__LLC_.pdf,"September 27, 2018",Avanthi  LLC,2018
FDA-2018-P-3709-0001_Citizen_Petition_from_Jennifer_Nelson_Redacted.pdf,"September 28, 2018",Jennifer Nelson Redacted,2018
FDA-2018-P-3709-0004_Addendum_to_Citizen_Petition_from_Jennifer_Nelson_.pdf,"October 26, 2018",Jennifer Nelson,2018
FDA-2018-P-3730-0001_Citizen_Petition_from_Aizant_Drug_Research_Solutio.pdf,"October 01, 2018",Aizant Drug Research Solutio,2018
FDA-2018-P-3742-0001_Citizen_Petition_from_Pharmacmechanics.pdf,"October 1, 2018",Pharmacmechanics,2018
FDA-2018-P-3746-0001_Citizen_Petition_from_BF_Innovation_Inc_on_behalf_.pdf,"October 01, 2018",BF Innovation Inc on behalf,2018
FDA-2018-P-3770-0001_Citizen_Petition_from_Luitpold_Pharmaceuticals_Inc.pdf,"September 4, 2018",Luitpold Pharmaceuticals Inc,2018
FDA-2018-P-3786-0001_Citizen_Petition_from_Hyman__Phelps___McNamara_PC.pdf,"October 3,2018",Hyman  Phelps   McNamara PC,2018
FDA-2018-P-3806-0001_Citizen_Petition_from_Greg_Grillo_Redacted.pdf,August 2017,Greg Grillo Redacted,2018
FDA-2018-P-3825-0001_Citizen_Petition_from_Pei_Wei_Asian_Diner__LLC_.pdf,"October 8, 2018",Pei Wei Asian Diner  LLC,2018
FDA-2018-P-3843-0001_Citizen_Petition_from_Hooman_Noorchashm_Readacted.pdf,December 2013,Hooman Noorchashm Readacted,2018
FDA-2018-P-3861-0001_Citizen_Petition_from_Innogenix_LLC.pdf,"October 11, 2018",Innogenix LLC,2018
FDA-2018-P-3883-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"October 11, 2018",Foley   Lardner LLP,2018
FDA-2018-P-3896-0001_Citizen_Petition_from_Chul_Hi_Park_Ph_D___Redacted.pdf,"October 14, 2018",Chul Hi Park Ph D   Redacted,2018
FDA-2018-P-3933-0001_Citizen_Petition_from_Fresenius_Kabi_USA_LLC.pdf,October 2018,Fresenius Kabi USA LLC,2018
FDA-2018-P-3949-0001_Citizens_Petition_from_Lachman_Consultant_Services.pdf,"October 17, 2018",Lachman Consultant Services,2018
FDA-2018-P-3951-0001_Citizen_Petition_from_Chul_Hi_Park_Redacted.pdf,"October 18, 2018",Chul Hi Park Redacted,2018
FDA-2018-P-4088-0001_Citizen_Petition_from_Data_Based_Medicine_Americas.pdf,"October 26, 2018",Data Based Medicine Americas,2018
FDA-2018-P-4143-0001_Citizen_Petition_from_University_of_Toledo.pdf,10/31/2018,University of Toledo,2018
FDA-2018-P-4281-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC.pdf,"November 7, 2018",Fresenius Kabi USA  LLC,2018
FDA-2018-P-4281-0004_Attachment_2___Amendment_to_Suitability_Petition_f.pdf,"November 7, 2018",Suitability Petition f,2018
FDA-2018-P-4281-0005_Attachment_3___Amendment_to_Suitability_Petition_f.pdf,"November 7, 2018",Suitability Petition f,2018
FDA-2018-P-4306-0001_Citizen_Petition_from_Jill_H__Osborne_Redacted.pdf,"November 8, 2018",Jill H  Osborne Redacted,2018
FDA-2018-P-4338-0001_Citizen_Petition_from_PMRS.pdf,"November 13, 2018",PMRS,2018
FDA-2018-P-4340-0001_Citizen_Petition_from_Freyr_Inc_.pdf,"November 14, 2018",Freyr Inc,2018
FDA-2018-P-4454-0001_Citizen_Petition_from_Bonumose_LLC.pdf,"November 19, 2018",Bonumose LLC,2018
FDA-2018-P-4490-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"November 21, 2018",Hyman  Phelps   McNamara  P,2018
FDA-2018-P-4549-0001_Citizen_Petition_from_Unichem_Pharmaceuticals__USA.pdf,"November 28, 2018",Unichem Pharmaceuticals  USA,2018
FDA-2018-P-4590-0001_Citizen_Petition_from_Ascend_Laboratories__LLC.pdf,"November 30, 2018",Ascend Laboratories  LLC,2018
FDA-2018-P-4591-0001_Citizen_Petition_from_International_Maple_Syrup_In.pdf,"Mar. 15, 1977",International Maple Syrup In,2018
FDA-2018-P-4642-0001_Citizen_Petition_from_Provetica_Animal_Health_LLC.pdf,"November 20, 2018",Provetica Animal Health LLC,2018
FDA-2018-P-4656-0001_Citizen_Petition_from_Animal_Legal_Defense_Fund.pdf,"December 6, 2018",Animal Legal Defense Fund,2018
FDA-2018-P-4661-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"December 6, 2018",Hyman  Phelps   McNamara  P,2018
FDA-2018-P-4664-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC.pdf,December 2018,Fresenius Kabi USA  LLC,2018
FDA-2018-P-4714-0001_Citizen_Petition_from_TherapeuticsMD__Inc_.pdf,"December 11, 2018",TherapeuticsMD  Inc,2018
FDA-2018-P-4769-0001_CITIZEN_PETITION__FROM_EXELA_PHARMA_SCIENCES__LLC_.pdf,"December 16, 2018",EXELA PHARMA SCIENCES  LLC,2018
FDA-2018-P-4812-0001_Citizen_Petition_from_Arent_Fox_LLP.pdf,"December 19, 2018",Arent Fox LLP,2018
FDA-2018-P-4832-0001_Citizen_Petition_from_Goodwin_Procter_LLP__on_beha.pdf,"December 21, 2018",Goodwin Procter LLP  on beha,2018
FDA-2018-P-4851-0001_Citizen_Petition_from_Hetero_Labs_Limited.pdf,"December 20, 2018",Hetero Labs Limited,2018
FDA-2019-P-0076-0001_Citizen_Petition_from_Unichem_Pharmaceuticals__USA.pdf,"December 28, 2018",Unichem Pharmaceuticals  USA,2019
FDA-2019-P-0114-0001_Citizen_Petition_from__Pfizer_Innovative_Health_Gl.pdf,"Jan 1, 1982",Pfizer Innovative Health Gl,2019
FDA-2019-P-0175-0001_Citizen_Petition__from_Fresenius_Kabi_USA__LLC.pdf,"January 9, 2019",Fresenius Kabi USA  LLC,2019
FDA-2019-P-0198-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"January 10, 2019",Lachman Consultant Services,2019
FDA-2019-P-0372-0001_Citizen_Petition_from_Hyman_Phelps___McNamara__P_C.pdf,"January 23, 2019",Hyman Phelps   McNamara  P C,2019
FDA-2019-P-0412-0001_Citizen_Petition_from_Summit_Pharmaceuticals_Inc.pdf,1/29/19,Summit Pharmaceuticals Inc,2019
FDA-2019-P-0417-0001_Citizen_Petition_from_Scilex_Pharmaceuticals_Inc.pdf,"December 28, 2018",Scilex Pharmaceuticals Inc,2019
FDA-2019-P-0466-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC.pdf,"January 29, 2019",Fresenius Kabi USA  LLC,2019
FDA-2019-P-0537-0001_Citizen_Petition_from_Kulkarni_Law_Firm.pdf,"February 2, 2019",Kulkarni Law Firm,2019
FDA-2019-P-0538-0001_Citizen_Petition_from__K_L_Gates_LLP_on_behalf_of_.pdf,"February 1, 2019",K L Gates LLP on behalf of,2019
FDA-2019-P-0622-0001_Citizen_Petition___redacted.pdf,"January 31, 2019",,2019
FDA-2019-P-0692-0001_Citizen_Petition_from_Arent_Fox_LLP.pdf,"January 30, 2019",Arent Fox LLP,2019
FDA-2019-P-0726-0001_Suitability_Citizen_Petition_from_Sunny_Pharmtech_.pdf,2/14/19,Sunny Pharmtech,2019
FDA-2019-P-0777-0001_Citizen_Petition_from_National_Milk_Producers_Fede.pdf,"February 21, 2019",National Milk Producers Fede,2019
FDA-2019-P-0837-0001_Citizen_Petition_from_Takeda_Pharmaceuticals_U_S_A.pdf,"February 20, 2019",Takeda Pharmaceuticals U S A,2019
FDA-2019-P-0913-0001_Citizen_Petition_from_Independent_Nutrition_Inc.pdf,3/20/19,Independent Nutrition Inc,2019
FDA-2019-P-0915-0001_Suitability_Petition_from_Sunshine_Lake_Pharma_Co_.pdf,"February 26, 2019",Sunshine Lake Pharma Co,2019
FDA-2019-P-0916-0001_Suitability_Petition_from_Schafer_Veterinary_Consu.pdf,"February 21, 2019",Schafer Veterinary Consu,2019
FDA-2019-P-0941-0001_Suitability_Petition_from_Felix_Pharmaceuticals_Pv.pdf,"February 21, 2019",Felix Pharmaceuticals Pv,2019
FDA-2019-P-1009-0001_Citizen_Petition_from_Rossman_Law_Group__PLLC_on_b.pdf,"February 28,2019",Rossman Law Group  PLLC on b,2019
FDA-2019-P-1130-0001_Citizen_Petition_from_Kent_Heckenlively_et_al_Reda.pdf,3/11/19,Kent Heckenlively et al Reda,2019
FDA-2019-P-1198-0001_Citizen_Petition_from_KIND_LLC.pdf,"March 12, 2019",KIND LLC,2019
FDA-2019-P-1236-0001_Citizen_Petition_from_Sarfaraz_K__Niazi.pdf,March 2019,Sarfaraz K  Niazi,2019
FDA-2019-P-1318-0001_Citizen_Petition_from_Lachman_Consultants.pdf,"March 19, 2019",Lachman Consultants,2019
FDA-2019-P-1351-0001_Citizen_Petition_from_Law_Office_of_Alan_Dumoff_on.pdf,"February 19, 2019",Law Office of Alan Dumoff on,2019
FDA-2019-P-1364-0001_Citizen_Petition_from_Public_Citizen_s_Health_Rese.pdf,"March 21, 2019",Public Citizen s Health Rese,2019
FDA-2019-P-1364-0002_Cover_Letter_Petition_to_from_Public_Citizen_s_Hea.pdf,"March 21, 2019",Public Citizen s Hea,2019
FDA-2019-P-1366-0001_Citizen_Petition_from_Cardinal_Health_Regulatory_S.pdf,"January 1, 1982",Cardinal Health Regulatory S,2019
FDA-2019-P-1525-0001_Revised_Citizen_Petition_from_Baxter_Healthcare_Co.pdf,"March 29, 2019",Baxter Healthcare Co,2019
FDA-2019-P-1534-0001_Citizen_Petition_from_American_Association_of_Pro_.pdf,"March 29, 2019",American Association of Pro,2019
FDA-2019-P-1560-0001_Citizen_Petition_from_Hyman__Phelps___McNamara_on_.pdf,"April 1, 2019",Hyman  Phelps   McNamara on,2019
FDA-2019-P-1566-0001_Citizen_Petition_from_Noble_Pharma__LLC.pdf,"April 1, 2019",Noble Pharma  LLC,2019
FDA-2019-P-1594-0001_QHC_Petition___Petition_for_the_Authorization_of_a.pdf,"December 18, 2018",QHC Petition,2019
FDA-2019-P-1594-0003_Letter_re_Qualified_Health_Claim_Petition___Yogurt.pdf,"March 13, 2019",Letter re Qualified,2019
FDA-2019-P-1607-0001_Citizen_Petition_from_Aurobindo_Pharma_USA__Inc_.pdf,"April 02, 2019",Aurobindo Pharma USA  Inc,2019
FDA-2019-P-1636-0001_Citizen_Petition_from_Nexsen_Pruet__LLC.pdf,"April 4, 2019",Nexsen Pruet  LLC,2019
FDA-2019-P-1640-0001_Citizen_Petition_from_Top_Health_Ingredients__Inc.pdf,"March 4, 2019",Top Health Ingredients  Inc,2019
FDA-2019-P-1643-0001_Citizen_Petition_from_Public_Citizen_s_Health_Rese.pdf,"April 5, 2019",Public Citizen s Health Rese,2019
FDA-2019-P-1678-0001_Citizen_Petition_from_Exela_Pharma_Sciences__LLC_.pdf,"April 5, 2019",Exela Pharma Sciences  LLC,2019
FDA-2019-P-1679-0001_Citizen_Petition_from_Goodwin_Procter___LLP_on_beh.pdf,"April 5, 2019",Goodwin Procter   LLP on beh,2019
FDA-2019-P-1781-0001_Citizen_Petition_from_Association_of_Independent_B.pdf,4/16/19,Association of Independent B,2019
FDA-2019-P-1783-0001_Citizen_Petition_from_Public_Citizen.pdf,"April 10, 2019",Public Citizen,2019
FDA-2019-P-1800-0001_Citizen_Petition_from_Boditech_Med_Inc_.pdf,"April 12, 2018",Boditech Med Inc,2019
FDA-2019-P-1800-0007_Submission_of_a__Reclassification_Petition__under_.pdf,4/15/19,Boditech Med Inc.,2019
FDA-2019-P-1818-0001_Citizen_Petition_from_Public_Citizen_Health_Resear.pdf,"April 16, 2019",Public Citizen Health Resear,2019
FDA-2019-P-1893-0001_Citizen_Petition_from_Novartis_Pharmaceuticals_Cor.pdf,"April 18, 2019",Novartis Pharmaceuticals Cor,2019
FDA-2019-P-1911-0001_Citizen_Petition_from_Keller_and_Heckman_LLP_on_be.pdf,"April 19, 2019",Keller and Heckman LLP on be,2019
FDA-2019-P-1980-0001_Citizen_Petition_from_Novitium_Pharma_LLC.pdf,"April 23, 2019",Novitium Pharma LLC,2019
FDA-2019-P-2038-0001_Citizen_Petition_from_American_Dental_Association.pdf,"April 25, 2019",American Dental Association,2019
FDA-2019-P-2070-0001_Citizen_Petition_from_TechReg_Services__Inc_.pdf,"April 29, 2019",TechReg Services  Inc,2019
FDA-2019-P-2074-0001_Citizen_Petition_from_Encube_Ethicals_Private_Limi.pdf,"April 30, 2019",Encube Ethicals Private Limi,2019
FDA-2019-P-2088-0001_Citizen_Petition_from_Summit_Health_Pharmacy_Inc.pdf,"December 16, 2016",Summit Health Pharmacy Inc,2019
FDA-2019-P-2122-0001_Citizen_Petition_from_Handcrafted_Soap___Cosmetic_.pdf,"May 1, 2019",Handcrafted Soap   Cosmetic,2019
FDA-2019-P-2123-0001_Citizen_Petition_from_Lachman_Consultants.pdf,"May 01, 2019",Lachman Consultants,2019
FDA-2019-P-2124-0001_Petition_for_Administrative_Reconsideration_from_C.pdf,"April 28, 2018",C,2019
FDA-2019-P-2142-0002_Citizen_Petition_from_Archer_Daniels_Midland_Compa.pdf,"May 02, 2019",Archer Daniels Midland Compa,2019
FDA-2019-P-2239-0001_Citizen_Petition_from_BioNeutra_North_America_Inc.pdf,May 2019,BioNeutra North America Inc,2019
FDA-2019-P-2240-0001_Citizen_Petition_from_Axinn_on_behalf_of_Zydus_Pha.pdf,"May 6, 2019",Axinn on behalf of Zydus Pha,2019
FDA-2019-P-2289-0001_Citizen_Petition_from_Contraceptive_Study_Group.pdf,5/10/19,Contraceptive Study Group,2019
FDA-2019-P-2290-0001_Citizen_Petition_from_ALEMBIC_PHARMACEUTICALS_LIMI.pdf,"May 10, 2019",ALEMBIC PHARMACEUTICALS LIMI,2019
FDA-2019-P-2370-0001_Citizen_Petition_from_ALEMBIC_PHARMACEUTICALS_LIMI.pdf,"May 15, 2019",ALEMBIC PHARMACEUTICALS LIMI,2019
FDA-2019-P-2407-0001_Citizen_Petition_from_Kratz___Barry_LLP_on_behalf_.pdf,"May 15, 2019",Kratz   Barry LLP on behalf,2019
FDA-2019-P-2537-0001_Citizen_Petition_from_Allergan_Holdings_Unlimited_.pdf,"May 23, 2019",Allergan Holdings Unlimited,2019
FDA-2019-P-2559-0001_Citizen_Petition_from_Ajanta_Pharma_USA_Inc.pdf,"May 27, 2019",Ajanta Pharma USA Inc,2019
FDA-2019-P-2590-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC.pdf,May 2019,Fresenius Kabi USA  LLC,2019
FDA-2019-P-2687-0001_Citizen_Petition_from_AuroMedics_Pharma_LLC.pdf,"June 3, 2019",AuroMedics Pharma LLC,2019
FDA-2019-P-2853-0001_Citizen_Petition_from_Fresenius_Medical_Care_North.pdf,"June 11, 2019",Fresenius Medical Care North,2019
FDA-2019-P-2869-0001_Citizen_Petition_from_Valisure__LLC.pdf,"June 13, 2019",Valisure  LLC,2019
FDA-2019-P-2945-0001_Additional_Petitioners_Supporters_of_the_Petition_.pdf,6/25/19,Jesse J LeBlanc III,2019
FDA-2019-P-2982-0001_Citizen_Petition_from_Hetero_Labs_Limited.pdf,"June 19, 2019",Hetero Labs Limited,2019
FDA-2019-P-2998-0001_Citizen_Petition_from_SONAR.pdf,12/20/1996,SONAR,2019
FDA-2019-P-3022-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"June 24, 2019",Foley   Lardner LLP,2019
FDA-2019-P-3024-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"June 24, 2019",Foley   Lardner LLP,2019
FDA-2019-P-3082-0001_Citizen_Petition_from_Andarix_Pharmaceuticals__Inc.pdf,"June 25, 2019",Andarix Pharmaceuticals  Inc,2019
FDA-2019-P-3109-0001_Citizen_Petition_from_Noble_Pharma__LLC.pdf,"June 24, 2019",Noble Pharma  LLC,2019
FDA-2019-P-3156-0001_Citizen_Petition_from_Medical_Research_Collaborati.pdf,"June 29, 2019",Medical Research Collaborati,2019
FDA-2019-P-3192-0001_Citizen_Petition_from_US_WorldMeds.pdf,"July 1, 2019",US WorldMeds,2019
FDA-2019-P-3232-0001_Citizen_Petition_from_Lachman_Consultants.pdf,"July 02, 2019",Lachman Consultants,2019
FDA-2019-P-3265-0001_Citizen_Petition_from_Medical_Research_Collaborati.pdf,"July 8, 2019",Medical Research Collaborati,2019
FDA-2019-P-3266-0001_Citizen_Petition_from_Medical_Research_Collaborati.pdf,"July 8, 2019",Medical Research Collaborati,2019
FDA-2019-P-3311-0001_Citizen_Petition_from_RC_Outsourcing__LLC_.pdf,7/10/19,RC Outsourcing  LLC,2019
FDA-2019-P-3347-0001_Citizen_Petition_from_Stryker.pdf,"July 10, 2019",Stryker,2019
FDA-2019-P-3423-0001_Suitability_Petition_from_Oxford_Pharmaceuticals__.pdf,"June 06, 2019",Oxford Pharmaceuticals,2019
FDA-2019-P-3424-0001_Citizen_Petition_from_Medical_Research_Collaborati.pdf,"July 16, 2019",Medical Research Collaborati,2019
FDA-2019-P-3545-0001_Citizen_Petition_from_Axinn_on_behalf_of__Zydus_Ph.pdf,"July 24, 2019",Axinn on behalf of  Zydus Ph,2019
FDA-2019-P-3800-0001_Citizen_Petition_from_Hyman__Phelps___McNamara_P_C.pdf,"August 12, 2019",Hyman  Phelps   McNamara P C,2019
FDA-2019-P-3803-0001_Citizen_Petition_from_Hyman__Phelps___McNamara_P_C.pdf,"August 12, 2019",Hyman  Phelps   McNamara P C,2019
FDA-2019-P-3809-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"August 12, 2019",Lachman Consultant Services,2019
FDA-2019-P-3855-0001_Citizen_Petition_from_Latham_Watkins_LLP_on_behalf.pdf,"August 14, 2019",Latham Watkins LLP on behalf,2019
FDA-2019-P-3855-0025_Amendment_to_Citizen_Petition_from_Latham___Watkin.pdf,"November 27, 2019",Latham   Watkin,2019
FDA-2019-P-3855-0026_Amendment_to_Citizen_Petition_from_Latham___Watkin.pdf,"November 27, 2019",Latham   Watkin,2019
FDA-2019-P-3877-0001_Citizen_Petition_from_Harman_Finochem_Limited.pdf,"August 17, 2019",Harman Finochem Limited,2019
FDA-2019-P-3886-0001_Citizen_Petition_from_Turner_Scientific.pdf,8/19/19,Turner Scientific,2019
FDA-2019-P-3903-0001_Citizen_Petition_from_Hyman__Phelps___McNamara_P_C.pdf,"August 16, 2019",Hyman  Phelps   McNamara P C,2019
FDA-2019-P-3907-0001_Citizen_Petition_from_Novitium_Pharma_LLC.pdf,"August 16, 2019",Novitium Pharma LLC,2019
FDA-2019-P-3934-0001_Suitability_Petition_from_AuroMedics_Pharma_LLC_on.pdf,"August 20, 2019",AuroMedics Pharma LLC on,2019
FDA-2019-P-3937-0001_Citizen_Petition_from_Teva_Pharmaceuticals_USA__In.pdf,"August 20, 2019",Teva Pharmaceuticals USA  In,2019
FDA-2019-P-4002-0001_Citizen_Petition_from_Otsuka_Pharmaceutical_Develo.pdf,"August 22, 2019",Otsuka Pharmaceutical Develo,2019
FDA-2019-P-4003-0001_Citizen_Petition_from_Lisa_Myslinski____Redacted.pdf,"August 23, 2019",Lisa Myslinski    Redacted,2019
FDA-2019-P-4006-0001_Citizen_Petition_from_Tate___Lyle_Ingredients_Amer.pdf,"August 21, 2019",Tate   Lyle Ingredients Amer,2019
FDA-2019-P-4101-0001_Citizen_Petition_from_IQVIA_RDS_Inc_.pdf,"August 29, 2019",IQVIA RDS Inc,2019
FDA-2019-P-4140-0001_Citizen_Petition_from_Persion_Pharmaceuticals_LLC.pdf,"August 29, 2019",Persion Pharmaceuticals LLC,2019
FDA-2019-P-4155-0001_Citizen_Petition_from_Teva_Pharmaceuticals_USA__In.pdf,"September 5, 2019",Teva Pharmaceuticals USA  In,2019
FDA-2019-P-4261-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"September 10, 2019",Hyman  Phelps   McNamara  P,2019
FDA-2019-P-4281-0001_Citizen_Petition_from_Valisure__LLC.pdf,"September 9, 2019",Valisure  LLC,2019
FDA-2019-P-4362-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"September 17, 2019",Hyman  Phelps   McNamara  P,2019
FDA-2019-P-4363-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"September 17, 2019",Hyman  Phelps   McNamara  P,2019
FDA-2019-P-4386-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC.pdf,"August 30, 2019",Fresenius Kabi USA  LLC,2019
FDA-2019-P-4424-0001_Citizen_Petition_from_Hibrow_Healthcare_LLC.pdf,"September 23, 2019",Hibrow Healthcare LLC,2019
FDA-2019-P-4448-0001_Citizen_Petition_from_Samuel_A__Gonzalez___Redacte.pdf,09/24/2019,Samuel A  Gonzalez   Redacte,2019
FDA-2019-P-4481-0001_Citizen_Petition_from_Macleods_Pharmaceuticals_Lim.pdf,"September 25, 2019",Macleods Pharmaceuticals Lim,2019
FDA-2019-P-4507-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"September 26, 2019",Foley   Lardner LLP,2019
FDA-2019-P-4515-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"September 26, 2019",Foley   Lardner LLP,2019
FDA-2019-P-4523-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC.pdf,"September 26, 2019",Fresenius Kabi USA  LLC,2019
FDA-2019-P-4540-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"September 27, 2019",Foley   Lardner LLP,2019
FDA-2019-P-4643-0001_Citizen_Petition_from_Physicians_Committee_for_Res.pdf,"October 3, 2019",Physicians Committee for Res,2019
FDA-2019-P-4644-0001_Citizen_Petition_from_Clarus_Therapeutics__Inc_.pdf,"October 2, 2019",Clarus Therapeutics  Inc,2019
FDA-2019-P-4645-0001_Citizen_Petition_from_Reguliance_LLC_on_behalf_of_.pdf,"October 4, 2019",Reguliance LLC on behalf of,2019
FDA-2019-P-4669-0001_Citizen_Petition_from_RdR_Solutions_on_behalf_of__.pdf,"September 4, 2019",RdR Solutions on behalf of,2019
FDA-2019-P-4670-0001_Citizen_Petition_from_Lonza_Inc_.pdf,October 2019,Lonza Inc,2019
FDA-2019-P-4683-0001_Citizen_Petition_from_Public_Citizen.pdf,"October 8, 2019",Public Citizen,2019
FDA-2019-P-4830-0001_Citizen_Petition_from_Ipsen_Biopharmaceuticals__In.pdf,"October 15, 2019",Ipsen Biopharmaceuticals  In,2019
FDA-2019-P-4830-0017_Petition_for_Stay_of_Action_from_Ipsen_Biopharmace.pdf,"June 20, 2024",Ipsen Biopharmace,2019
FDA-2019-P-4830-0031_Petition_for_Reconsideration_from_Ipsen_Biopharmac.pdf,"June 20, 2024",Ipsen Biopharmac,2019
FDA-2019-P-4879-0001_Citizen_Petition_from__Lachman_Consultant_Services.pdf,"October 18, 2019",Lachman Consultant Services,2019
FDA-2019-P-4962-0001_Citizen_Petition_for_Fresenius_Kabi_USA__LLC.pdf,October 2019,Citizen,2019
FDA-2019-P-4979-0001_Citizen_Petition_from_Andersen_Pharma_LLC.pdf,"October 22, 2019",Andersen Pharma LLC,2019
FDA-2019-P-5008-0001_Citizen_Petition_from_Foley_Hoag_LLP_on_behalf_of_.pdf,"October 25, 2019",Foley Hoag LLP on behalf of,2019
FDA-2019-P-5048-0001_Citizen_Petition_from_Epstein__Becker_and_Green_P_.pdf,"October 29, 2019",Epstein  Becker and Green P,2019
FDA-2019-P-5069-0001_Citizen_Petition_from_Ontario_Ginseng_Growers_Asso.pdf,"October 4, 2019",Ontario Ginseng Growers Asso,2019
FDA-2019-P-5121-0001_Citizen_Petition_and_Petition_for_Stay_of_Action_f.pdf,"November 1, 2019",Citizen Petition and,2019
FDA-2019-P-5151-0001_Citizen_Petition_from_GlaxoSmithKline.pdf,"November 4, 2019",GlaxoSmithKline,2019
FDA-2019-P-5191-0001_Citizen_Petition.pdf,11/6/19,American Olive Oil Producers Association,2019
FDA-2019-P-5191-0015_Amended_Citizen_Petition_for_Standards_of_Identity.pdf,11/6/19,American Olive Oil Producers Association,2019
FDA-2019-P-5237-0001_Citizen_Petition_from_Aurobindo_Pharma_USA__Inc__R.pdf,"November 05, 2019",Aurobindo Pharma USA  Inc  R,2019
FDA-2019-P-5266-0001_Citizen_Petition_from_James_Grote__Redacted_.pdf,"Feb 25, 1994",James Grote  Redacted,2019
FDA-2019-P-5268-0001_Citizen_Petition_from_Public_Citizen_s_Health_Rese.pdf,"November 6, 2019",Public Citizen s Health Rese,2019
FDA-2019-P-5394-0001_Citizen_Petition_from_Consumer_Healthcare_Products.pdf,"November 14, 2019",Consumer Healthcare Products,2019
FDA-2019-P-5403-0001_Citizen_Petition_from_Husch_Blackwell_LLP.pdf,"November 14, 2019",Husch Blackwell LLP,2019
FDA-2019-P-5403-0008_Request_to_withdraw_Citizen_petition_from_Seth_Mai.pdf,"January 13, 2021",Seth Mai,2019
FDA-2019-P-5440-0001_Citizen_Petition_from_Diane_Kramer_Redacted.pdf,11/18/19,Diane Kramer Redacted,2019
FDA-2019-P-5441-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"November 18, 2019",Hyman  Phelps   McNamara  P,2019
FDA-2019-P-5441-0003_Supplemental_to_Citizen_Petition_from_Hyman__Phelp.pdf,"December 2, 2019",Hyman  Phelp,2019
FDA-2019-P-5463-0001_Citizen_Petition_from_Sheppard__Mullin__Richter___.pdf,November 2019,Sheppard  Mullin  Richter,2019
FDA-2019-P-5535-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"November 20, 2019",Foley   Lardner LLP,2019
FDA-2019-P-5571-0001_Citizen_Petition_from_Sheppard__Mullin__Richter___.pdf,November 2019,Sheppard  Mullin  Richter,2019
FDA-2019-P-5593-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"November 25, 2019",Hyman  Phelps   McNamara  P,2019
FDA-2019-P-5691-0001_Suitability_Petition_from_Foley___Lardner__LLP.pdf,"December 3, 2019",Foley   Lardner  LLP,2019
FDA-2019-P-5759-0001_Citizen_Petition_from_Aavis_Pharmaceuticals.pdf,"December 6, 2019",Aavis Pharmaceuticals,2019
FDA-2019-P-5760-0001_Citizen_Petition_from_Sun_Pharmaceutical_Industrie.pdf,"December 06, 2019",Sun Pharmaceutical Industrie,2019
FDA-2019-P-5760-0006_Amend_to_Citizen_Petition_from_Sun_Pharmaceutical_.pdf,"July 7, 2021",Sun Pharmaceutical,2019
FDA-2019-P-5791-0001_Citizen_Petition_from_Guvam_Pharma_LLC_.pdf,"December 6, 2019",Guvam Pharma LLC,2019
FDA-2019-P-5800-0001_Citizen_Petition_from_Akin_Gump_Strauss_Hauer___Fe.pdf,"December 6, 2019",Akin Gump Strauss Hauer   Fe,2019
FDA-2019-P-5833-0001_Citizen_Petition_for_Archway_Apothecary__LLC.pdf,"December 10, 2019",Citizen,2019
FDA-2019-P-5887-0001_Citizen_Petition_from_Upfield_US_Inc_.pdf,"December 13, 2019",Upfield US Inc,2019
FDA-2019-P-5922-0001_Citizen_Petition_for_Respira_Technologies__Inc.pdf,"December 16, 2019",Citizen,2019
FDA-2019-P-5943-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"December 16, 2019",Hyman  Phelps   McNamara  P,2019
FDA-2019-P-5970-0001_Citizen_Petition_from_IQVIA_RDS_Inc.pdf,"December 13, 2019",IQVIA RDS Inc,2019
FDA-2019-P-5997-0001_Citizen_Petition_for_Center_for_Biological_Diversi.pdf,12/20/19,"for Center for Biological Diversity, Center for Environmental Health, Farmworkers Association of Florida, Johns Hopkins Center for a Livable Future, Migrant Clinicians Network, and U.S. Public Interest Research Group",2019
FDA-2019-P-6044-0001_Citizen_Petition_from_Latham___Watkins_LLP_on_beha.pdf,"December 20, 2019",Latham   Watkins LLP on beha,2019
FDA-2019-P-6045-0001_Cover_Letter_re_Citizen_Petition_from_Hyman__Phelp.pdf,"December 20, 2019",Hyman  Phelp,2019
FDA-2019-P-6047-0001_Suitability_Petition_from_Fresenius_Kabi_USA__LLC.pdf,December 2019,Fresenius Kabi USA  LLC,2019
FDA-2019-P-6048-0001_Suitability_Petition_from_Fresenius_Kabi_USA__LLC.pdf,December 2019,Fresenius Kabi USA  LLC,2019
FDA-2019-P-6049-0001_Citizen_Petition_from_US_WorldMeds__LLC.pdf,"December 23, 2019",US WorldMeds  LLC,2019
FDA-2019-P-6099-0001_Citizen_Petition_from_George_M__Stone_on_behalf_of.pdf,12/31/19,George M  Stone on behalf of,2019
FDA-2019-P-6100-0001_Citizen_Petition_from_American_Association_of_Tiss.pdf,"December 30, 2019",American Association of Tiss,2019
FDA-2020-P-0042-0001_Citizen_Petition_from_Emery_Pharm_on_behalf_of_Naj.pdf,"January 2, 2020",Emery Pharm on behalf of Naj,2020
FDA-2020-P-0102-0001_Citizen_Petition_from_The_Ritedose_Corporation.pdf,"January 8, 2020",The Ritedose Corporation,2020
FDA-2020-P-0129-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"January 8, 2020",Hyman  Phelps   McNamara  P,2020
FDA-2020-P-0284-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"January 16, 2020",Hyman  Phelps   McNamara  P,2020
FDA-2020-P-0368-0001_Citizen_Petition_from_Crowell___Moring__LLP.pdf,"January 22, 2020",Crowell   Moring  LLP,2020
FDA-2020-P-0421-0001_Citizen_Petition_from_Cooley_s_Anemia_Foundation__.pdf,"January 24, 2020",Cooley s Anemia Foundation,2020
FDA-2020-P-0436-0001_Citizen_Petition_from_Foley_and_Lardner_LLP_on_beh.pdf,"January 24, 2020",Foley and Lardner LLP on beh,2020
FDA-2020-P-0438-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"January 27, 2020",Hyman  Phelps   McNamara  P,2020
FDA-2020-P-0511-0001_Citizen_Petition_from_Novitium_Pharma_LLC.pdf,"January 30, 2020",Novitium Pharma LLC,2020
FDA-2020-P-0512-0001_Citizen_Petition_from_Hyman__Phelps____McNamara_PC.pdf,"January 23, 2020",Hyman  Phelps    McNamara PC,2020
FDA-2020-P-0513-0001_Citizen_Petition_from_Foley_and_Lardner_LLP_on_beh.pdf,"January 29, 2020",Foley and Lardner LLP on beh,2020
FDA-2020-P-0598-0001_Citizen_Petition_from_Lachman_Consultants.pdf,"January 22, 2020",Lachman Consultants,2020
FDA-2020-P-0599-0001_Citizen_Petition_from_Foley___Lardner__LLP__on_beh.pdf,"February 4, 2020",Foley   Lardner  LLP  on beh,2020
FDA-2020-P-0624-0001_Citizen_Petition_from_Reguliance__LLC_on_behalf_of.pdf,2/5/20,Reguliance  LLC on behalf of,2020
FDA-2020-P-0678-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC_.pdf,February 2020,Fresenius Kabi USA  LLC,2020
FDA-2020-P-0698-0001_Citizen_Petition_from_Physicians_Committee_for_Res.pdf,"Feb. 10, 2020",Physicians Committee for Res,2020
FDA-2020-P-0725-0001_Citizen_Petition_from_GBUK_Group_Ltd.pdf,February 2020,GBUK Group Ltd,2020
FDA-2020-P-0734-0001_Citizen_Petition_from_GBUK_Group_Ltd.pdf,February 2020,GBUK Group Ltd,2020
FDA-2020-P-0745-0001_Citizen_Petition_from_Fox_Rothschild_LLP.pdf,"February 11, 2020",Fox Rothschild LLP,2020
FDA-2020-P-0763-0001_Citizen_Petition_from_Clark_Anderson.pdf,"April 23, 2018",Clark Anderson,2020
FDA-2020-P-0813-0001_Citizen_Petition_from_Unichem_Pharmaceuticals__USA.pdf,"February 13, 2020",Unichem Pharmaceuticals  USA,2020
FDA-2020-P-0863-0003_Filing_Letter_of_Qualified_Health_Claim_Petition_f.pdf,"January 6, 2020",Filing Letter of Qualified,2020
FDA-2020-P-0945-0001_Citizen_Petition_from_Dr__Ernest_C__Chisena_and_Dr.pdf,"February 25, 2020",Dr  Ernest C  Chisena and Dr,2020
FDA-2020-P-0947-0001_Citizen_Petition_from_Hyman__Phelps_and_McNamara__.pdf,"February 24, 2020",Hyman  Phelps and McNamara,2020
FDA-2020-P-0963-0001_Suitability_Citizen_Petition_for_Aurora_Pharmaceut.pdf,February 2020,Suitability,2020
FDA-2020-P-0978-0001_Citizen_Petition_from_Valisure__LLC_.pdf,"March 2, 2020",Valisure  LLC,2020
FDA-2020-P-0983-0001_Citizen_Petition_from_grBiosystems_Inc_.pdf,02/26/2020,grBiosystems Inc,2020
FDA-2020-P-1003-0001_Citizen_Petition_from_John_J__Coleman___M_A___M_S_.pdf,"February 25, 2020",John J  Coleman   M A   M S,2020
FDA-2020-P-1016-0001_Citizen_Petition_from_CellTrion__Inc_.pdf,"March 03, 2020",CellTrion  Inc,2020
FDA-2020-P-1052-0001_Citizen_Petition_from_National_Tobacco_Reform_Init.pdf,"March 6, 2020",National Tobacco Reform Init,2020
FDA-2020-P-1065-0001_Citizen_Petition_from_B__Braun_Medical_Inc_.pdf,"March 10, 2020",B  Braun Medical Inc,2020
FDA-2020-P-1071-0001_Suitability_Petition_from_Hyman__Phelps___McNamara.pdf,"March 9, 2020",Hyman  Phelps   McNamara,2020
FDA-2020-P-1072-0001_Citizen_Petition_from_Yiling_Pharmaceutical__LTD_.pdf,"March 10, 2020",Yiling Pharmaceutical  LTD,2020
FDA-2020-P-1074-0001_Citizen_Petition_from_Akorn_Animal_Health_Inc.pdf,"March 10, 2020",Akorn Animal Health Inc,2020
FDA-2020-P-1166-0001_PETITION_FOR_STAY_OF_ACTION__from_Eckert_Seamans_C.pdf,"March 20, 2020",Eckert Seamans C,2020
FDA-2020-P-1181-0001_Petition_for_Stay_of_Action_from_Todd___Weld__LLP.pdf,"March 23, 2020",Todd   Weld  LLP,2020
FDA-2020-P-1205-0001_Petition_for_Stay_of_Action_from_Steptoe___Johnson.pdf,"March 23, 2020",Steptoe   Johnson,2020
FDA-2020-P-1220-0001_Petition_for_Reconsideration_from_C_Laser_Inc.pdf,"April 28, 2018",C Laser Inc,2020
FDA-2020-P-1236-0001_Citizen_Petition_from_Foley___Lardner_LLP.pdf,"March 30, 2020",Foley   Lardner LLP,2020
FDA-2020-P-1237-0001_Citizen_Petition_from_Wiley_Rein__LLP.pdf,"March 30, 2020",Wiley Rein  LLP,2020
FDA-2020-P-1238-0001_Petition_for_Stay_of_Action_from_Cigar_Association.pdf,"May 10, 2016",Cigar Association,2020
FDA-2020-P-1239-0001_Petition_for_Stay_of_Action_from_Wiley_Rein__LLP.pdf,"March 30, 2020",Wiley Rein  LLP,2020
FDA-2020-P-1246-0001_Citizen_Petition_from_Fresenius_KabiUSA__LLC.pdf,April 2020,Fresenius KabiUSA  LLC,2020
FDA-2020-P-1247-0001_Citizen_Petition_from_Belcher_Pharmaceuticals__LLC.pdf,"March 31, 2020",Belcher Pharmaceuticals  LLC,2020
FDA-2020-P-1248-0001_Citizen_Petition_from_Mark_Miles_Redacted.pdf,"March 16, 2020",Mark Miles Redacted,2020
FDA-2020-P-1251-0001_Citizen_Petition_from_Varun_Verada_Redacted.pdf,April 2020,Varun Verada Redacted,2020
FDA-2020-P-1297-0001_Citizen_Petition_from_Joe_DiNardo_Redacted.pdf,4/17/20,Joe DiNardo Redacted,2020
FDA-2020-P-1305-0001_Citizen_Petition_from_Dr__Albert_Edwards___Redacte.pdf,4/24/20,Dr  Albert Edwards   Redacte,2020
FDA-2020-P-1312-0001_Citizen_Petition_from_Foley___Lardner_LLP_on_behal.pdf,"April 28, 2020",Foley   Lardner LLP on behal,2020
FDA-2020-P-1334-0001_Citizen_Petition_from_Therapeutics_MD__Inc.pdf,"May 1, 2020",Therapeutics MD  Inc,2020
FDA-2020-P-1344-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"May 5, 2020",Lachman Consultant Services,2020
FDA-2020-P-1356-0001_Citizen_petition__from_Qilu_Pharmaceutical_Co___Lt.pdf,"May 7, 2020",Qilu Pharmaceutical Co   Lt,2020
FDA-2020-P-1393-0001_Suitability_Petition_from_Nexus_Pharmaceuticals_In.pdf,"May 13, 2020",Nexus Pharmaceuticals In,2020
FDA-2020-P-1403-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_(1).pdf,"May 19, 2020",Hyman  Phelps   McNamara  P,2020
FDA-2020-P-1403-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"May 19, 2020",Hyman  Phelps   McNamara  P,2020
FDA-2020-P-1405-0001_Citizen_Petition_from__bioMerieux.pdf,"April 1, 2020",bioMerieux,2020
FDA-2020-P-1416-0001_Citizen_Petition_from_Sidley_Austin__LLP__on_behal.pdf,"May 20, 2020",Sidley Austin  LLP  on behal,2020
FDA-2020-P-1423-0001_Citizen_Petition_from_North_American_Olive_Oil_Ass.pdf,5/22/20,North American Olive Oil Ass,2020
FDA-2020-P-1423-0039_SOI_CORRECTION_LETTER_to_Citizen_Petition_from_Nor.pdf,"June 18, 2020",Nor,2020
FDA-2020-P-1427-0001_Citizen_Petition_from_Aurobindo_Pharma_USA__Inc_.pdf,"May 27, 2020",Aurobindo Pharma USA  Inc,2020
FDA-2020-P-1427-0001_Citizen_Petition_from_Aurobindo_Pharma_USA__Inc___.pdf,"May 27, 2020",Aurobindo Pharma USA  Inc,2020
FDA-2020-P-1443-0002_Citizen_Petition_from_Elanco_Animal_Health.pdf,"May 28, 2020",Elanco Animal Health,2020
FDA-2020-P-1478-0001_Citizen_Petition_from_The_Sugar_Association.pdf,"June 3, 2020",The Sugar Association,2020
FDA-2020-P-1506-0001_Citizen_Petition_from_Animal_Legal_Defense_Fund.pdf,6/8/20,Animal Legal Defense Fund,2020
FDA-2020-P-1510-0002_Citizen_s_Petition_from_AMERICANS_FOR_HOMEOPATHY_C.pdf,"June 5, 2020",AMERICANS FOR HOMEOPATHY C,2020
FDA-2020-P-1523-0001_Citizens_Petition_from_WineAmerica_and_Wine_Instit.pdf,"June 8, 2020",WineAmerica and Wine Instit,2020
FDA-2020-P-1540-0001_Citizen_Petition_from_Alliance_For_Natural_Health_.pdf,6/11/20,Alliance For Natural Health,2020
FDA-2020-P-1549-0001_Citizen_Petition_from_Windels_Marx_Lane___Mittendo.pdf,"June 10, 2020",Windels Marx Lane   Mittendo,2020
FDA-2020-P-1575-0001_Citizen_Petition_from_Francis_E__O_Donnell__Redact.pdf,6/17/20,Francis E  O Donnell  Redact,2020
FDA-2020-P-1582-0001_Citizen_Petition_from_The_Council_for_Responsible_.pdf,"June 16, 2020",The Council for Responsible,2020
FDA-2020-P-1601-0027_Petition_for_Stay_of_Action__from_Siri___Glimstad_(1).pdf,"June 22, 2020",Siri   Glimstad (1),2020
FDA-2020-P-1601-0027_Petition_for_Stay_of_Action__from_Siri___Glimstad_.pdf,"June 22, 2020",Siri   Glimstad (1),2020
FDA-2020-P-1611-0001_Citizen_Petition_from_Public_Citizen_s_Health_Rese.pdf,"June 24, 2020",Public Citizen s Health Rese,2020
FDA-2020-P-1617-0001_Citizen_Petition_from_E4_Consulting.pdf,"June 24, 2020",E4 Consulting,2020
FDA-2020-P-1626-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"July 1, 2020",Hyman  Phelps   McNamara  P,2020
FDA-2020-P-1633-0001_Citizen_Petition_from_Foley_Hoag__LLP__on_behalf_o.pdf,"July 2, 2020",Foley Hoag  LLP  on behalf o,2020
FDA-2020-P-1641-0001_Citizen_Petition_from_John_J_Coleman_Redacted.pdf,7/8/20,John J Coleman Redacted,2020
FDA-2020-P-1650-0001_Citizen_Petition_from_Cardinal_Health_Regulatory_S.pdf,"July 9, 2020",Cardinal Health Regulatory S,2020
FDA-2020-P-1653-0001_Citizen_Petition_from_Aurobindo_Pharma_USA__Inc__R.pdf,"July 10, 2020",Aurobindo Pharma USA  Inc  R,2020
FDA-2020-P-1689-0001_Citizen_Petition_from_Lassman_Law___Policy.pdf,"July 20, 2020",Lassman Law   Policy,2020
FDA-2020-P-1701-0001_Citizen_Petition_from_Harman_Finochem_Limited.pdf,"July 25, 2020",Harman Finochem Limited,2020
FDA-2020-P-1718-0001_Citizen_Petition_from_Public_Health_Advocacy_Insti.pdf,"July 28, 2020",Public Health Advocacy Insti,2020
FDA-2020-P-1725-0001_Citizen_Petition_from_Knowledge_Ecology_Internatio.pdf,"August 3, 2020",Knowledge Ecology Internatio,2020
FDA-2020-P-1768-0001_Citizen_Petition_from_SIRI___GLIMSTAD_LLP_on_behal.pdf,"August 17, 2020",SIRI   GLIMSTAD LLP on behal,2020
FDA-2020-P-1768-0010_Amended_Citizen_Petition_SIRI___GLIMSTAD_LLP_on_be.pdf,"October 16, 2020",Amended,2020
FDA-2020-P-1769-0001_Citizen_Petition_from_SIRI___GLIMSTAD_LLP_on_behal.pdf,"August 17, 2020",SIRI   GLIMSTAD LLP on behal,2020
FDA-2020-P-1769-0006_Amended_Citizen_Petition_from_SIRI___GLIMSTAD_LLP_.pdf,"October 16, 2020",SIRI   GLIMSTAD LLP,2020
FDA-2020-P-1770-0001_Citizen_Petition_from_SIRI___GLIMSTAD_LLP_on_behal.pdf,"August 17, 2020",SIRI   GLIMSTAD LLP on behal,2020
FDA-2020-P-1770-0013_Amendment_to_Citizen_Petition_from_SIRI___GLIMSTAD.pdf,"October 16, 2020",SIRI   GLIMSTAD,2020
FDA-2020-P-1792-0001_Citizen_Petition_from_Macleods_Pharmaceuticals_Lim.pdf,"August 21, 2020",Macleods Pharmaceuticals Lim,2020
FDA-2020-P-1844-0001_Citizen_Petition_from_HYMAN__PHELPS___MCNAMARA__P_.pdf,"September 1, 2020",HYMAN  PHELPS   MCNAMARA  P,2020
FDA-2020-P-1849-0001_Citizen_Petition_from_FOLEY___LARDNER_LLP.pdf,"September 3, 2020",FOLEY   LARDNER LLP,2020
FDA-2020-P-1857-0001_Citizen_Petition_from_SIRI___GLIMSTAD_LLP.pdf,"September 4, 2020",SIRI   GLIMSTAD LLP,2020
FDA-2020-P-1859-0001_Suitability_Petition_from_GLAND_PHARMA_LIMITED.pdf,September 2020,GLAND PHARMA LIMITED,2020
FDA-2020-P-1864-0001_Citizen_Petition_from_Kambiz_Tajkarimi__MD_Redacte.pdf,"September 11, 2020",Kambiz Tajkarimi  MD Redacte,2020
FDA-2020-P-1873-0001_Citizen_Petition_from_Bentley_Biomedical_Consultin.pdf,9/14/20,Bentley Biomedical Consultin,2020
FDA-2020-P-1875-0001_Citizen_Petition_from_Grain_Processing_Corporation.pdf,"November 20, 2020",Grain Processing Corporation,2020
FDA-2020-P-1878-0001_Citizen_Petition_from_Foley___Lardner__LLP.pdf,"September 17, 2020",Foley   Lardner  LLP,2020
FDA-2020-P-1914-0001_Citizen_Petition_from_Aurolife_Pharma__LLC____Reda.pdf,"September 16, 2020",Aurolife Pharma  LLC    Reda,2020
FDA-2020-P-1919-0001_Citizen_Petition_from_Acella_Pharmaceuticals__LLC.pdf,"September 16, 2020",Acella Pharmaceuticals  LLC,2020
FDA-2020-P-2003-0001_Citizen_Petition_from_Environmental_Defense_Fund.pdf,"September 23, 2020",Environmental Defense Fund,2020
FDA-2020-P-2004-0001_Citizen_Petition_from_Lachman_Consulting_Services_.pdf,"September 23, 2020",Lachman Consulting Services,2020
FDA-2020-P-2005-0001_Suitability_Petition_from_HYMAN__PHELPS___MCNAMARA.pdf,"September 23, 2020",HYMAN  PHELPS   MCNAMARA,2020
FDA-2020-P-2010-0001_Citizen_Petition_from_Philips_Respironics.pdf,"September 22, 2020",Philips Respironics,2020
FDA-2020-P-2013-0001_Citizen_Petition_from_Lachman_Consulting_Services_.pdf,"September 24, 2020",Lachman Consulting Services,2020
FDA-2020-P-2017-0001_Citizen_Petition_from_Alston___Bird_LLP.pdf,"September 28, 2020",Alston   Bird LLP,2020
FDA-2020-P-2028-0001_Citizen_Petition_from_Outsourcing_Facilities_Assoc.pdf,"September 30, 2020",Outsourcing Facilities Assoc,2020
FDA-2020-P-2033-0001_Citizen_Petition_from_University_of_Kentucky_Drug_.pdf,"September 30, 2019",University of Kentucky Drug,2020
FDA-2020-P-2060-0001_Citizen_Petition_from_Penn_Avenue_Law___Policy.pdf,"October7,2020",Penn Avenue Law   Policy,2020
FDA-2020-P-2066-0001_Citizens_Petition_from_The_America_s_Frontline_Doc.pdf,"October 12, 2020",The America s Frontline Doc,2020
FDA-2020-P-2067-0001_Suitability_Petition_from_Hyman__Phelps___McNamara.pdf,"October 12, 2020",Hyman  Phelps   McNamara,2020
FDA-2020-P-2077-0001_Suitability_Petition_from_The_Weinberg_Group_LLC.pdf,"August 21, 2020",The Weinberg Group LLC,2020
FDA-2020-P-2096-0001_Citizen_Petition_from_Siri___Glimstad_LLP_on_behal.pdf,"October 16, 2020",Siri   Glimstad LLP on behal,2020
FDA-2020-P-2096-0010_Petition_for_Reconsideration_from_Siri___Glimstad_.pdf,"March 23, 2021",Siri   Glimstad,2020
FDA-2020-P-2102-0001_Suitability_Petition_from_Aurora_Pharmaceutical__I.pdf,October 2020,Aurora Pharmaceutical  I,2020
FDA-2020-P-2132-0001_Citizen_Petition_from_HYMAN__PHELPS___MCNAMARA__P_.pdf,"October 26, 2020",HYMAN  PHELPS   MCNAMARA  P,2020
FDA-2020-P-2133-0001_Citizen_Petition_from_Fresenius_Kabi_USA_LLC.pdf,"April 11, 2019",Fresenius Kabi USA LLC,2020
FDA-2020-P-2133-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC.pdf,"April 11, 2019",Fresenius Kabi USA LLC,2020
FDA-2020-P-2134-0001_Citizen_Petition_from_Natural_Products_Association.pdf,"October 26, 2020",Natural Products Association,2020
FDA-2020-P-2136-0001_Citizen_Petition_from_SIRI___GLIMSTAD__LLP__on_beh(1).pdf,"October 28, 2020",SIRI   GLIMSTAD  LLP  on beh(1),2020
FDA-2020-P-2136-0001_Citizen_Petition_from_SIRI___GLIMSTAD__LLP__on_beh.pdf,"October 28, 2020",SIRI   GLIMSTAD  LLP  on beh(1),2020
FDA-2020-P-2144-0001_Citizen_Petition_from_Robert_van_Osdel___redacted.pdf,"November 2, 2020",Robert van Osdel   redacted,2020
FDA-2020-P-2146-0001_Citizen_Petition_from_BF_Innovation__Inc_.pdf,11/3/20,BF Innovation  Inc,2020
FDA-2020-P-2166-0001_Suitability_Petition_from_Emprise_Pharma_LLC__on_b.pdf,"Nov 4, 2020",Emprise Pharma LLC  on b,2020
FDA-2020-P-2174-0001_Citizen_Petition_from_Lachman_Consulting_Services_.pdf,"November 5, 2020",Lachman Consulting Services,2020
FDA-2020-P-2175-0001_Citizen_Petition_from_Lachman_Consulting_Services_.pdf,"November 5, 2020",Lachman Consulting Services,2020
FDA-2020-P-2180-0005_CITIZEN_PETITION_FOR_STAY_OF_ACTION_REGARDING_EFFI.pdf,"November 11, 2020",,2020
FDA-2020-P-2181-0001_Suitability_Petition_from_Hyman__Phelps___McNamara.pdf,"November 11, 2020",Hyman  Phelps   McNamara,2020
FDA-2020-P-2193-0001_Citizen_Petition_from_Epstein__Becker_and_Green__P.pdf,"November 13, 2020",Epstein  Becker and Green  P,2020
FDA-2020-P-2212-0001_Citizen_Petition_from_Encore_Dermatology_Inc___red.pdf,"November 13, 2020",Encore Dermatology Inc   red,2020
FDA-2020-P-2213-0001_Citizen_Petition_from_Kenneth_E__Surprenant_Redact.pdf,November 2020,Kenneth E  Surprenant Redact,2020
FDA-2020-P-2225-0001_Citizen_Petition_from_Siri___Glimstad_LLP_on_behal.pdf,"November 23, 2020",Siri   Glimstad LLP on behal,2020
FDA-2020-P-2236-0001_Citizen_Petition_from_Covington___Burling__LLP_on_.pdf,"July 24, 2020",Covington   Burling  LLP on,2020
FDA-2020-P-2244-0001_Citizen_Petition_from_Camargo_Pharmaceutical_Servi.pdf,November 2020,Camargo Pharmaceutical Servi,2020
FDA-2020-P-2245-0001_Citizen_Petition_from_Camargo_Pharmaceutical_Servi.pdf,November 2020,Camargo Pharmaceutical Servi,2020
FDA-2020-P-2276-0001_Citizen_Petition_from_Environmental_Defense_Fund.pdf,"December 9, 2020",Environmental Defense Fund,2020
FDA-2020-P-2289-0001_Citizen_Petition_from_Loeb___Loeb__LLP.pdf,"December 10, 2020",Loeb   Loeb  LLP,2020
FDA-2020-P-2296-0001_Citizen_Petition_from_Parenteral_Technologies_LLC.pdf,"November 21, 2020",Parenteral Technologies LLC,2020
FDA-2020-P-2299-0001_Citizen_Petition_from_Zydus_Pharmaceuticals_USA_In.pdf,"November 30, 2020",Zydus Pharmaceuticals USA In,2020
FDA-2020-P-2301-0001_Citizen_Petition_from_Alpha_Cognition_USA__Inc.pdf,"December 10, 2020",Alpha Cognition USA  Inc,2020
FDA-2020-P-2304-0001_Citizens_Petition_from_Fresenius_Kabi_USA__LLC.pdf,"December 16, 2020",Fresenius Kabi USA  LLC,2020
FDA-2020-P-2313-0002_Petition_for_Stay_of_Action_from_Covington___Burli.pdf,"November 17, 2020",Covington   Burli,2020
FDA-2020-P-2322-0001_Citizen_Petition_from_Covington___Burling_LLP_on_b.pdf,"December 17, 2020",Covington   Burling LLP on b,2020
FDA-2020-P-2360-0001_Citizen_Petition_from_Pet_Schooled_The_Educated_Co.pdf,"December 30, 2020",Pet Schooled The Educated Co,2020
FDA-2021-P-0533-0001_Citizen_Petition_from_RVL_Pharmaceuticals__Inc_.pdf,"June 2, 2021",RVL Pharmaceuticals  Inc,2021
FDA-2021-P-0545-0001_Citizen_Petition_from_Theo_Allen_Redacted.pdf,"June 8, 2021",Theo Allen Redacted,2021
FDA-2021-P-0567-0001_Suitability_Petition_from_M_A_Pharmaceutical_Consu.pdf,"June 17, 2021",M A Pharmaceutical Consu,2021
FDA-2021-P-0653-0001_Citizen_Petition_from_Environmental_Defense_Fund.pdf,"June 9, 2021",Environmental Defense Fund,2021
FDA-2021-P-0677-0001_Suitability_Petition_from_Hyman__Phelps___McNamara.pdf,"July 2, 2021",Hyman  Phelps   McNamara,2021
FDA-2021-P-0680-0001_Citizen_Petition_from_Joe_DiNardo_and_Craig_A_Down.pdf,7/9/21,Joe DiNardo and Craig A Down,2021
FDA-2021-P-0714-0001_Citizen_Petition_from_Lassman_Law___Policy.pdf,"July 8, 2021",Lassman Law   Policy,2021
FDA-2021-P-0850-0001_Citizen_Petition_from_Donavan_Melton_Redacted.pdf,"July 29, 2021",Donavan Melton Redacted,2021
FDA-2021-P-0894-0001_Citizen_Petition_from_Pet_Schooled.pdf,"August 10, 2021",Pet Schooled,2021
FDA-2022-P-0028-0001_Citizen_Petition_from_Donavan_Melton_redacted.pdf,1/3/22,Donavan Melton redacted,2022
FDA-2022-P-0032-0001_Citizen_Petition_from_Cristina_Maria_Rosa_Redacted.pdf,1/5/22,Cristina Maria Rosa Redacted,2022
FDA-2022-P-0052-0001_Suitability_Petition_from_Pharmobedient_Consulting.pdf,"January 03, 2022",Pharmobedient Consulting,2022
FDA-2022-P-0058-0001_Citizen_Petition_from_Donavan_Melton_Redacted.pdf,1/11/22,Donavan Melton Redacted,2022
FDA-2022-P-0059-0001_Citizen_Petition_from_Pet_Schooled.pdf,1/10/22,Pet Schooled,2022
FDA-2022-P-0060-0001_Citizen_Petition_from_B__Braun_Medical_Inc_.pdf,"January 10, 2022",B  Braun Medical Inc,2022
FDA-2022-P-0063-0001_Citizen_Petition_from_Krysta_Fox_Redacted.pdf,"January 10, 2022",Krysta Fox Redacted,2022
FDA-2022-P-0068-0001_Citizen_Petition_from_HYMAN__PHELPS___MCNAMARA__P_.pdf,"January 11, 2022",HYMAN  PHELPS   MCNAMARA  P,2022
FDA-2022-P-0069-0001_Citizen_Petition_from_Aurobindo_Pharma_USA_Inc.pdf,"January 11, 2022",Aurobindo Pharma USA Inc,2022
FDA-2022-P-0077-0001_Citizen_Petition_from_Aurobindo_Pharma_USA_Inc.pdf,"January 14, 2022",Aurobindo Pharma USA Inc,2022
FDA-2022-P-0086-0002_Citizen_Petition_from_Carol_Taccetta.pdf,"January 19, 2022",Carol Taccetta,2022
FDA-2022-P-0088-0001_Citizen_Petition_from_Tufts_University.pdf,1/24/22,Tufts University,2022
FDA-2022-P-0094-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,1/27/22,Harry Duty Redacted,2022
FDA-2022-P-0095-0001_CITIZEN_PETITION_FROM_HARRY_DUTY_REDACTED.pdf,1/26/22,HARRY DUTY REDACTED,2022
FDA-2022-P-0107-0001_Citizen_Petition_from_Pet_Schooled.pdf,1/28/22,Pet Schooled,2022
FDA-2022-P-0110-0001_Citizen_Petition_from_Center_for_Science_in_the_Pu.pdf,"January 31, 2022",Center for Science in the Pu,2022
FDA-2022-P-0115-0001_Citizen_Petition_from_Baxter_Healthcare_Corporatio.pdf,"January 1, 1982",Baxter Healthcare Corporatio,2022
FDA-2022-P-0118-0001_Suitability_Petition_from_Lachman_Consulting_Servi.pdf,"February 2, 2022",Lachman Consulting Servi,2022
FDA-2022-P-0119-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,2/4/22,Harry Duty Redacted,2022
FDA-2022-P-0120-0001_Citizen_Petition_from_Chelsea_Kent_Redacted.pdf,"February 3, 2022",Chelsea Kent Redacted,2022
FDA-2022-P-0121-0001_Citizen_Petition_from_Pet_Schooled.pdf,2/4/22,Pet Schooled,2022
FDA-2022-P-0122-0001_Citizen_Petition_from_Jianqing_Wu___Redacted.pdf,"January 27, 2022",Jianqing Wu   Redacted,2022
FDA-2022-P-0126-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,2/7/22,Harry Duty Redacted,2022
FDA-2022-P-0144-0001_Citizen_Petition_from_Axinn_Veltrop_and_Harkrider_.pdf,"February 3, 2022",Axinn Veltrop and Harkrider,2022
FDA-2022-P-0144-0031_2023_01_11_Supplement_to_Citizen_Petition.pdf,"January 11, 2023",Citizen Petition,2022
FDA-2022-P-0149-0001_Citizen_Petition_from_Public_Citizen_s_Health_Rese.pdf,"February 9, 2022",Public Citizen s Health Rese,2022
FDA-2022-P-0151-0001_Citizen_Petition_from_Ascend_Laboratories_LLC.pdf,2/10/22,Ascend Laboratories LLC,2022
FDA-2022-P-0152-0001_Citizen_Petition_from_Qilu_Pharmaceutical__Hainan_.pdf,"February 10, 2022",Qilu Pharmaceutical  Hainan,2022
FDA-2022-P-0155-0001_Citizen_Petition_from_Kleinfeld_Kaplan_Becker__on_.pdf,"February 10, 2022",Kleinfeld Kaplan Becker  on,2022
FDA-2022-P-0160-0001_Citizen_Petition_from_Ferring_Pharmaceuticals__Inc.pdf,"February 9, 2022",Ferring Pharmaceuticals  Inc,2022
FDA-2022-P-0160-0014_Petition_for_Reconsideration_from_Hogan_Lovells_US.pdf,"December 4, 2022",Hogan Lovells US,2022
FDA-2022-P-0172-0001_Citizen_Petition_from_Ronald_Brock___Redacted.pdf,"February 13, 2022",Ronald Brock   Redacted,2022
FDA-2022-P-0174-0002_Citizen_Petition_from_Ronald_Brock___Redacted.pdf,2/14/22,Ronald Brock   Redacted,2022
FDA-2022-P-0182-0001_Citizen_Petition_from_Center_for_Food_and_Safety__.pdf,"February 14, 2022",Center for Food and Safty an,2022
FDA-2022-P-0182-0001_Citizen_Petition_from_Center_for_Food_and_Safty_an.pdf,"February 14, 2022",Center for Food and Safty an,2022
FDA-2022-P-0195-0001_Citizen_Petition_from_Connor_Carmichael_Redacted.pdf,"January 10, 2022",Connor Carmichael Redacted,2022
FDA-2022-P-0200-0001_Suitability_Petition__Petition_from_Lachman_Consul.pdf,"February 9, 2021",Lachman Consul,2022
FDA-2022-P-0208-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,2/22/22,Harry Duty Redacted,2022
FDA-2022-P-0209-0001_Citizen_Petition_from_Harry_Duty___Redacted.pdf,2/22/22,Harry Duty   Redacted,2022
FDA-2022-P-0210-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,2/22/22,Harry Duty Redacted,2022
FDA-2022-P-0211-0002_Citizen_Petition_from_Harry_Duty___Redacted.pdf,2/22/22,Harry Duty   Redacted,2022
FDA-2022-P-0213-0001_Citizen_Petition_from_Leslie_Novosel_Redacted.pdf,"February 22, 2022",Leslie Novosel Redacted,2022
FDA-2022-P-0214-0001_Suitability_Petition_from_Upadhye_Tang__LLP.pdf,Feb. 2022,Upadhye Tang  LLP,2022
FDA-2022-P-0215-0001_Citizen_Petition_from_Jonathan_Smith.pdf,2/25/22,Jonathan Smith,2022
FDA-2022-P-0220-0001_Citizen_Petition_from_Pet_Schooled.pdf,"February 23, 2022",Pet Schooled,2022
FDA-2022-P-0232-0001_Citizen_Petition_from_Nancy_Tanner.pdf,"February 25, 2022",Nancy Tanner,2022
FDA-2022-P-0232-0001_Citizen_Petition_from_Nancy_Tanner_Redacted.pdf,"February 25, 2022",Nancy Tanner,2022
FDA-2022-P-0234-0001_Citizen_Petition_from_Pink_Concussions.pdf,"February 26, 2022",Pink Concussions,2022
FDA-2022-P-0237-0001_Citizens_Petition_from_Only_Orphans_Cote_LLC.pdf,"February 22, 2022",Timothy R  Cote,2022
FDA-2022-P-0237-0001_Citizens_Petition_from_Timothy_R__Cote.pdf,"February 22, 2022",Timothy R  Cote,2022
FDA-2022-P-0253-0001_Citizen_Petition_from_Tyler_Burch_Redacted.pdf,"February 28, 2022",Tyler Burch Redacted,2022
FDA-2022-P-0256-0001_Citizen_Petition_from_Center_for_Science_in_the_Pu.pdf,"February 28, 2022",Center for Science in the Pu,2022
FDA-2022-P-0270-0001_Citizen_Petition_from_Sanofi_Pasteur_Inc_.pdf,"Nov. 24, 2015",Sanofi Pasteur Inc,2022
FDA-2022-P-0287-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC.pdf,March 2022,Fresenius Kabi USA  LLC,2022
FDA-2022-P-0290-0001_Citizen_Petition_from_Fresenius_Kabi_USA_LLC.pdf,March 2022,Fresenius Kabi USA LLC,2022
FDA-2022-P-0293-0001_Citizen_Petition_from_Chinova_Bioworks_Inc.pdf,March 2022,Chinova Bioworks Inc,2022
FDA-2022-P-0299-0001_Citizen_Petition_from_Donavan_Melton_Redacted.pdf,"March 7, 2022",Donavan Melton Redacted,2022
FDA-2022-P-0306-0001_Citizen_Petition_from_Donavan_Melton___Redacted.pdf,"March 8, 2022",Donavan Melton   Redacted,2022
FDA-2022-P-0307-0001_Citizen_Petition_from_Chelsea_Kent_Redacted.pdf,"March 7, 2022",Chelsea Kent Redacted,2022
FDA-2022-P-0309-0001_Citizen_Petition_from_Hary_Duty_Redacted.pdf,"March 8, 2022",Hary Duty Redacted,2022
FDA-2022-P-0311-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,"March 8, 2022",Harry Duty Redacted,2022
FDA-2022-P-0324-0001_Citizen_Petition_from_Karl_Schwartz__Redacted.pdf,"March 9, 2022",Karl Schwartz  Redacted,2022
FDA-2022-P-0329-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"March 10, 2022",Hyman  Phelps   McNamara  P,2022
FDA-2022-P-0356-0001_Citizen_Petition_from_Shasta_Evans__Redacted.pdf,"March 16, 2022",Shasta Evans  Redacted,2022
FDA-2022-P-0392-0001_Petition_for_Stay_of_Action_from_American_Frozen_F.pdf,"March 18, 2022",American Frozen F,2022
FDA-2022-P-0394-0001_Citizen_Petition_from_Harry_Duty.pdf,"March 21, 2022",Harry Duty,2022
FDA-2022-P-0394-0001_Citizen_Petition_from_Harry_Duty___Redacted.pdf,"March 21, 2022",Harry Duty,2022
FDA-2022-P-0395-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,"March 21, 2022",Harry Duty Redacted,2022
FDA-2022-P-0399-0001_Citizen_Petition_from_Harry_Duty.pdf,"March 21, 2022",Harry Duty Redacted,2022
FDA-2022-P-0399-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,"March 21, 2022",Harry Duty Redacted,2022
FDA-2022-P-0405-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,"March 22, 2022",Harry Duty Redacted,2022
FDA-2022-P-0414-0001_Citizen_Petition_from_King_and_Spalding_LLP.pdf,"March 22, 2022",King and Spalding LLP,2022
FDA-2022-P-0451-0001_Citizen_Petition_from_Chelsea_Kent_Redacted.pdf,"March 24, 2022",Chelsea Kent Redacted,2022
FDA-2022-P-0457-0001_Citizen_Petition_from_Chelsea_Kent__Redacted.pdf,"March 25, 2022",Chelsea Kent  Redacted,2022
FDA-2022-P-0475-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"March 29, 2022",Lachman Consultant Services,2022
FDA-2022-P-0476-0001_Citizen_Petition_from_Lachman_Consultant_Services_.pdf,"March 29, 2022",Lachman Consultant Services,2022
FDA-2022-P-0509-0001_Citizen_Petition_from_Arnall_Golden_Gregory_LLP.pdf,"March 31, 2022",Arnall Golden Gregory LLP,2022
FDA-2022-P-0535-0001_Citizen_Petition_from_Hospira_Inc_a_Pfizer_Company.pdf,4/6/22,Hospira Inc a Pfizer Company,2022
FDA-2022-P-0536-0001_Stay_of_Action_Petition_from_Bayer_U_S__LLC.pdf,"April 5, 2022",Bayer U S  LLC,2022
FDA-2022-P-0558-0001_Citizen_Petition_from_Novitium_Pharma_LLC.pdf,"April 6, 2022",Novitium Pharma LLC,2022
FDA-2022-P-0566-0001_Citizen_Petition_from_Ronald_Brock_Redacted.pdf,"April 7, 2022",Ronald Brock Redacted,2022
FDA-2022-P-0574-0001_Citizen_Petition_from_Harry_Duty_REDACTED.pdf,4/15/22,Harry Duty REDACTED,2022
FDA-2022-P-0585-0001_Citizen_Petition_from_Odin_Pharmaceuticals__LLC.pdf,"April 11, 2022",Odin Pharmaceuticals  LLC,2022
FDA-2022-P-0594-0001_Stay_of_Action_Petition_from_Fish___Richardson_P__.pdf,"April 14, 2022",Fish   Richardson P,2022
FDA-2022-P-0599-0001_Citizen_Petition_from_Steven_A__Zecola___Redacted.pdf,"April 12, 2022",Steven A  Zecola   Redacted,2022
FDA-2022-P-0600-0001_Citizen_Petition_from_Daniel_Fabricant__Ph_D__on_b.pdf,"February 21, 2022",Daniel Fabricant  Ph D  on b,2022
FDA-2022-P-0602-0001_Citizen_Petition_from_Harry_Duty_REDACTED.pdf,"April 16, 2022",Harry Duty REDACTED,2022
FDA-2022-P-0614-0001_Citizen_Petition_from_Yichang_Humanwell_Pharmaceut.pdf,"April 18, 2022",Yichang Humanwell Pharmaceut,2022
FDA-2022-P-0668-0001_Citizen_Petition_from_Wanda_Brock_Redacted.pdf,"April 24, 2022",Wanda Brock Redacted,2022
FDA-2022-P-0669-0001_Citizen_Petition_from_Ronald_Brock_Redacted.pdf,"April 24, 2022",Ronald Brock Redacted,2022
FDA-2022-P-0677-0001_Citizen_Petition_from_Fatima_Khan_Redacted.pdf,"April 25, 2022",Fatima Khan Redacted,2022
FDA-2022-P-0695-0001_Citizen_Petition_from_Ronald_Brock_Redacted.pdf,"April 27, 2022",Ronald Brock Redacted,2022
FDA-2022-P-0704-0001_Citizen_Petition_from_San_Rocco_Therapeutics.pdf,"April 27, 2022",San Rocco Therapeutics,2022
FDA-2022-P-0747-0001_Suitability_Citizen_Petition_from_RegCon_Solutions.pdf,"May 5, 2022",RegCon Solutions,2022
FDA-2022-P-0754-0001_Citizen_Petition_From_Pet_Schooled.pdf,"May 07, 2022",Pet Schooled,2022
FDA-2022-P-0776-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,"May 09, 2022",Harry Duty Redacted,2022
FDA-2022-P-0777-0001_Citizen_Petition_from_Donavan_Melton_REDACTED.pdf,"May 09, 2022",Donavan Melton REDACTED,2022
FDA-2022-P-0833-0001_Citizen_Petition_from_ApicHope_Pharmaceuticals__US.pdf,"May 18, 2022",ApicHope Pharmaceuticals  US,2022
FDA-2022-P-0872-0001_Stay_of_Action_Citizen_Petition_from_SIRI___GLIMST.pdf,"May 20, 2022",SIRI   GLIMST,2022
FDA-2022-P-0896-0001_Citizen_Petition_from_Greenberg_Traurig.pdf,"May 24, 2022",Greenberg Traurig,2022
FDA-2022-P-0929-0001_Citizen_Petition_from_Alembic_Labs_LLC__USA_.pdf,5/27/22,Alembic Labs LLC  USA,2022
FDA-2022-P-0948-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"May 27, 2022",Hyman  Phelps   McNamara  P,2022
FDA-2022-P-0966-0001_Suitability_Petition_from_Nostrum_Laboratories_Inc.pdf,"June 1, 2022",Nostrum Laboratories Inc,2022
FDA-2022-P-0979-0001_Suitability_Petition_from_ArentFox_Schiff_LLP.pdf,June 3 2022,ArentFox Schiff LLP,2022
FDA-2022-P-1013-0001_Citizen_Petition_from_Medley_Pharmaceuticals_Ltd_.pdf,"June 6, 2022",Medley Pharmaceuticals Ltd,2022
FDA-2022-P-1039-0001_Citizen_Petition_from_Epic_Pharma__LLC.pdf,"June 7, 2022",Epic Pharma  LLC,2022
FDA-2022-P-1049-0001_Suitability_Citizen_Petition_from_Noble_Pharma_LLC.pdf,"June 7, 2022",Noble Pharma LLC,2022
FDA-2022-P-1060-0001_Suitability_Petition_from_The_Wood_Burditt_Group_L.pdf,"June 1,2022",The Wood Burditt Group L,2022
FDA-2022-P-1065-0001_Citizen_Petition_from_Glycan_Technologies__Inc_.pdf,"June 7, 2022",Glycan Technologies  Inc,2022
FDA-2022-P-1080-0001_Citizen_Petition_from_King_and_Spalding.pdf,"June 7, 2022",King and Spalding,2022
FDA-2022-P-1104-0001_Citizen_Petition_from_Medexus_Pharma_Inc.pdf,"June 9, 2022",Medexus Pharma Inc,2022
FDA-2022-P-1125-0001_Citizen_Petition_from_Harry_Duty_REDACTED.pdf,"June 10, 2022",Harry Duty REDACTED,2022
FDA-2022-P-1151-0001_Citizen_Petition_from_Soft_Lights_Foundation_Redac.pdf,"June 13, 2022",Soft Lights Foundation Redac,2022
FDA-2022-P-1153-0001_Suitability_Petition_Lachman_Consulting_Services__.pdf,"June 13, 2022",,2022
FDA-2022-P-1168-0001_Suitability_Petition_from_Medexus_Pharma__Inc_.pdf,"June 14, 2022",Medexus Pharma  Inc,2022
FDA-2022-P-1186-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,"June 15, 2022",Harry Duty Redacted,2022
FDA-2022-P-1211-0001_Citizen_Petition_from_American_Vapor_Manufacturers.pdf,"June 16, 2022",American Vapor Manufacturers,2022
FDA-2022-P-1248-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,"June 20, 2022",Harry Duty Redacted,2022
FDA-2022-P-1255-0001_Citizen_Petition_from_Harry_Duty_REDACTED.pdf,"June 21, 2022",Harry Duty REDACTED,2022
FDA-2022-P-1342-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,"June 24, 2022",Harry Duty Redacted,2022
FDA-2022-P-1343-0001_Citizen_Petition_from_Harry_Duty_REDACTED.pdf,"June 24, 2022",Harry Duty REDACTED,2022
FDA-2022-P-1367-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,"June 28, 2022",Harry Duty Redacted,2022
FDA-2022-P-1399-0001_Citizen_Petition_from_Siri___Glimstad_LLP.pdf,6/30/22,Siri   Glimstad LLP,2022
FDA-2022-P-1407-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,"June 30, 2022",Harry Duty Redacted,2022
FDA-2022-P-1408-0001_Citizen_Petition_from_Harry_Duty_Redacted.pdf,"June 30, 2022",Harry Duty Redacted,2022
FDA-2022-P-1409-0001_Citizen_Petition_from_Providence_St__Peter_Hospita.pdf,"June 17, 2022",Providence St  Peter Hospita,2022
FDA-2022-P-1444-0001_Citizen_Petition_National_Hemophilia_Foundation.pdf,"July 1, 2022",,2022
FDA-2022-P-1452-0001_Citizen_Petition_from_Planet_Vapor_LLC.pdf,"July 5, 2022",Planet Vapor LLC,2022
FDA-2022-P-1457-0001_Citizen_Petition_from_AOOPA_DEOLEO_and_NAOOA.pdf,"July 5, 2022",AOOPA DEOLEO and NAOOA,2022
FDA-2022-P-1471-0001_Citizen_Petition_from_J_W__Howard_Attorneys__on_be.pdf,"July 1,2022",J W  Howard Attorneys  on be,2022
FDA-2022-P-1576-0001_Citizen_Petition_from_Alliance_for_Natural_Health_.pdf,"July 15, 2022",Alliance for Natural Health,2022
FDA-2022-P-1589-0001_Citizen_Petition_from_Donavan_Melton_Redacted.pdf,"July 16, 2022",Donavan Melton Redacted,2022
FDA-2022-P-1632-0001_Citizen_Petition_from_Randall_Steinmeyer.pdf,"July 19,  2022",Randall Steinmeyer,2022
FDA-2022-P-1642-0001_Suitability_Petition_from_Noble_Pharma__LLC.pdf,"July 20, 2022",Noble Pharma  LLC,2022
FDA-2022-P-1643-0001_Citizen_Petition_from_Association_for_Truth_in_Pet.pdf,7/21/2022,Association for Truth in Pet,2022
FDA-2022-P-1656-0001_Citizen_Petition_from_Fresenius_Kabi_USA_LLC.pdf,July 2022,Fresenius Kabi USA LLC,2022
FDA-2022-P-1667-0001_Citizen_Petition_from_Chem_IQ_FZCO.pdf,7/25/22,Chem IQ FZCO,2022
FDA-2022-P-1668-0001_Citizen_Petition_from_Akin_Gump_Strauss_Hauer___Fe.pdf,"July 22, 2022",Akin Gump Strauss Hauer   Fe,2022
FDA-2022-P-1668-0012_Citizen_Petition_Supplemental_Materials_Letter_fro.pdf,"May 23, 2024",,2022
FDA-2022-P-1739-0001_Citizen_Petition_from_Fujian_Shengdi_Pharmaceutica.pdf,"July 28, 2022",Fujian Shengdi Pharmaceutica,2022
FDA-2022-P-1764-0001_Citizen_Petition_from_Charles_River_Laboratories__.pdf,"May 16, 2022",Charles River Laboratories,2022
FDA-2022-P-1785-0001_Citizen_Petition_from_Aurobindo_Pharma_USA__Inc_.pdf,"August 03, 2022",Aurobindo Pharma USA  Inc,2022
FDA-2022-P-1913-0003_Exhibits_A_through_F_re_Citizen_Petition_from_Siri.pdf,"May 17, 2021",Siri,2022
FDA-2022-P-3121-0001_Citizen_Petition_from_Karl_Guenther.pdf,12/6/22,Karl Guenther,2022
FDA-2022-P-3260-0004_Amended_Suitability_Petition_from_Noble_Pharma_LLC.pdf,,Noble Pharma LLC,2022
FDA-2023-P-0037-0001_Citizen_Petition_from_Karl_Guenther___Redacted.pdf,1/2/23,Karl Guenther   Redacted,2023
FDA-2023-P-0042-0001_Petition_for_Stay_of_Action_from_ZOLT__LLC.pdf,"December 29, 2022",ZOLT  LLC,2023
FDA-2023-P-0075-0001_Suitability_Petition_from_Mizner_Bioscience_LLC.pdf,"January 5, 2023",Mizner Bioscience LLC,2023
FDA-2023-P-0076-0001_Petition_for_Stay_of_Action_from_SMS_BZ__LLC.pdf,"December 26,2022",SMS BZ  LLC,2023
FDA-2023-P-0083-0001_Petition_for_Stay_of_Action_from_MYBAR__LLC.pdf,"December 27,2022",MYBAR  LLC,2023
FDA-2023-P-0087-0001_Petition_for_Stay_of_Action_from_Shenzhen_Yanyang_.pdf,"December 29, 2022",Shenzhen Yanyang,2023
FDA-2023-P-0092-0001_Suitability_Petition_from_Felix_Pharmaceuticals_Pv.pdf,"January 9, 2023",Felix Pharmaceuticals Pv,2023
FDA-2023-P-0101-0001_Suitability_Petition_from_Mizner_Bioscience__LLC.pdf,"January 09, 2023",Mizner Bioscience  LLC,2023
FDA-2023-P-0118-0003_Envelope_RE__Petition_for_Internal_Supervisory_Rev.pdf,1/12/23,"Thompson Hine, LLP on behalf of Freenoms, LLC",2023
FDA-2023-P-0120-0001_Citizen_Petition_from_Epic_Pharma_LLC.pdf,"January 10, 2023",Epic Pharma LLC,2023
FDA-2023-P-0127-0001_Citizen_Petition_from_Melinta_Therapeutics__LLC.pdf,"January 10, 2023",Melinta Therapeutics  LLC,2023
FDA-2023-P-0203-0001_Citizen_Petition_from_Najam_Azmat___Redacted.pdf,1/20/23,Najam Azmat   Redacted,2023
FDA-2023-P-0203-0003_Addendum_from_Najam_Azmat_RE_Citizen_Petition_from.pdf,03/08/2023,Najam Azmat RE Citizen Petition from,2023
FDA-2023-P-0232-0001_Citizen_Petition_from_Hyman__Phelps___McNamra__P_C.pdf,"January 20, 2023",Hyman  Phelps   McNamra  P C,2023
FDA-2023-P-0233-0001_Citizen_Petition_from_Soft_Lights_Foundation.pdf,"JANUARY 22, 2023",Soft Lights Foundation,2023
FDA-2023-P-0264-0001_Petition_for_Stay_of_Action_from_International_Sup.pdf,"January 18, 2023",International Sup,2023
FDA-2023-P-0265-0001_Citizen_Petition_from_Coalition_Advocating_for_Ade.pdf,"January 24, 2023",Coalition Advocating for Ade,2023
FDA-2023-P-0313-0001_Citizen_Petition_from_McDermott_Will___Emery__LLP.pdf,"January 25, 2023",McDermott Will   Emery  LLP,2023
FDA-2023-P-0342-0001_Citizen_Petition_from_Center_for_Science_in_the_Pu.pdf,"January 30, 2023",Center for Science in the Pu,2023
FDA-2023-P-0360-0001_Citizen_Petition_from_Coalition_Advocating_for_Ade.pdf,"January 31, 2023",Coalition Advocating for Ade,2023
FDA-2023-P-0362-0001_Petition_for_Stay_of_Action_from_NSTY_Worldwide_Sd.pdf,"January 25, 2023",NSTY Worldwide Sd,2023
FDA-2023-P-0422-0001_Citizen_Petition_from_Epstein_Becker___Green__P_C_.pdf,"February 6, 2023",Epstein Becker   Green  P C,2023
FDA-2023-P-0423-0001_Citizen_Petition_from_Kitchen_Concepts_Unlimited__.pdf,02/06/2023,Kitchen Concepts Unlimited,2023
FDA-2023-P-0686-0001_Petition_for_Stay_of_Action_from_Performance_Plus_.pdf,3/1/23,Performance Plus,2023
FDA-2023-P-2655-0001_Citizen_Petition_from_Epic_Pharma_LLC.pdf,"June 27, 2023",Epic Pharma LLC,2023
FDA-2023-P-2729-0001_Suitability_Petition_from_PETNET_Solutions__Inc_.pdf,"June 20, 2023",PETNET Solutions  Inc,2023
FDA-2024-P-0105-0001_Citizen_Petition_from_Graviti_Pharmaceuticals_Priv.pdf,1/5/24,Graviti Pharmaceuticals Private Limited,2024
FDA-2024-P-0109-0001_Citizen_Petition_from_Bausch_Lomb.pdf,1/8/24,Bausch+Lomb,2024
FDA-2024-P-0227-0001_Suitability_Petition_from_Zydus_Pharmaceuticals__U.pdf,"January 10, 2024",Zydus Pharmaceuticals  U,2024
FDA-2024-P-0279-0001_Stay_of_Action_Petition_from_Hyman__Phelps___McNam.pdf,1/16/24,Nautilus Gloves LLC,2024
FDA-2024-P-0422-0001_Suitablity_Petition_from_Method_Pharmaceuticals__L.pdf,"January 11, 2024",Method Pharmaceuticals  L,2024
FDA-2024-P-0422-0008_Suitability_Petition_Amendment_from_Method_Pharmac.pdf,"January 11, 2024",Method Pharmac,2024
FDA-2024-P-0422-0009_Suitability_Petition_Amendment_from_Method_Pharmac.pdf,"March 8, 2024",Method Pharmac,2024
FDA-2024-P-0425-0001_Suitability_Petition_from_RegCon_Solutions__LLC.pdf,"January 22, 2024",RegCon Solutions  LLC,2024
FDA-2024-P-0425-0006_Amended_Suitability_Petition_from_RegCon_Solutions.pdf,"February 8, 2024",RegCon Solutions,2024
FDA-2024-P-0427-0001_Suitability_Petition_from_DDReg_Pharma_Inc_.pdf,January 2024,DDReg Pharma Inc,2024
FDA-2024-P-0427-0005_Suitability_Petition_Amendment_from_DDReg_Pharma_I.pdf,February 2024,DDReg Pharma I,2024
FDA-2024-P-0435-0001_Suitability_Petition_from_Zydus_Pharmaceuticals__U.pdf,"January 22, 2024",Zydus Pharmaceuticals  U,2024
FDA-2024-P-0521-0001_Citizen_Petition_from_Kasowitz_Benson_Torres_LLP_o.pdf,1/26/24,Adventapharma Dwc Llc,2024
FDA-2024-P-0522-0001_Citizen_Petition_from_Kasowitz_Benson_Torres_LLP_o.pdf,1/26/24,Adventapharma Dwc Llc,2024
FDA-2024-P-0526-0001_Suitability_Petition_from_Lupin__Inc_.pdf,"January 26, 2024",Lupin  Inc,2024
FDA-2024-P-0545-0001_Suitability_Petition_from_HYMAN__PHELPS___MCNAMARA.pdf,"January 29, 2024",HYMAN  PHELPS   MCNAMARA,2024
FDA-2024-P-0666-0001_Petition_for_Stay_of_Action_from_Royal_Diamond_Imp.pdf,2/6/24,Royal Diamond Imports,2024
FDA-2024-P-0667-0001_Suitability_Petition_from_Lachman_Consultant_Servi.pdf,"February 5, 2024",Lachman Consultant Servi,2024
FDA-2024-P-0761-0001_Suitability_Petition_from_RegCon_Solutions_LLC.pdf,2/22/24,"Pharmobedient Consulting, Llc",2024
FDA-2024-P-0805-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,2/14/24,"Hyman, Phelps & Mcnamara, P.C.",2024
FDA-2024-P-0806-0001_Citizen_Petition_from_Center_for_Science_in_the_Pu.pdf,2/14/24,Center For Science In The Public Interest,2024
FDA-2024-P-0827-0001_Citizen_Petition_from_Aurobindo_Pharma_USA__Inc__.pdf,2/14/24,"Aurobindo Pharma Usa, Inc.,",2024
FDA-2024-P-0889-0001_Suitability_Petition_from_Aurora_Pharmaceutical__I.pdf,"February 19, 2024",Aurora Pharmaceutical  I,2024
FDA-2024-P-0973-0001_Citizen_Petition_from_Robin_Webb.pdf,2/26/24,Robin Webb,2024
FDA-2024-P-0973-0001_Citizen_Petition_from_Robin_Webb___Redacted.pdf,2/26/24,Robin Webb,2024
FDA-2024-P-1030-0001_Citizen_Petition_from_William_D__Drake___Redacted.pdf,2/29/24,William D. Drake,2024
FDA-2024-P-1058-0001_Citizen_Petition_from_Aimed_Alliance.pdf,3/1/24,Aimed Alliance,2024
FDA-2024-P-1130-0001_Citizen_Petition_from_Valisure.pdf,3/6/24,Valisure,2024
FDA-2024-P-1131-0001_Citizen_Petition_from_Fresenius_Kabi_USA__LLC.pdf,3/6/24,"Fresenius Kabi Usa, Llc",2024
FDA-2024-P-1223-0001_Citizen_Petition_from_Charles_Ludlam_Redacted.pdf,3/13/24,Charles Ludlam,2024
FDA-2024-P-1378-0001_Citizen_Petition_from_Organon_USA__LLC_Redacted.pdf,3/20/24,"Organon Usa, Llc",2024
FDA-2024-P-1379-0001_Citizen_Petition_from_Physicians_Committee_for_Res.pdf,3/20/24,Physicians Committee For Responsible Medicine,2024
FDA-2024-P-1380-0001_Citizen_Petition_from_Kohl_Harrington___Redacted.pdf,3/20/24,Kohl Harrington,2024
FDA-2024-P-1403-0001_Suitability_Petition_from_Pharmobedient_Consulting.pdf,"March 20, 2024",Pharmobedient Consulting,2024
FDA-2024-P-1440-0001_Citizen_Petition_from_pH_D_Feminine_Health__LLC.pdf,3/25/24,"Ph-D Feminine Health, Llc",2024
FDA-2024-P-1441-0001_Suitability_Petition_from_Epic_Pharma__LLC.pdf,"March 22, 2024",Epic Pharma  LLC,2024
FDA-2024-P-1441-0012_Suitability_Petition_Completeness_Assessment_Corre.pdf,"March 22, 2024",,2024
FDA-2024-P-1483-0001_Suitability_Petition_from_Hyman_Phelps_and_McNamar.pdf,"March 26, 2024",Hyman Phelps and McNamar,2024
FDA-2024-P-1483-0001_Suitability_Petition_from_Hyman__Phelps___McNamara.pdf,"March 26, 2024",Hyman Phelps and McNamar,2024
FDA-2024-P-1570-0001_Citizen_Petition_from_Bongards_Premium_Cheese.pdf,4/1/24,Bongards Premium Cheese,2024
FDA-2024-P-1570-0001_Citizen_Petition_from_Bongards_Premium_Cheese___Co.pdf,4/1/24,Bongards Premium Cheese,2024
FDA-2024-P-1570-0005_Amendment_to_Citizen_Petition_from_Bongards_Premiu.pdf,"October 17,2024",Bongards Premiu,2024
FDA-2024-P-1715-0001_Citizen_Petition_from_AbbVie_Inc_.pdf,4/5/24,Abbvie Inc.,2024
FDA-2024-P-1716-0001_Suitability_Petition_from_Aurora_Pharmaceutical__I.pdf,April 2024,Aurora Pharmaceutical  I,2024
FDA-2024-P-1717-0001_Citizen_Petition_from_Kohl_Harrington_Redacted.pdf,4/5/24,Kohl Harrington,2024
FDA-2024-P-1788-0001_Suitability_Petition_from_Pharmobedient_Consulting.pdf,"April 10, 2024",Pharmobedient Consulting,2024
FDA-2024-P-1810-0001_Suitability_Petition_from_Pharmobedient_Consulting.pdf,"April 10, 2024",Pharmobedient Consulting,2024
FDA-2024-P-1870-0001_Suitability_Petition_from_Newcastle_Bioscience__LL.pdf,"April 15, 2024",Newcastle Bioscience  LL,2024
FDA-2024-P-1871-0001_Citizen_Petition_from_Advanced_Accelerator_Applica.pdf,"April 12, 2024",Advanced Accelerator Applica,2024
FDA-2024-P-1913-0001_Citizen_Petition_from_Amivas__Inc_.pdf,April 2024,Amivas  Inc,2024
FDA-2024-P-1913-0001_Suitability_Petition_from_Amivas__Inc_.pdf,April 2024,Amivas  Inc,2024
FDA-2024-P-1916-0001_Citizen_Petition_from_Association_for_Truth_in_Pet.pdf,4/18/24,Association For Truth In Pet Food,2024
FDA-2024-P-1937-0001_Citizen_Petition_from_Kohl_Harrington_Redacted.pdf,"April 18, 2024",Kohl Harrington Redacted,2024
FDA-2024-P-1960-0001_Citizen_Petition_from_Kohl_Harrington_Redacted.pdf,"April 20, 2024",Kohl Harrington Redacted,2024
FDA-2024-P-1988-0001_Citizen_Petition_from_HealthyWomen.pdf,"April 22, 2024",HealthyWomen,2024
FDA-2024-P-2084-0001_Citizen_Petition_from_People_for_the_Ethical_Treat.pdf,"April 25, 2024",People for the Ethical Treat,2024
FDA-2024-P-2085-0001_Suitability_Petition_from_Hospira__Inc_.pdf,"April 26, 2024",Hospira  Inc,2024
FDA-2024-P-2148-0001_Citizen_Petition_from_Nese_Devenot_Redacted.pdf,June 2024,Nese Devenot Redacted,2024
FDA-2024-P-2151-0001_Citizen_Petition_from_UnidosUS.pdf,"May 7, 2024",UnidosUS,2024
FDA-2024-P-2215-0001_Citizen_Petition_from_Metaltronica_Spa.pdf,"October 28, 2024",Metaltronica Spa,2024
FDA-2024-P-2220-0001_Citizen_Petition_from_Encube_Ethicals_Private_Limi.pdf,"May 06, 2024",Encube Ethicals Private Limi,2024
FDA-2024-P-2242-0001_Citizen_Petition_from_David_Behar_Redacted.pdf,"April 28, 2024",David Behar Redacted,2024
FDA-2024-P-2272-0001_Citizen_Petition_from_Aurobindo_Pharma_USA__Inc_.pdf,"May 07, 2024",Aurobindo Pharma USA  Inc,2024
FDA-2024-P-2314-0001_Citizen_Petition_from_Aurobindo_Pharma_USA_Inc_.pdf,"May 09, 2024",Aurobindo Pharma USA  Inc,2024
FDA-2024-P-2314-0001_Citizen_Petition_from_Aurobindo_Pharma_USA__Inc_.pdf,"May 09, 2024",Aurobindo Pharma USA  Inc,2024
FDA-2024-P-2326-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"May 10, 2024",Hyman  Phelps   McNamara  P,2024
FDA-2024-P-2379-0001_Citizen_Petition_from_The_Humane_Society_of_the_Un.pdf,"May 15, 2024",The Humane Society of the Un,2024
FDA-2024-P-2461-0001_Citizen_Petition_from_Ho_Chunk__Inc__on_behalf_of_.pdf,"May 17, 2024",Ho Chunk  Inc  on behalf of,2024
FDA-2024-P-2482-0001_Citizen_Petition_from_Age_Reversal_Unity.pdf,05/07/2024,Age Reversal Unity,2024
FDA-2024-P-2513-0001_Citizen_Petition_from_Innogenix_LLC.pdf,"May 21, 2024",Innogenix  LLC,2024
FDA-2024-P-2513-0001_Citizen_Petition_from_Innogenix__LLC.pdf,"May 21, 2024",Innogenix  LLC,2024
FDA-2024-P-2514-0001_Citizen_Petition_from_Zydus_Pharmaceuticals__USA__.pdf,"May 22, 2024",Zydus Pharmaceuticals  USA,2024
FDA-2024-P-2515-0001_Citizen_Petition_from_Encube_Ethicals_Private_Limi.pdf,"May 22, 2024",Encube Ethicals Private Limi,2024
FDA-2024-P-2538-0001_Suitability_Petition_from_Hyman__Phelps___McNamara.pdf,"May 23, 2024",Hyman  Phelps   McNamara,2024
FDA-2024-P-2730-0001_Citizen_Petition_from_Kenneth_D__Eichenbaum.pdf,"June 2, 2024",Kenneth D  Eichenbaum,2024
FDA-2024-P-2752-0001_Suitability_Petition_from_Hyman__Phelps___McNamara.pdf,"June 6, 2024",Hyman  Phelps   McNamara,2024
FDA-2024-P-2753-0001_Suitability_Petition_from_Hyman__Phelps___McNamara.pdf,"June 6, 2024",Hyman  Phelps   McNamara,2024
FDA-2024-P-2757-0001_Suitability_Petition_from_Hyman__Phelps___McNamara.pdf,"June 6, 2024",Hyman  Phelps   McNamara,2024
FDA-2024-P-2758-0001_Suitability_Petition_from_Hyman__Phelps___McNamara.pdf,"June 6, 2024",Hyman  Phelps   McNamara,2024
FDA-2024-P-2778-0001_Suitability_Petition_from_Pharmobedient_Consulting.pdf,"June 07, 2024",Pharmobedient Consulting,2024
FDA-2024-P-2778-0007_Suitability_Petition_Amendment_from_Pharmobedient_.pdf,"June 28, 2024",Pharmobedient,2024
FDA-2024-P-2779-0001_Suitability_Petition_from_Hyman__Phelps___McNamara.pdf,"June 10, 2024",Hyman  Phelps   McNamara,2024
FDA-2024-P-2779-0010_Amendment_for_Suitability_Petition_from_Hyman__Phe.pdf,"June 10, 2024",Hyman  Phe,2024
FDA-2024-P-2843-0001_Citizen_Petition_from_Zach_Richardson_Redacted.pdf,,Zach Richardson Redacted,2024
FDA-2024-P-2846-0001_Petition_for_Reclassification_from_Pyrexar_Medical.pdf,"October 28, 2024",Pyrexar Medical,2024
FDA-2024-P-2846-0003_Petition_for_Reclassification_from_Pyrexar_Medical.pdf,"October 28, 2024",Pyrexar Medical,2024
FDA-2024-P-2885-0001_Suitability_Petition_from_Hyman__Phelps___McNamara.pdf,"June 17, 2024",Hyman  Phelps   McNamara,2024
FDA-2024-P-2909-0001_Suitability_Petition_from_Hyman__Phelps___McNamara.pdf,"June 17, 2024",Hyman  Phelps   McNamara,2024
FDA-2024-P-2932-0001_Suitability_Petition_from_Newcastle_Bioscience_LLC.pdf,"June 19, 2024",Newcastle Bioscience LLC,2024
FDA-2024-P-2933-0001_Citizen_Petition_from_Chobani_LLC.pdf,"June 18, 2024",Chobani LLC,2024
FDA-2024-P-2952-0001_Citizen_Petition_from_Sarah_A__Norring___Redacted.pdf,"June 20, 2024",Sarah A  Norring   Redacted,2024
FDA-2024-P-2955-0001_Citizen_Petition_from_Dsquare_LLC.pdf,"June 18, 2024",Dsquare LLC,2024
FDA-2024-P-3090-0001_Suitability_Petition_from_Epic_Pharma__LLC__on_beh.pdf,"June 28, 2024",Epic Pharma  LLC  on beh,2024
FDA-2024-P-3188-0001_Suitability_Petition_from_Lachman_Consulting_Servi.pdf,"July 3, 2024",Lachman Consulting Servi,2024
FDA-2024-P-3292-0001_Suitability_Petition_from_Felix_Pharmaceuticals_Pv.pdf,"July 10, 2024",Felix Pharmaceuticals Pv,2024
FDA-2024-P-3292-0005_Suitability_Petition_Amendment_from_Felix_Pharmace.pdf,"July 10, 2024",Felix Pharmace,2024
FDA-2024-P-3292-0009_Suitability_Petition_Amendment_from_Felix_Pharmace.pdf,"July 10, 2024",Felix Pharmace,2024
FDA-2024-P-3293-0001_Suitability_Petition_from_Newcastle_Bioscience_LLC.pdf,7/9/24,Newcastle Bioscience LLC,2024
FDA-2024-P-3293-0009_Suitability_Petition_Amendment_from_Newcastle_Bios.pdf,7/31/24,Newcastle Bios,2024
FDA-2024-P-3357-0001_Citizen_Petition_from_Randall_Steinmeyer___Redacte.pdf,June 2024,Randall Steinmeyer   Redacte,2024
FDA-2024-P-3479-0001_Citizen_Petition_from_Jingwei_Pharmaceutical_Compa.pdf,"July 23, 2024",Jingwei Pharmaceutical Compa,2024
FDA-2024-P-3482-0001_Citizen_Petition_from_Qilu_Pharmaceutical__Hainan_.pdf,July 24 2024,Qilu Pharmaceutical  Hainan,2024
FDA-2024-P-3484-0001_Petition_for_Reclassification_of_next_generation_s.pdf,"June 28, 2024",,2024
FDA-2024-P-3563-0001_Citizen_Petition_from_Hyman__Phelps___McNamara__P_.pdf,"July 29, 2024",Hyman  Phelps   McNamara  P,2024
FDA-2024-P-3567-0001_Suitability_Petition_from_Lachman_Consulting_Servi.pdf,"July 25, 2024",Lachman Consulting Servi,2024
FDA-2024-P-3571-0001_Suitability_Petition_from_Premier_Consulting.pdf,"July 29, 2024",Premier Consulting,2024
FDA-2024-P-3571-0007_Amendment_to_Suitability_Petition_from_Premier_Con.pdf,"July 29, 2024",Premier Con,2024
FDA-2024-P-3571-0008_Amendment_to_Suitability_Petition_from_Premier_Con.pdf,"November 28, 2024",Premier Con,2024
FDA-2024-P-3573-0001_Suitability_Petition_from_Premier_Consulting.pdf,"July 29, 2024",Premier Consulting,2024
FDA-2024-P-3573-0004_Suitability_Petition_Amendment_from_Premier_Consul.pdf,"November 28, 2024",Premier Consul,2024
FDA-2024-P-3699-0001_Citizen_Petition_from_Zydus_Pharmaceuticals__USA__.pdf,"August 2, 2024",Zydus Pharmaceuticals  USA,2024
FDA-2024-P-3761-0001_Citizen_Petition_from_Spark_Biomedical__Inc_.pdf,"July 31, 2024",Spark Biomedical  Inc,2024
FDA-2024-P-3799-0001_Citizen_Petition_from_Raaha_LLC.pdf,"June 2, 2024",Raaha LLC,2024
FDA-2024-P-3820-0001_Citizen_Petition_from_Vanguard_Regulatory_Services.pdf,"August 9, 2024",Vanguard Regulatory Services,2024
FDA-2024-P-3821-0001_Cover_Letter_for_Suitability_Petition_from_Aurora_.pdf,"August 08, 2024",Aurora,2024
FDA-2024-P-3822-0001_Citizen_Petition_from_University_of_Illinois__Coll.pdf,August 2024,University of Illinois  Coll,2024
FDA-2024-P-3881-0001_Suitability_Petition_from_Zydus_Pharmaceuticals__U.pdf,"August 13, 2024",Zydus Pharmaceuticals  U,2024
FDA-2024-P-3905-0001_Suitability_Petition_from_Lachman_Consulting_Servi.pdf,"August 15, 2024",Lachman Consulting Servi,2024
FDA-2024-P-3997-0001_Citizen_Petition_from_Aylstock__Witkin__Kreis___Ov.pdf,"August 20, 2024",Aylstock  Witkin  Kreis   Ov,2024
FDA-2024-P-4015-0001_Citizen_Petition_from_Kohl_Harrington_Redacted.pdf,"August 22, 2024",Kohl Harrington Redacted,2024
FDA-2024-P-4126-0001_Suitability_Petition_from_Aurora_Pharmaceutical__I.pdf,August 2024,Aurora Pharmaceutical  I,2024
FDA-2024-P-4134-0001_Suitability_Petition_from_Pharmobedient_Consulting.pdf,"August 24, 2024",Pharmobedient Consulting,2024
FDA-2024-P-4134-0010_Suitability_Petition_for_Reconsideration_from_Phar.pdf,"March 18, 2025",Phar,2024
FDA-2024-P-4135-0001_Suitability_Petition_from_Fresenius_Kabi_USA__LLC.pdf,August 2024,Fresenius Kabi USA  LLC,2024
